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Abstract 
 
A strong body of observational evidence supports the notion that physical activity 
(PA) is inversely associated with colon cancer (CC) risk. Epigenetic alterations, such 
as aberrant DNA methylation, are apparent in the early stages of carcinogenesis. 
Recent evidence has suggested that PA can alter DNA methylation patterns in a 
variety of tissues. It is not known whether PA can affect DNA methylation patterns in 
genes implicated in CC risk. Study 1 was a longitudinal investigation of 253 females 
(70.7 ± 4.0 yrs) and 137 males (71.4 ± 4.3 yrs) for whom DNA from peripheral blood 
leukocytes were available. Participants showed differential DNA methylation of 
relevant genes depending on whether they had increased, decreased, or maintained 
their PA level over eight years. Study 2 was a randomised controlled trial of sedentary 
colon adenoma patients (n = 31; 68.5 ± 3.2 yrs) who were randomised to a 6-12 
month Active Lifestyle Programme or Usual Care. DNA methylation patterns of CC 
risk genes in buccal cells were unaffected by taking part in the Active Lifestyle 
Programme. Low recruitment probably resulted in the study being underpowered, and 
buccal cells may not have been a suitable surrogate marker of colon DNA 
methylation. A lack of colon biopsies prevented any analysis of changes in 
methylation in this tissue. Due to the absence of colon biopsies, Study 3 tested 
whether serum from physically active or inactive volunteers affected the proliferation 
of in vitro models of colon epithelia, in the fasted state and after a single bout of 
treadmill running. A randomised controlled trial with a crossover design was 
conducted in 20 male participants (59 ± 6.0 yrs) free of metabolic or cardiovascular 
disease, and data pooled together with 20 male colon adenoma patients from the 
previous investigation. This study showed that male adenoma patients’ 
cardiorespiratory fitness was inversely correlated with serum-stimulated growth of the 
colorectal cancer cell line Caco-2 in vitro, but no relationship was observed in 
disease-free volunteers at rest or after exercise. In conclusion, this series of studies 
demonstrated that whilst PA is associated with beneficial changes in DNA methylation 
longitudinally, this might not be realised in a trial setting with sedentary older persons. 
It remains unclear whether increasing PA is an effective strategy for reducing CC risk 
via changes to DNA methylation patterns. Furthermore, it has suggested that 
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cardiorespiratory fitness might be important in modulating the growth of the Caco-2 
cell line, but more investigation is needed.  
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Chapter 1 
 
Review of Literature 
 
1.1 Aetiology of colon cancer 
 
Cancer is characterised by unchecked cell growth, including, but not limited to, 
inhibition of programmed cell death (apoptosis) and acceleration of cellular 
proliferation. In the UK, approximately two thirds of colorectal cancers (CRC) are 
colon cancer (CC) (CRUK, 2015). Colon cancer (CC) is a progressive, non-
communicable disease affecting the large colon, and the third most common form of 
cancer in the United Kingdom. Over 90% of cases occur in individuals over the age of 
50, with two thirds of these being in men. There are three principal methods of 
determining the severity of the disease in the clinical setting: Duke’s stage (A-D), 
TNM (tumour, node, metastasis) and Stage (0 – IV). Briefly, a cancer at stage 0-1 is 
contained within the colon. A Stage II tumour has penetrated the outer lining and 
perhaps spread to other nearby tissue. At Stage III, the morphology of the tumour may 
be similar to 0 – II, but it has spread to regional lymph nodes. Finally, stage IV 
tumours have metastasized to other organs via the lymph or circulatory system, which 
leads to organ failure and ultimately death. The chances of survival are inversely 
correlated to the stage, so early diagnosis and treatment improves patient outcomes.  
CC in the absence of a known hereditary cancer syndrome, accounts for > 
90% of cases (Watson and Collins, 2011; Weitz et al., 2005). The age of onset is 
usually 60 years and above and although lacking a definitive inherited component, it 
is estimated that > 20% of CC cases are related to family history (de la Chapelle, 
2004; Weitz et al., 2005). Its aetiology broadly follows the adenoma-carcinoma 
sequence model described by Fearon & Vogelstein, whereby mutations can inactivate 
tumour suppressor genes and concurrently activate oncogenes associated with tumour 
development (Fearon and Vogelstein, 1990). This can lead to the formation of benign 
abnormal tissue, known as an adenoma. Adenomas usually take the form of polyps 
(small extrusions on the lining of the large intestine) which can eventually become 
cancerous should somatic mutations continue to accumulate (Figure 1.1) (Fearon, 
Chapter 1 Review of Literature 
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2011). The adenomatous polyp is a physical indicator of deregulated cell growth, 
differentiation and apoptosis in the early stages of CC (Figure 1.1).  
 
 
Figure 1.1 Transition from normal epithelium to cancer via the ‘classic’ sequence 
model and some of the common molecular perturbations at each stage. 
 
1.2 Global incidence of colorectal cancer 
 
In developed countries, colorectal cancer (CRC) is estimated to be the third most 
prevalent by absolute incidence in males and females combined, accounting for 
approximately 727,400 new cases and 320,100 deaths in 2008 (Jemal et al., 2011). 
Globally, its incidence and mortality is markedly higher in males than females, 
although this varies by region (Center et al., 2009b). Alarmingly, the incidence of 
these cancers appears to be increasing in several countries with developing 
economies, notably in Eastern Europe and South East Asia (Center et al., 2009b). For 
example, CRC incidence in Slovakia per 100,000 persons has increased by 54% and 
31% in males and females, respectively, between the periods of 1983-87 to 1998-2002 
(Center et al., 2009b). This is reflected in mortality rates from such regions, with 
seven of the ten countries with the highest CRC mortality rates as of 2005 being 
located in Central and Eastern Europe (Center et al., 2009a). Mortality from the 
disease has decreased or stabilised in developed economies such as the United States 
(Edwards et al., 2010), UK, and Japan. For instance, mortality in Japan has decreased 
1) Normal epithelium 2) Aberrant crypt foci  
APC mutation 
3) Small adenoma 
COX-2 overexpression 
4) Large adenoma 
K-Ras activation 
MMR gene silencing 
5) Cancer 
p53 mutation 
DCC mutation  
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year-on-year by 0.9% and 5% in males and females, respectively, from 1996 – 2005 
(Center et al., 2009a), despite incidence in the northern Miyagi and Yamagata 
prefectures increasing two-fold in men and by approximately half in women between 
the years 1983 – 2002 (Center et al., 2009b). This might reflect improving treatment 
and/or detection of CRC in economically developed nations; many of whom have 
national bowel cancer screening programmes in place (Center et al., 2009a). The same 
cannot be said of some developing countries, particularly in Eastern Europe, where 
the increase in CRC incidence over the last three decades is associated with increased 
mortality.  
Rates of CRC are typically low in less industrialised world regions, and are 
highest in developed and transitional economies. It has been observed that migrants to 
Western nations typically adopt the CRC risk profile of the host country (Key et al., 
2002). As a case in point, Japanese migrants to the western United States – whilst 
initially maintaining a similar risk of CRC mortality as their nation of birth (Haenszel 
and Kurihara, 1968) – adopted the risk profile of the resident white population within 
two generations (Shimizu et al., 1987), and even exceeded the risk of the latter (Flood 
et al., 2000). Furthermore, > 90% of CRC cases occur in the absence of a known 
heritable disease (Watson and Collins, 2011; Weitz et al., 2005). Thus, it has been 
postulated that CRC is a disease of ‘Westernisation’ (Watson and Collins, 2011). That 
is, aspects of a ‘Western’ lifestyle e.g. increased life expectancy, smoking, and diet 
composed of surplus energy, meat and processed foods and deficient in fruit, fibre and 
vegetables, and a lack of physical activity (PA) contribute to the incidence of CRC.  
 
1.3 Colon cancer risk factors 
 
1.3.1 Age 
 
Advancing age is the single biggest risk factor for CRC and CC (Armitage and Doll, 
1954). The authors predicted that this was due to a sequential change in cell 
phenotype in response to chronic stimuli some 36 years before Fearon and Vogelstein 
published their adenoma-carcinoma sequence model (Fearon and Vogelstein, 1990) 
Indeed, CC was responsible for 8248 deaths in England and Wales in 2010, of which 
95% were in persons aged 60 or over (ONS, 2011). This, in part, is due to the 
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increased probability of replicating cells acquiring a mutation over time (Kelly, 2012). 
Lifestyle factors appear to be able to influence this rate of acquisition, which in turn 
alter risk. 
1.3.2 Smoking 
 
Whilst strongly implicated in a host of cancers, particularly lung and nasopharyngeal, 
its relationship with CRC is less straightforward. A recent meta-analysis reported that 
current or former smokers, compared with those who have never smoked, were 18% 
more likely to develop CRC. In addition, the likelihood of developing CRC 
accumulated by 9.5% per 10 years of smoking, which posed a statistically significant 
risk after 30 years (Botteri et al., 2008a) Moreover, another meta-analysis from the 
same group reported that current smokers were more than twice as likely to develop 
adenomatous polyps (the pre-cancerous lesion underpinning the majority of CRC 
cases), than never-smokers (Botteri et al., 2008b). One explanation for an increase in 
risk is a greater prevalence of smoking in developed nations. 
1.3.3 Gender 
 
Men are at greater risk than women for contracting CRC (Watson and Collins, 2011). 
The mechanisms by which this occurs are not known, however, it has been observed 
that peak incidence rates in developed countries amongst women is delayed by 4-8 
years compared with men (Brenner et al., 2007a). The author suggests that this could 
be related to the onset of menopause, as age-matched premenopausal women are at 
reduced risk for CC than postmenopausal women (Franceschi et al., 2000b). 
Furthermore, risk behaviours for CC are more frequent amongst men than women, 
such as obesity and/or abdominal adiposity, higher alcohol intake, higher red meat 
consumption and smoking (Johnson et al., 2013).     
1.3.4 Anthropometry 
 
Five meta-analyses of body mass index (BMI) and CC incidence and mortality have 
indicated that there is strong association between increasing BMI and disease risk, 
particularly in men (Dai et al., 2007; Harriss et al., 2009b; Larsson and Wolk, 2007; 
Moghaddam et al., 2007; Ning et al., 2010). The latest of these reported pooled data 
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from 56 studies of BMI and CRC, and the authors surmised that there is an 18% 
increase in risk with every 5 kg/m² increment in BMI. The risk increase amounted to 
41% in obese individuals (BMI ≥ 30 kg/m²) (Ning et al., 2010). Given that the 
correlation between rectal cancer and BMI is less strong than for CC (Larsson and 
Wolk, 2007; Ning et al., 2010) it might be that these alarming estimations are too 
conservative for CC alone. Indeed, other reviewers have calculated that the 
incremental risk per 5 kg/m² for CC specifically is 30% and 12% for males and 
females, respectively (Larsson and Wolk, 2007). However, it is possible that the effect 
of BMI might have been overestimated due to the tendency to understate BMI in self-
report measures, and many of the cohort studies included for analysis by Larsson & 
Wolk (2007) employed this technique (Larsson and Wolk, 2007). Waist circumference 
and waist-hip ratio, as proxy measures of visceral adiposity, are considered stronger 
risk factors for CC than BMI (Pischon et al., 2006). Per added inch of waist 
circumference, RR increases by 0.04 (0.01-0.07), and a 0.1 point increment in waist-
hip ratio is associated with a RR increase of 0.27 (0.15-0.41) (World Cancer Research 
Fund/American Insitute of Cancer Research; WCRF/AICR, 2011). In addition, there 
is compelling evidence emerging for obesity increasing risk of the precursor for CC, 
colon adenomas (Omata et al., 2013), particularly in obese, white men (Comstock et 
al., 2014a).  
1.3.5 Diet 
 
The foods considered most likely to increase risk of CC are red and processed meat 
and alcohol (WCRF/AICR, 2011). Indeed, according to the WCRF/AICR Systematic 
Literature Review Continuous Update Project Report, a dose-response relationship is 
observed for processed meat (Risk Ratio (RR) = 1.24 per 50 g/day consumed), red 
meat (RR = 1.17 per 100 g/day) and alcohol (RR = 1.11 per drink/day) (WCRF/AICR, 
2011). The mechanisms by which this might occur are beyond the scope of this 
review, but briefly it is posited that higher red and processed meats consumption 
might encourage neoplasia through the pro-carcinogenic effects of heterocyclic 
amines, and through DNA and tissue damage by surplus iron and N-nitroso compound 
formation (for review, see Lund et al., 2011b).  
Conversely, the foodstuffs with the most evidence of decreasing risk are 
dietary fibre, garlic, milk and calcium (WCRF/AICR, 2011: Table 2.1). However, it is 
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apparent that studies into the effects of isolated dietary constituents on risk have not 
attempted to account for the confounding effects of obesity and physical activity (or 
lack thereof). Hence, it is difficult to extricate the risk posed by, for example, meat 
consumption alone (Alexander et al., 2011; Huxley et al., 2009). This is a common 
problem across the cohort studies included in the WCRF/AICR Expert Report for a 
variety of foods. Interestingly, some inverse associations between physical activity 
and CC risk appear not to be confounded by diet (Slattery and Potter, 2002) 
Importantly, the authors observed that a ‘high risk’ diet was associated with the 
greatest relative risk increase in sedentary persons (Slattery and Potter, 2002). This 
suggests that the relative importance of dietary risk factors is tempered by physical 
activity.  
 
Table 1.1 Lifestyle factors associated with risk of colon cancer (adapted from 
WCRF/AICR, 2011). 
 
Level of evidence Lifestyle factors associated with risk of colon cancer 
 
Convincing 
 
 
 
Probable 
 
Limited-suggestive 
 
Increases risk: 
Smoking, alcohol drinks (men), red 
and processed meat, abdominal 
fatness, obesity 
 
Alcoholic drinks (women) 
 
Foods containing iron, cheese, foods 
containing animal fats, foods 
containing sugars 
Decreases risk: 
Physical activity, 
dietary fibre 
 
 
Garlic, milk 
 
Non-starchy 
vegetables, fruits, 
foods containing 
Vitamin D  
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1.3.6 Physical activity 
 
1.3.6.1 Epidemiological studies 
 
The first investigation to propose a link between PA and cases of CC was conducted 
by Garabrant and colleagues, who discovered that the disease tended to afflict men in 
long-term sedentary jobs. From the findings, they calculated that such individuals, 
irrespective of ethnicity and socioeconomic status, had 1.6 times the risk of peers in 
labour-intensive occupations (Garabrant et al., 1984). Subsequent observational 
studies found similar associations between occupational PA (Brownson et al., 1989; 
Vena et al., 1985) and total PA (Albanes et al., 1989; Fredriksson et al., 1989; 
Gerhardsson et al., 1988; Severson et al., 1989; Slattery et al., 1988; Wu et al., 1987).  
Since then, many more studies have been produced in the field, and a host of 
systematic reviews have supported the association between PA and reduced risk of CC 
(Friedenreich et al., 2010a; Kushi et al., 2006; Samad et al., 2005; Slattery, 2004); 
although the strength of this relationship has been disputed by others (Harriss et al., 
2009a; Spence et al., 2009). Indeed, the work of Harriss and colleagues only included 
those studies that collected leisure-time PA data before a cancer diagnosis, thereby 
reducing the impact of recall bias. Whilst it still indicated that leisure-time PA shows a 
modest inverse association with CC, it suggested that PA interventions targeting 
leisure-time PA are unlikely to bring about CC risk reduction owing to the modesty of 
the relationship (Harris et al., 2009a). Similarly, in a systematic review of cohort 
studies the latter group found that despite a non-linear trend between CC risk and PA, 
it did not amount to a substantial association (Spence et al., 2009).  
A meta-analysis of case-control and cohort studies published after the 
pioneering work of Garabrant et al. (1984) estimated that persons participating in the 
greatest volume and duration of PA had a 24% decrease in CC risk, compared with 
those engaging in the least amount on average per study (Wolin et al., 2009). 
However, it should be noted that the definition of ‘greatest’ and ‘least’ PA was 
different across studies, and that the 24% average might not be an adequate reflection 
of the state of any relationship. Currently, the most recent WCRF/AICR continuous 
update report states that the evidence is ‘convincing’ that increased lifetime PA is 
inversely associated with CC risk, (WCRF/AICR, 2011).  
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1.3.6.2 Intervention studies 
 
1.3.6.2.1 Rodent models 
 
In male Wistar or Fischer 344 rats treated with a cancer-causing agent 
(dimethylhydrazine (DMH) or azoxymethane (AOM)) numerous modes of regular (> 
4 d/wk) exercise training resulted in consistently reduced indices of cancer 
progression i.e. colonic tumour size, multiplicity, and pre-cancerous lesions 
(Andrianopoulos et al., 1987; Demarzo et al., 2008; Fuku et al., 2007; Lunz et al., 
2008; Thorling et al., 1994). On the other hand, results have been less consistent in 
the Adenomatous Polyposis Coli with Multiple intestinal neoplasia (APCMin) mouse, 
which mimics the symptoms of familial adenomatous polyposis (FAP; see 2.3 
Aetiology of Colon Cancer) in humans, and seem to be affected by gender, mode of 
exercise, energy balance and diet composition (Baltgalvis et al., 2009; Basterfield and 
Mathers, 2010; Colbert et al., 2000; Colbert et al., 2003; Colbert et al., 2006; Ju et al., 
2008; McClellan et al., 2014; Mehl et al., 2005). Arguably the most consistent finding 
in this mouse model is that exercise training might reduce the number of large polyps 
in male APCMin mice.  
Although these lend support to the current paradigm of PA and exercise having 
a preventative effect against CC, the applicability of these models to an aged human is 
questionable. Indeed, the use of highly pernicious carcinogens in young rats 
(Andrianopoulos et al., 1987; Demarzo et al., 2008; Fuku et al., 2007; Lunz et al., 
2008; Thorling et al., 1994) and mice (Aoi et al., 2010; Ju et al., 2008) is probably not 
reflective of the protracted time course of CC development in humans. In addition, to 
the best of the author’s knowledge, all of the investigations which successfully 
reduced the number of colon tumours in rats also reduced body fat in the exercisers 
(Andrianopoulos et al., 1987; Demarzo et al., 2008; Fuku et al., 2007; Thorling et al., 
1994). This confounds any insight into the role of exercise alone, since increased body 
fat is independently associated with CC and adenoma risk in humans (Comstock et 
al., 2014a; Ning et al., 2010; Omata et al., 2013). Also, the aforementioned rat studies 
utilised wheel/treadmill running for a minimum of 2 km or 60 min per day on 5 days 
per week. It is not clear whether the biological impact of such extreme levels of 
exercise in rodents would be equivocal in humans who perform sufficient activity for 
maintenance of health. 
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1.3.6.2.2 Human intervention studies 
 
The mechanisms through which PA might exert these effects upon risk, in both rodent 
models and in humans, are not clear. In the main, there has been a focus on circulating 
growth factors, sex hormones and chronic inflammation, which have been associated 
with cancer risk with varying degrees of evidence (Friedenreich et al., 2010a). What 
is also not clear is whether an increase in PA or fitness in sedentary individuals affects 
risk. To date, only one randomised controlled trial has investigated whether an 
increase in PA affects any biological markers associated with risk. Amongst the 
findings, sedentary male polyp patients who increased their levels of moderate to 
vigorous PA (MVPA) to ≥ 250 min/wk or their cardiorespiratory fitness (CRF) by ≥ 
5% through a 12 month exercise training programme displayed reduced proliferation 
of colon crypt cells (McTiernan et al., 2006), and a more ‘pro-apoptotic’ protein 
profile in crypt bases (Campbell et al., 2007). This suggests that an increase in PA 
reduces crypt cell growth (particularly in men), which might reduce the likelihood of 
a polyp forming. However, no data were published pertaining to any genetic or 
epigenetic effects in the crypts that could underlie the findings. Indeed, it has been 
known for decades that CC progression is fundamentally fuelled by molecular 
changes (Fearon and Vogelstein, 1990).  
 
1.4 The molecular features of colon cancer 
 
Whilst the majority of CC cases do not have purely genetic causes, it is important to 
acknowledge that the somatic mutations observed in colorectal tumours are often 
mirrored in hereditary cases. Indeed, the two most common types of hereditary CC, 
familial adenomatous polyposis (FAP) and hereditary nonpolyposis CRC 
(HNPCC/Lynch syndrome) share common genetic features with non-hereditary cases. 
> 90% of FAP is caused by germ-line (i.e. in sperm or egg cells) autosomal mutations 
on the adenomatous polyposis coli (APC) tumour suppressor gene (TSG). These are 
overwhelmingly attributed to frameshift mutations (atypical nucleotide insertions or 
deletions on the APC DNA sequence, altering the eventual amino acid formed and 
subsequent amino acids produced) or nonsense mutations (premature appearance of a 
stop codon on the DNA sequence, preventing full transcription), which result in non-
functioning or truncated protein production (Fearon, 2011). Although not causing 
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carcinoma per se, it dramatically increases the appearance of benign colon polyps in 
afflicted individuals. These adenomatous growths occasionally become cancerous 
with additional mutations – as per the progression of sporadic CC – but such is the 
extreme number of polyps (> 100 by middle age, often thousands) the likelihood of 
untreated FAP patients developing CC increases indefinitely with age (Fearon, 2011). 
At present, prophylactic removal of the colon is the only treatment option to prevent 
CC.  
On the other hand, HNPCC does not cause an abnormal production of polyps 
as seen in FAP. Rather, once an adenoma has formed, its progression to a carcinoma 
can be rapid. Indeed, the timescale for the ‘classic’ sporadic adenoma-carcinoma 
sequence described by Fearon & Vogelstein (Fearon and Vogelstein, 1990) is between 
20 – 40 years; whereas in HNPCC this can be as little as 3-5 years (Fearon, 2011). 
This explains why the age of onset of HNPCC is significantly earlier than sporadic 
CC i.e. by ten years or more. The molecular basis of HNPCC is proposed to be due to 
germ-line mutations in DNA mismatch repair (MMR) genes, for example MSH2 and 
MLH1. Consequently, the proteins produced by these genes are less able to recognise 
mismatch errors at microsatellite repeats on the genome, resulting in increased 
copying errors in daughter strands. This is known as microsatellite instability (MSI). 
Although there is no loss of heterozygosity (LOH), the unaffected allele can be 
inactivated by somatic (i.e. not in germ-line cells) mutations or epigenetic changes. 
Once this occurs, the accumulation of mutations in TSGs can be markedly faster than 
sporadic CC. These cancers are often associated with secondary carcinomas in other 
regions (e.g. endometrium and stomach), multiple CRCs at surgery (synchronous 
cancer), and tendency for development of a consecutive CRC unrelated to the initial 
lesions (metachronous cancer) after 6 months of surgery (Lynch and de la Chapelle, 
2003). Typically, these cancers arise in individuals aged 40-50 years, and together 
they account for approximately 5 – 10% of CC cases (Lynch and de la Chapelle, 
2003). A small fraction of hereditary CC is attributed to related syndromes, such as 
Gardner syndrome, Turcot’s syndrome, and Cowden disease (Fearon, 2011).  
There are other genotypic aberrations that occur in somatic incidences of the 
disease, as evidenced by cell lines that have been harvested and cultured from 
individual cancer patients. These specimens are used for in vitro research, and have 
been especially useful in the absence of being able to reliably obtain colon tissue. 
Each has a number of shared and different molecular features, which highlights the 
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heterogeneity of the disease. Some of these commonly used in our laboratory are 
summarised in Table 1.2.   
 
Table 1.2 Cell lines commonly used in laboratory setting with common mutations and 
molecular phenotypes. Key: wt = wild type; mt = mutant; CIMP: CpG island 
methylator phenotype; CIN: chromosomal instability; MSI: microsatellite instability; 
+ = positive for this phenotype; - = negative for this phenotype (adapted from Ahmed 
et al., 2013). 
 
 Gene Molecular phenotype 
Cell line BRAF KRAS PIKC3A PTEN TP53 CIMP  CIN MSI 
Caco-2 Wt wt Wt wt mt + + _ 
DLD-1 Wt mt mt wt mt + + + 
HCT-116 Wt mt Mt wt wt + + _ 
HT-29 Mt wt Mt mt mt + + _ 
LoVo Wt mt Wt wt wt _ _ + 
 
There is accumulating evidence that alternative molecular processes are responsible 
for creating a ‘tumour-friendly’ environment, allowing the pernicious mutations seen 
in CC to occur. The following section will discuss the potential role of ‘epigenetic’ 
factors in this phenomenon. 
 
1.4.1 An introduction to epigenetics 
 
Since Conrad Waddington provided the first working description of epigenetics 
(Waddington, 1942), it now may be described as processes that produce a “stably 
heritable phenotype resulting from changes in a chromosome without alterations in 
the DNA sequence.” (Berger et al., 2009). Thus far, three of these processes have been 
discovered, namely interference from non-coding RNA (ncRNA), histone 
modifications, and DNA methylation. It is now recognised that aberrant expression of 
one class of ncRNAs, microRNAs, is apparent at each stage of CC (Schetter et al., 
2012). Additionally, the modification of histones (proteins around which the DNA 
strand is ‘wound’) has been implicated in human colon carcinogenesis, notably via 
aberrant activation of histone deacetylases (HDAC) (Wilson et al., 2006). Whilst a 
detailed discussion of all of the epigenetic influences on CC progression is beyond the 
Chapter 1 Review of Literature 
12 
 
scope of this review, it should be acknowledged that they play a pivotal role in the 
aetiology of the disease.  
The third, and most intensively researched, epigenetic marker of CC is 
aberrant DNA methylation. DNA methylation is perhaps the best researched 
epigenetic phenomenon because the discovery of 5-methylcytosine in bacterial 
cultures occurred early in the 20th century (Johnson and Coghill, 1925) and it was 
subsequently detected as a separate residue by paper chromatography (Hotchkiss, 
1948). Its relevance to human cancer was first shown in the early 1980s, owing to the 
finding that methylated cytosine is not cleaved by restrictive endonucleases, allowing 
for separation of methylated and unmethylated fragments by gel electrophoresis (Bird 
and Southern, 1978). Using this technique, it was observed that a genomic loss of 5-
methylcytosine distinguishes colon cancers and adenomas from normal tissue 
(Feinberg and Vogelstein, 1983; Goelz et al., 1985). It has been postulated that this 
process of ‘hypomethylation’ allows colon tumours to rapidly alter their phenotype, 
which could be why it is associated with progression and metastatic potential 
(Hoffmann and Schulz, 2005). The mechanisms by which this occurs are not 
completely understood. Recent work has implicated the oxidation of 5-methylcytosine 
by ten-eleven translocation (TET) enzymes in this process, resulting in the methyl 
attachment not being not being copied in daughter cells either passively or via base-
excision repair (Kohli and Zhang, 2013).  
With the advent of bisulphite sequencing in 1992, it was made possible to 
quantify the extent of methylation at specific genomic loci (Frommer et al., 1992).   
At the turn of the 21st century, a landmark study used this method to identify that 
aberrant methylation in gene promoter regions is a ubiquitous occurrence in a range of 
tumours (Esteller et al., 2001). Indeed, cancer occurs in the context of gene-specific 
methylation in TSGs, but global loss of methylation (hypomethylation) across the 
methylome (Esteller, 2005). Regarding the former, de novo methylation of is typically 
facilitated by DNMT (DNA methyltransferase) enzymes 3a and 3b (Okano et al., 
1999). Whilst the understanding of the numerous mechanisms by which methylation 
represses transcription is not yet complete, there is plentiful evidence for a role of 
methylated binding proteins (MeBP), HDAC complexes and co-repressors recruited 
to the methylated region (Esteller, 2005; Jones and Baylin, 2002; Jones et al., 1998). 
The action of HDAC results in the deacetylation of histones, ultimately causing 
chromatin compaction and prevention of transcription (Figure 1.2).   
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A cytosine-guanine pair linked by a phosphodiester bond (5’ – cytosine – 
phosphate – G – 3’) is universally known as a CpG. Many gene promoters contain 
regions rich in these pairs, and are known as CpG islands (CGI). The addition of a 
methyl group to the 5-carbon position of cytosine (forming methylcytosine) is called 
methylation. The DNA methylation process is vital for normal cell differentiation and 
development, since the process can transcriptionally silence genes that do not need to 
be expressed (Jones et al., 1998). However, inappropriate activation and deactivation 
of this process has been linked to cancer (Ehrlich, 2009; Jones and Baylin, 2002). 
Indeed, aberrant methylation of CGIs is a hallmark of cancerous and pre-cancerous 
tissue, and can be used to distinguish between normal and malignant tissue (Ahuja et 
al., 1998; Belshaw et al., 2008; Chan et al., 2002; Horvath, 2013). Intriguingly, more 
recent work has suggested that variation in methylation at CpG sites 2 kilobases (kb) 
upstream from the promoter makes this distinction more accurately, and is more 
conserved among tissue types independent of the species from which it originated 
(Irizarry et al., 2009).   
1.4.2 DNA methylation patterns in humans 
 
There is ongoing debate as to how well DNA methylation patterns are conserved 
across different tissues. However, it appears that there is greater conservancy of DNA 
methylation patterns in the same tissues from different persons than there is between 
different tissues from the same person (Rakyan et al., 2008; Byun et al., 2009; Slieker 
et al., 2013; Lokk et al., 2014). All human investigations sampling multiple organs 
and tissues have come from autopsies. Initial work in these samples have suggested 
that across sixteen tissue types, including lung, colon, pancreas and whole blood, 18% 
of the genomic loci investigated could be classified as differentially methylated. 
Interestingly, there was a tendency for this variation to occur in promoters that were 
relatively less rich in CpGs (Rakyan et al., 2008). Later work, which analysed the 
methylation status of 1505 CpG loci in sixteen tissues from six autopsy specimens, 
found that 29% were differentially methylated (Byun et al., 2009). Both of these 
works were limited by the available technology, in that only relatively small, select 
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Figure 1.2 Methylation-induced transcriptional repression at a CpG island. A) depicts 
chromatin in its ‘open’ state with histones acetylated allowing for transcription. De 
novo methylation of cytosine residues by DNMTs occurs in B), recruiting histone 
deacetylase and associated methyl-binding proteins to cause chromatin compaction 
and suppression of transcription in C).  
 
regions of the ‘methylome’ were investigated. More recent studies that took advantage 
of an Illumina 450k array, that interrogates > 450,000 CpG sites on the genome, found 
X 
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that the DNA methylation patterns vary greatly by tissue type. Indeed, in one 
investigation, 14,441 differentially methylated regions were identified, of which 79% 
were in the same locale as genes. Perhaps surprisingly, 41.7% of these were in the 
promoter region and a mere 36.5% were in CGIs (Lokk et al., 2014). The second such 
study using this method showed there is a very strong correlation between whole 
blood DNA methylation marks and that of omentum and liver tissue, and that there is 
overlap of DNA methylation marks between tissues (Slieker et al., 2013). This is of 
particular interest to research into finding surrogate indices of disease risk (e.g. whole 
blood DNA methylation) to predict or track health in less accessible tissues. However, 
it should be noted that that study only used blood/organ samples from two individuals, 
and that it is possible that the correlation could be explained by genetic variations i.e. 
SNPs (Slieker et al., 2013), and are as such not modifiable by lifestyle factors.  
1.4.3 Role of DNA methylation in colon cancer development 
 
Some colorectal tumours have been identified as having particularly high levels of 
CGI methylation, and have been dubbed ‘CGI methylator phenotype’ (CIMP; see 
Table 1.2) (Jass, 2007). However, there is emerging evidence to suggest that aberrant 
age-related CGI methylation is an early event in CC development, irrespective of the 
eventual phenotype of the tumour (Belshaw et al., 2010). The lining of the colon 
consists of billions of small indentations that secrete mucus and absorb faecal water, 
known as crypts. CGI methylation in a panel of genes known to regulate colon crypt 
cell homeostasis is dramatically raised in colon tumour cells compared with normal 
intestinal mucosa from cancer patients (Belshaw et al., 2008). Yet this study also 
demonstrated that, compared with neoplasm-free and polyp patients, the normal 
mucosa from cancer patients had identifiably altered CGI methylation in the same 
genes (Belshaw et al., 2008). This suggests that aberrant CGI methylation is a global 
phenomenon that consists of epigenetic modification of the entire mucosal field. This 
so called ‘field effect’ is also observed in mucosal protein expression, which is altered 
in normal epithelia of cancer patients compared with healthy controls (Polley et al., 
2006). Given that aberrant CGI methylation is apparent in ‘normal’ mucosa of CC 
patients, this could signify that such epigenetic changes occur early in cancer 
development. These changes might ‘prime’ the affected mucosa for the formation of 
aberrant crypt foci (ACF) that are thought to be the initial precursor lesions in the 
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neoplastic pathway (Nucci et al., 1997; Roncucci et al., 1991). Certainly, CGI 
methylation is a frequent finding in ACF (Chan et al., 2002). Aberrant methylation, 
therefore, could increase susceptibility to CC by creating an environment that selects 
for tumour propagation.  
 
1.5 How might physical activity affect DNA 
methylation in the colon? 
 
PA is purported to reduce the risk of CC through several biologically plausible 
mechanisms of action, including effects on gastrointestinal transit time (GITT), bile 
acid production, localised gut inflammation, chronic inflammation, steroid hormones, 
insulin action, immune function, and adipokines (Friedenreich et al., 2010). The next 
section of this review will focus on the available evidence for these biomarkers of risk 
affecting DNA methylation processes, and whether PA has been shown to play a role 
in modifying them. 
1.5.1 Gastrointestinal Transit Time (GITT) 
 
The authors of the initial investigations into PA and CC risk (Garabrant et al., 1984) 
proposed that accelerated movement of the faecal stream in the large bowel 
encouraged by physical exertion (Holdstock et al., 1970; Koffler et al., 1992; Oettle, 
1991) is the principal mechanism of combating neoplasia. In essence, the contact time 
between dietary carcinogens and the lining of the colon is theoretically reduced, hence 
decreasing the likelihood of a cancer. Although this explanation is attractively simple, 
there is now sufficient evidence to confirm that reduced gastrointestinal transit time is 
unlikely to have a bearing on CC development (Chan and Giovannucci, 2010; Harriss 
et al., 2007; Rogers et al., 2008). Also, it is likely that any changes in gut motility 
brought about by exercise have a negligible effect on risk (Friedenreich et al., 2010a).  
1.5.2 Bile acids 
 
Identified as an endogenous carcinogen 75 years ago (Cook, 1940) bile acids have 
long been suspected as a risk factor for CC. Indeed, an early epidemiological study 
found that faecal content of deoxycholic acid (DCA) is higher in CC and adenoma 
patients than colorectal disease-free controls (Reddy and Wynder, 1977). More recent 
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studies showed that human and mouse colon crypt cells and CC cell lines exposed to 
bile acids consistently induced reactive oxygen species (ROS) with evidence of DNA 
damage (Bernstein et al., 2009). These observations have led to the hypothesis that 
prolonged exposure to bile acids, which have a pro-apoptotic effect on normal colonic 
epithelial cells, promotes the selection of cells that are resistant to apoptosis, thereby 
increasing the likelihood of cancer (Crowley-Weber et al., 2002; Magnuson et al., 
1994). This process might be mediated in part by epigenetic processes, as studies in 
rodents have found that feeding supraphysiological concentrations of deoxycholate in 
Fischer 344 rats and B6C3F1 mice induced aberrant DNA hypomethylation in the 
colon (Pereira et al., 2004). More recently, the expression of the bile acid receptor, 
Farnesoid X receptor (FXR), in human colon adenomas and tumours was found to be 
partially regulated by DNA methylation (Bailey et al., 2014).  
It is not known whether PA affects bile acid production in humans. To date, 
only two studies have examined this possibility. Compared with sedentary controls, 
male distance runners produced less faecal bile acids, but this observation was non-
significant when adjusted for diet composition (Sutherland et al., 1991). In another 
study, the number of self-reported minutes of recreational PA (which consisted of a 
host of moderate to vigorous intensity activities) performed daily by colon adenoma 
patients aged 40-80 was inversely related to faecal bile acid presence, except in 
patients who exhibited ‘high’ (> 136 mg/dl) levels of circulating triglycerides 
(Wertheim et al., 2009). However, these results must be viewed with caution, as the 
mean number of minutes patients reported as exercising was 75 min/day, which is 
highly improbable given that this would equate to 525 min per week of moderate to 
vigorous PA. For reference, according to the 2008 Health Survey for England (HSE) 
self-report measures of PA, only 33% of males and 29% of females aged 16 or over 
are achieving the 150 min per week minimum, and according to accelerometry data, 
this is as low as 6% and 4% in males and females, respectively (Aresu et al., 2009). 
As such, there is a need for more robust observational studies, with better 
measurements of PA, before any associations between PA and bile acids can be 
confirmed.  
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1.5.3 Cardiorespiratory fitness 
 
Low cardiorespiratory fitness (CRF) is a powerful predictor of all-cause mortality 
(Lee et al., 1999; Lee et al., 2011a; Myers et al., 2002); and research suggests that 
cardiorespiratory fitness predicts cancer-specific mortality irrespective of BMI in men 
and women (Evenson et al., 2003; Farrell et al., 2007; Farrell et al., 2011) and 
digestive cancer mortality in men (Peel et al., 2009). It should be acknowledged that 
these studies did not derive the risk of CC specifically, and the association between 
CC and CRF (rather than amount of PA) is yet to be investigated. Nonetheless, a 
Finnish study found a 3.5 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛−1  increase in baseline maximal aerobic 
capacity (𝑉𝑂2𝑚𝑎𝑥 ) conferred a 12% reduced risk of gastrointestinal cancers in a 
cohort of men aged 42-60 years during ~17 years of follow-up, after adjusting for age, 
BMI and other lifestyle behaviours (Laukkanen et al., 2010). At present it is unclear 
whether 𝑉𝑂2𝑚𝑎𝑥 directly affects risk; or merely appears to do so, as those who are 
younger and/or do more PA tend to have a higher 𝑉𝑂2𝑚𝑎𝑥. This is an important point, 
as it is apparent that some individuals do not improve their 𝑉𝑂2𝑚𝑎𝑥 in response to 
exercise training (Bouchard et al., 2011; Timmons et al., 2010). The available, albeit 
limited, evidence suggests that increased PA in the absence of improving 𝑉𝑂2𝑚𝑎𝑥 
might be sufficient to reduce risk. Indeed, sedentary male adenoma patients who 
increased their levels of moderate PA to ≥ 250 min/wk or their 𝑉𝑂2𝑚𝑎𝑥  by ≥ 5% 
through a 12 month exercise training programme, displayed reduced indices of 
proliferation in colon crypts (McTiernan et al., 2006).  
The physiological mechanisms underpinning any possible relationships are, 
again, not clear. It might be that CRF is associated with the maintenance of ‘healthy’ 
levels of other markers linked to risk. It might also be argued that enhanced CRF 
reflects a greater capacity to ‘cope’ with oxidative stress. Oxidative stress is 
purportedly associated with degenerative diseases, such as ageing and cancer (Ames 
et al., 1993), and might be one mechanism by which chronic inflammation could 
promote tumorigenesis (Federico et al., 2007; Tudek and Speina, 2012). It has been 
reported that 8-oxo-7,8-dihydroguanosine (8-oxodG), a marker of oxidative DNA 
damage, is more prevalent in leukocytes and urine of colorectal adenoma patients 
compared with healthy controls. This was associated with a plasma reduction of the 
antioxidants retinol and α-tocopherol (Obtulowicz et al., 2010). Similar findings were 
reported in the EPIC cohort, where plasma reactive oxygen metabolites were 
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positively associated with CC risk (Leufkens et al., 2012). Such changes could be 
indicative of risk; but equally might reflect disease progression, since these changes 
are exacerbated in CC (Obtulowicz et al., 2010). Indeed, researchers in the EPIC 
investigation concluded that pre-clinical tumours were most likely to have been 
responsible for the associations between oxidative stress biomarkers and CC 
(Leufkens et al., 2012).  
Furthermore, particular single nucleotide polymorphisms (SNPs) in genes 
associated with oxidative stress (e.g. eoisinophil peroxidise (EPX) and nitric oxide 
synthase (NOS2)) have been associated with greater risk of CC, and that the risk 
increases with number of ‘risky’ SNPs. Interestingly, the authors noted that this risk 
was reduced by dietary antioxidant intake, including Vitamin D, lycopene and folate, 
even in those with the ‘riskiest’ SNP profile (Slattery et al., 2012). If exercise has an 
‘anti-oxidant’ effect similar to that of dietary antioxidants, it might reduce oxidative 
stress and, possibly, CC risk. There is accumulating evidence that oxidative stress can 
exert effects on gene-specific DNA methylation (Rang and Boonstra, 2014). Specific 
examples include the findings that exposure to ROS induces CpG methylation of Oct-
1 in liver carcinoma cells in vitro (Quan et al., 2011), and that DNA adducts caused by 
ROS impair de novo methylation by DNMT3a in human placental (Turk et al., 1995) 
and murine tissue (Maltseva et al., 2009). However, to the author’s knowledge this is 
yet to be found in human colon or colon cancer models.   
Although aerobic exercise training probably reduces post-exercise oxidative 
stress after a single bout of exercise (Finaud et al., 2006), studies into the effects of 
regular exercise on basal systemic oxidative stress and/or the capacity to deal with 
local, pathological stressors are lacking. In men over 70 years of age, chronic training 
was associated with increased plasma oxidative stress biomarkers, but improved 
health, compared with sedentary controls (de Gonzalo-Calvo et al., 2012a). On the 
other hand, aerobically fit individuals aged 60-80 displayed significantly less urinary 
stress biomarkers than their less fit counterparts and were better able to cope with 
ischaemia/reperfusion injury, as measured by plasma F2-isoprostanes. These findings 
were not related to plasma or urinary antioxidant status (Traustadottir et al., 2012).  
One RCT in overweight postmenopausal women found a reduction in F2-
isprostanes after a 12-month exercise intervention, but only when CRF increased by 
>15% (Campbell et al., 2010b). This strategy might therefore only be of use to the 
minority whose CRF responds greatly to exercise training, given the heterogeneity in 
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ability to increase CRF in response to exercise training in a given population 
(Bouchard et al., 2011; Timmons et al., 2010). Taken together, it is unclear whether 
systemic oxidative stress is a risk factor for CC, since the associations that have been 
found can be explained by disease progression (Leufkens et al., 2012; Obtulowicz et 
al., 2010). Plus, there is limited evidence that long-term exercise training affects 
systemic oxidative stress or the ability to cope with a localised inflammatory insult 
that can induce increased production of ROS, as is the case in colon adenoma 
formation (McLean et al., 2011).   
1.5.4 Insulin-IGF axis 
 
1.5.4.1 Insulin 
 
Fasting insulin levels and glucose tolerance have long been known to be associated 
with habitual PA (Helmrich et al., 1991), and PA interventions have improved these 
parameters in individuals with impaired glucose tolerance (Knowler et al., 2002; Pan 
et al., 1997). Whilst studies have been conflicting as to whether hyperinsulinaemia 
per se increases CC risk (Giovannucci, 2007), it has been argued that this creates an 
environment that promotes cancer cell growth (Gallagher and LeRoith, 2011; 
Giouleme et al., 2011). For example, HT-29 and Caco-2 human CC cell lines and the 
rat intestinal epithelial cell line IEC-6 showed increased proliferation in media 
supplemented with insulin (Sun and Jin, 2008). At present, there is no evidence to 
suggest that insulin alone contributes to the generation of ACF. For example, 
hyperinsulinaemia via regular insulin injections after AOM administration in Fischer 
344 rats increased colon ACF crypt multiplicity but did not affect ACF number 
(Corpet et al., 1997). In this model at least, insulin does not seem to contribute to the 
transition from normal epithelia to ACF, but might accelerate the stepwise progression 
to a carcinoma in affected areas. This is potentially through downstream activation of 
Akt and forkhead transcription factors, resulting in induction of cell proliferation 
(Gallagher and LeRoith, 2011).  
Despite insulin not being a de facto mutagen (Godsland, 2010), it might serve 
to ‘prime’ cells for subsequent mutagenesis. Rat and human colon epithelia express 
insulin receptors (Drew et al., 2007; Silviera et al., 2012) and Fischer 344 rat colon 
epithelial cells show a dose-dependent increase in proliferation in response 10 h of 
Chapter 1 Review of Literature 
21 
 
hyperinsulinaemia (Tran et al., 2006). Recent work has also demonstrated that 
neonate Wistar rat overfeeding results in silencing, by methylation, of the 
hypothalamic insulin receptor promoter (IRP) (Plagemann et al., 2010), showing that 
hyperinsulinaemia could modulate the epigenetic programming of a metabolically 
responsive cell. Indeed, CpG methylation in the insulin gene promoter (INS) in 
apparently normal colon mucosa from bowel cancer patients is significantly increased 
compared with controls without cancer (Silviera et al., 2012). The significance of this 
with respect to neoplasia formation is not clear (especially given that the normal 
mucosa from cancer patients in this particular study expressed significantly more INS 
despite being more frequently methylated), but suggests that epigenetic modification 
of pathways related to insulin action might be related to cancer risk. Since circulating 
insulin is modified by PA, both by stimulating glucose uptake during a bout of 
exercise and increasing muscle insulin sensitivity thereafter (Goodyear and Kahn, 
1998) its effect upon epigenetic modifications is worthy of further investigation.   
1.5.4.2 Insulin-like growth factors (IGF) 
 
Circulating IGF-1 has been associated with colorectal cancer risk (Ma et al., 1999; 
Renehan et al., 2004). IGF-1 is a growth factor for LNCaP prostate cancer cells (Ngo 
et al., 2003) and both IGF-1 and 2 induce cell proliferation in a number of colorectal 
cancer cell lines (Lahm et al., 1992). CC cells express the IGF receptor (Guo et al., 
1992) and its expression level directly correlates with the stage of the disease (Hakam 
et al., 1999). IGF-1, in particular, might encourage neoplasia by deregulating cell 
apoptosis (Pollak et al., 2004). Similarly to insulin, these pathways are subject to 
epigenetic modification. Promoter methylation of IGF-2 results in increased IGF-2 
expression in ageing and cancer (Issa et al., 1996). Conversely, loss of imprinting 
(LOI) in the IGF2 gene locus (caused by loss of methylation of the usually methylated 
maternal allele) is associated with a 5-fold increase in risk (Cui et al., 2003). In IGF2 
LOI positive (+/+) mice AOM treatment resulted in 60% more colon ACF than in LOI 
negative (-/-) mice. Remarkably, when this was accompanied by IGF-1 receptor 
blockade in both strains, the number of ACF was reduced by 30% in the LOI +/+ mice 
only (Kaneda et al., 2007). This suggests that the pathway downstream of the IGF-1 
receptor becomes accustomed to higher levels of IGF-2, and is thus highly sensitive to 
perturbations in IGF-2 signalling. Therefore, if exercise has the capacity to reduce 
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circulating IGF-1, particularly if it is at a highly elevated level to which the receptor 
has become accustomed, this could drastically reduce cell proliferation via aberrant 
IGF-1 signalling. This might be a mechanism by which PA, via epigenetic 
modifications, regulates cell proliferation and reduces risk of adenoma development, 
and its subsequent progression to carcinoma.  
The evidence regarding PA and regulation of IGF is mixed. Serum IGF-1 was 
reduced by four weeks of military training in young, healthy men (Rosendal et al., 
2002), an intensive two-week diet and aerobic exercise programme in overweight, 
sedentary men aged 50+ (Ngo et al., 2002) and a 15 week cycling intervention in 
post-menopausal breast cancer survivors (Fairey et al., 2003).  However, an aerobic 
exercise-induced effect on serum IGF-1 or IGF binding proteins (IGFBP) in the long-
term is not a ubiquitous finding (Frystyk, 2010; Nindl and Pierce, 2010). For example, 
the Alberta Physical Activity and Breast Cancer Prevention Trial found that a 12-
month aerobic exercise intervention had no impact on IGF-1 or IGFBP-3 
concentrations (Friedenreich et al., 2011). Paradoxically, it is also reported that 
circulating IGF-1 increases with sustained endurance training in older persons 
(Poehlman et al., 1994) and resistance exercise programmes (Kraemer and Ratamess, 
2005). It appears, then, that an exercise-induced effect on IGF and IGFBP is highly 
variable, and probably depends upon age, adiposity, diet, mode of exercise and 
circulating insulin, which suppresses IGFBP-1 production, thereby increasing 
bioavailable IGF-1 (Sandhu et al., 2002; Yu and Rohan, 2000). Given the potential 
involvement of IGFs in the epigenetic origins of CC, it is of great interest to 
investigate solutions to reduce IGF-1 in high-risk populations. However, it seems 
unlikely that increasing exercise or PA behaviour will be an effective means of doing 
so.   
1.5.5 Adipose tissue regulation 
 
1.5.5.1 Adipose tissue physiology 
 
Regular PA can help to prevent the accumulation of adipose (fat) tissue, which far 
from being an inert energy depot, is now considered to be a physiologically 
significant endocrine organ (Kershaw and Flier, 2004) whose function is, at least 
transiently, altered by exercise (Thompson et al., 2012). An accumulation of visceral 
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adipose tissue resulting from positive energy balance can lead to several metabolic 
derangements in adipocytes (fat cells) (van Kruijsdijk et al., 2009). Indeed, adipocytes 
enlarge in response to positive energy balance (Björntorp and Sjostrom, 1971; Hirsch 
and Batchelor, 1976; Salans et al., 1973) and larger human adipocytes display a more 
‘pro-inflammatory phenotype’ ex vivo (Skurk et al., 2007). In addition, such cellular 
hypertrophy (and hyperplasia in the most extreme cases of truncal obesity) could 
reduce adipose tissue blood flow in vivo; resulting in adipocyte hypoxia, which some 
have argued is the basis of aberrant cytokine release (Trayhurn et al., 2008). Indeed, 
several studies have demonstrated that hypoxic stress is a trigger for adipocyte 
dysfunction (Hosogai et al., 2007; O'Rourke et al., 2011; Wang et al., 2007). This 
might affect circulating levels of cytokines secreted by adipocytes in the vicinity of 
the colon (cytokines or adipokines), and which are emerging as potential risk factors 
for CC. 
1.5.5.2 Adipose-derived cytokines 
 
Obesity is also associated with adipose tissue infiltration by macrophages (Weisberg 
et al., 2003; Wellen and Hotamisligil, 2003; Xu et al., 2003), which could be 
responsible for the release of cytokines that contribute to systemic inflammation in 
Type II diabetes and cardiovascular disease (Kershaw and Flier, 2004; Ye, 2009) and 
perhaps CC. IL-6 is dramatically raised in morbid obesity (Fontana et al., 2007), and 
serum levels of IL-6 are also linked to risk of colorectal adenoma (Kim et al., 2008). 
Interestingly, one study found the mean concentrations of TNFα and IL-1β in 
morphologically ‘normal’ colon mucosa from obese, premenopausal women was 
approximately equivalent to that found in inflammatory bowel disease (IBD) patients 
(Pendyala et al., 2011; Reimund et al., 1996). After these women underwent diet-
induced weight loss of 10% body mass over 7 weeks, colon tissue expression of IL-
1β, TNFα, and IL-6 decreased, and expression of genes implicated in inflammatory 
processes was reduced (Pendyala et al., 2011).  
IBD patients are typically at 2-3 fold greater risk for CC (Terzic et al., 2010).  
IBD-associated cancer has been linked with increased age-related CGI methylation in 
colon biopsies (Issa et al., 2001) and IL-6 exposure induces DNA methyltransferase-1 
(DNMT1) expression in HCT116 colorectal cancer cells (Foran et al., 2010). Since 
IBD increases CC risk, it is noteworthy that substantial reductions in gut 
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inflammation can be achieved through a change in energy balance, although it is not 
clear whether these observations were a result of the change in diet, fat loss, or both.  
Given that obese, insulin-resistant humans secrete more tumour necrosis factor α 
(TNFα), interleukin-6 (IL-6) and interleukin-1 β (IL-1β) from visceral adipocytes than 
lean controls (Barbarroja et al., 2010; Tilg and Moschen, 2008), it is tempting to 
speculate that inflammatory cytokines, perhaps secreted from adipose tissue, could be 
one mechanistic link between lack of PA, obesity and CC risk via an effect on DNA 
methylation.  
How a high fat diet and/or adipose tissue inflammation might be related to gut 
inflammation in humans is not known. This may be mediated through systemic 
inflammation, as evidenced by the reductions in serum IL-8, TNFα and macrophage 
chemoattractant protein 1 (MCP-1) after weight loss (Pendyala et al., 2011). 
Alternatively, the author suggests that this could be related to changes in colon and 
adipose tissue ‘cross-talk’. For example, a high fat diet increases the permeability of 
the proximal colon in mice (Lam et al., 2012). One possible ramification of this is that 
the fat surrounding the colon is exposed to more enteric bacteria, triggering an 
inflammatory response. This appears to occur in rats fed a high-fat diet (Ding et al., 
2010). Also, such increased permeability could allow for inflammatory mediators 
from visceral adipose tissue to reciprocally activate inflammatory processes in the gut 
lumen as part of a vicious cycle between a high fat diet and central obesity. Indeed, in 
female APCMin mice, visceral fat removal but not calorie restriction was associated 
with a reduction in adenoma formation (Huffman et al., 2013). This was not 
associated with any changes in systemic cytokines or adipokines, which lends 
credence to the author’s postulation, that products of visceral fat can bypass this route 
and alter the gut environment directly. 
Regular exercise might be able to alleviate any effects of dysfunctional 
visceral fat on CC risk by preventing accrual of visceral adipose tissue, and by 
metabolising existing fat as part of a weight-loss intervention, limiting adipose-
derived cytokine secretion (Thompson et al., 2012). It has been argued that PA-only 
interventions in previously sedentary older persons, without reducing body fat, are 
unlikely to affect adipose-derived cytokine secretion (You and Nicklas, 2008). 
Independent of weight loss, perhaps exercise is beneficial by increasing adipose tissue 
blood flow, and hence oxygen availability to adipocytes. Blood flow to abdominal fat 
appears to increase during exercise and for (at least) several hours afterwards 
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(Thompson et al., 2012). This could have important implications for the metabolic 
regulation of adipocytes, even if the effects are transient. If adipose tissue hypoxia is a 
trigger for localised inflammation and release of inflammatory cytokines into the 
systemic circulation (Trayhurn et al., 2008), overcoming the oxygen ‘deficit’ through 
regular PA might restore deranged visceral adipocytes to normal function. However, 
as Thompson and colleagues have outlined in their recent review, it is unclear whether 
exercise stimulates long term changes in adipose tissue blood flow. Also, most 
measures express blood flow per unit of fat mass, so one cannot determine whether 
any increases in blood flow due to exercise training are a reflection of a reduction in 
fat mass (Thompson et al., 2012).   
1.5.5.3 Adipokines (Leptin and adiponectin) 
 
Increased central fat leads to an increase in localised and circulating leptin production 
from adipose tissue (Maffei et al., 1995), which could serve to promote colon cell 
proliferation and mutagenesis. Although an association between serum leptin and CC 
risk is not firmly established in population studies (Garofalo and Surmacz, 2006; 
Joshi et al., 2014), a recent meta-analysis of case-control studies has suggested that it 
could be linked with risk of adenoma (Gialamas et al., 2013). Serum leptin might be 
predictive of tubular adenomas in asymptomatic Caucasian men, as one cross-
sectional study observed that serum leptin > 9 ng/ml increased risk of polyps three-
fold (Comstock et al., 2014a). Leptin is a growth factor in human cancer cell lines 
(Aparicio et al., 2005; Hardwick et al., 2001; Ogunwobi and Beales, 2007) and in 
mouse colon epithelia through induction of the IL-6 promoter (Fenton et al., 2006; 
Fenton et al., 2007). Although AOM administration in mice does not affect the 
number of colon ACF between wild-type, leptin-deficient (ob/ob obese), or 
hyperleptinaemic (db/db obese) mice (Ealey et al., 2008), leptin increased pro-
inflammatory cytokine gene expression in mouse colon, specifically CXCL1, IL-6 and 
IL1-β (Padidar et al., 2011). Curiously, it has also been found that leptin mRNA (LEP) 
is greatly overexpressed in colonic mucosa from cancer patients compared with 
controls (Silviera et al., 2012). It is possible; therefore, that leptin overproduction 
might contribute to an inflammatory milieu in the colon, both indirectly via the 
systemic circulation and perhaps more directly in colonic mucosa. It has been 
observed that the extent of promoter methylation of LEP in adipose tissue predicts 
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weight loss response to a very low calorie diet over 8 weeks in obese women (Cordero 
et al., 2011). However, there is no evidence of differential methylation of LEP in the 
colon contributing to cancer risk, despite being differentially expressed (Silviera et 
al., 2012).  
There is emerging work that strongly implicates obesity and insulin resistance 
in the differential methylation of LEP and ADIPOQ (adiponectin) in peripheral blood 
of adolescents (Garcia-Cardona et al., 2014), but it is not known whether this could 
mediate the known associations between metabolic syndrome, obesity and CC risk 
(Giovannucci, 2007; Ning et al., 2010). In vitro, adiponectin suppresses colorectal 
cancer cell growth via the AMPK/mTOR pathway (Kim et al., 2010a; Sugiyama et 
al., 2009), and co-treatment of MC38 CC cells with adiponectin decreased IL-6-
induced cell proliferation via inhibition of STAT3 (Fenton and Birmingham, 2010). 
Also, in the Health Professionals Follow-up Study, the lowest quintiles of plasma total 
adiponectin were associated with an increase in CRC risk in men (Wei et al., 2005). 
This was also observed in the European Prospective Investigation into Cancer and 
Nutrition (EPIC) and the Nurses’ Health Study cohort, although neither of these 
studies reported significant associations when plasma adiponectin was corrected for 
waist circumference (Aleksandrova et al., 2012; Song et al., 2013). A meta-analysis of 
case-control and cohort studies also found that adiponectin levels were lower in 
colorectal cancer and adenoma patients (An et al., 2012; Joshi et al., 2014). It is not 
conclusive; however, that exercise independent of any effects on fat mass 
meaningfully alters systemic adiponectin or leptin levels (Bouassida et al., 2010; 
Simpson and Singh, 2008) let alone whether it is via alterations to the methylome. An 
isolated study found that a one-year diet and exercise intervention decreased serum 
leptin independently of body composition in obese, insulin resistant men and women, 
and was associated with improvements in insulin sensitivity (Corpeleijn et al., 2007). 
It is generally agreed that a lifestyle intervention that reduces fat mass reduces 
circulating leptin and increases adiponectin (Bouassida et al., 2010), but the evidence 
for PA exerting an independent effect is lacking. 
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1.5.6 Inflammation 
 
1.5.6.1 Chronic inflammation 
 
Age-related increases in chronic inflammation have been linked with cancer 
development (Caruso et al., 2004; Franceschi et al., 2000a; Il'yasova et al., 2005) and 
risk of colon adenoma (Kim et al., 2008). Chronic inflammation is purported to play a 
key role in the initial stages of the carcinogenic process (Shacter and Weitzman, 
2002). With respect to CC, levels of circulating C-reactive protein (CRP) and IL-6 
have been associated with increased risk in the Health, Aging and Body Composition 
cohort, although the association was stronger for risk of mortality than incidence 
(Il'yasova et al., 2005), and IL-6 in one study was linked with increased adenoma risk 
(Kim et al., 2008). On the other hand, a recent meta-analysis concluded that CRP, but 
not IL-6, was associated with CC risk (Zhou et al., 2014), and follow-up of patients in 
the Polyp Prevention Trial showed no associations between inflammatory biomarkers 
and adenoma recurrence (Bobe et al., 2010b). However, the risk of advanced 
adenomas in that study was directly related to IL-6 concentrations (Bobe et al., 2010a) 
pointing to a potential role of IL-6 in adenoma progression, but not initiation.  
Numerous observational studies have reported reduced markers of chronic 
inflammation with increasing PA in older persons (Brinkley et al., 2009; Cesari et al., 
2004; Colbert et al., 2004; de Gonzalo-Calvo et al., 2012b; Geffken et al., 2001; 
Jankord and Jemiolo, 2004; King et al., 2003; McFarlin et al., 2006; Reuben et al., 
2003; Verdaet et al., 2004) suggesting that a change in PA might reduce chronic 
inflammation, which could be implicated in CC risk. To date, treatments that have 
been effective in reducing systemic inflammation concomitant with apparently 
beneficial effects on colon health include rapid weight loss in obese women (Pendyala 
et al., 2011) and Vitamin D supplementation in adenoma patients (Ahearn et al., 2012; 
Fedirko et al., 2009; Hopkins et al., 2011). Nonetheless, it is important to state that 
whilst these studies have shown a correlation between some reductions in systemic 
inflammation and improved colon health, including reduced colon inflammation in the 
case of Pendyala and colleagues (Pendyala et al., 2011), the relationship might not be 
causal. For example, recent work in obese male and female APCMin mice 
demonstrated that visceral fat removal or caloric restriction reduced the number of 
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colon macroadenomas without affecting any measured serum inflammatory cytokines 
including IL-10, IL-6, IL-12 or IL-1β (Huffman et al., 2013).   
There is very mixed evidence that an increase in PA affects systemic 
inflammation in previously sedentary middle-aged and older persons. Some have 
reported reduced CRP (Campbell et al., 2009; Kohut et al., 2006; Stewart et al., 2007; 
Vieira et al., 2009) and IL-6 (Kohut et al., 2006; Nicklas et al., 2008) after moderate-
vigorous aerobic exercise interventions (65-80% estimated aerobic capacity) over 10-
12 months, although the findings of Vieira and colleagues were influenced by the 
degree of loss of central adipose tissue (Vieira et al., 2009). Similarly, fat loss over 18 
months in obese knee osteoarthritis patients has been demonstrated to reduce TNFα, 
IL-6 and CRP, with no effect of increasing PA via brisk walking for 3 h per week 
(Nicklas et al., 2004). Other studies have found no effect on serum inflammatory 
biomarkers (Beavers et al., 2010; Hammett et al., 2004; Nicklas et al., 2004; 
Thompson et al., 2010) including a 12 month intervention in a large (N = 424) 
community-dwelling older cohort aged 70-89 (Beavers et al., 2010) (for review, 
see(Woods et al., 2012).  
A role for inflammation in tumorigenesis is clear (Coussens and Werb, 2002), 
and in CC this could be at least partly mediated via DNA methylation (Issa et al., 
2001). In vitro studies have shown that a supra-physiological dose of IL-6 upregulates 
DNMT activity in HCT-116 cells (Foran et al., 2010), although whether such a 
mechanism operates at the lower concentrations of IL-6 present in serum over the 
course of several years, or decades, is not known. In summary, it appears that chronic 
inflammation could serve to promote CC progression from adenoma, but might not 
directly influence adenoma risk. A role for increasing PA alone in previously 
sedentary persons as a means of moderating chronic inflammation in the absence of 
weight loss is inconclusive. 
1.5.6.2 Localised inflammation 
 
1.5.6.2a Prostaglandins 
 
Prostaglandins (PG) are a marker of great clinical interest with regard to gut 
inflammation. Produced by cyclooxygenase (COX) enzyme activity, PGs have been 
the focus of much attention with regard to cancer progression since it was discovered 
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that adenomas and ‘normal’ mucosa from colorectal cancer patients produced more 
prostaglandin E2 (PGE2) than control tissue (Pugh and Thomas, 1994). This process 
might be regulated in part by DNA methylation, as PGE2 increases DNA 
methyltransferase -1 and -3 (DNMT1/3) enzyme expression in three human CC cell 
lines and in colonic mucosa from the APCMin mouse (Xia et al., 2012). Research has 
demonstrated that consumption of the non-steroidal anti-inflammatory (NSAID) 
aspirin, a COX-2 inhibitor, has a mild preventative effect on new adenoma formation 
in adenoma patients (Baron et al., 2003). Moreover, the recent Colorectal 
Adenoma/Carcinoma Prevention 2 (CAPP2) study reported a 63% reduction in cancer 
incidence in Lynch syndrome patients consuming 600 mg of aspirin daily for at least 
25 months (Burn et al., 2011). However, this did not translate into any reductions in 
initial adenoma formation.  
Whether exercise exerts a similar protective effect via inhibition of COX is 
uncertain. Treadmill running for 30 min/day in AOM-treated mice had no effect on 
colon cyclooxygenase-2 (COX-2) expression after 6 weeks compared with sedentary 
controls (Aoi et al., 2010). However, rats treated with dimethylhydrazine (DMH) and 
subjected to an intensive exercise protocol (50-90 min swimming on 5 days per week 
for 8 weeks) reduced COX-2 expression in colon crypts compared with controls who 
did not exercise (Demarzo et al., 2008). It is possible that an exercise-induced 
decrease in COX-2 is particular to the rat-DMH model of CC and/or very intense 
exercise; equally the lack of effect reported by Aoi and colleagues could have 
occurred due to the less intense exercise mode and/or AOM-mouse model. 
Furthermore, it might be that exercise reduces COX-2 recruitment at the site of an 
adenoma, thereby slowing the adenoma-carcinoma progression. This could be the 
case with chronic NSAID use, which might explain why Burn and colleagues found 
no difference in number of colon adenomas but a significantly reduced incidence of 
cancer (Burn et al., 2011). In partial support of this interpretation, the original 
investigations into PGE2 and CC did not find any difference in concentrations 
between normal mucosa from control participants and polyp patients (Pugh and 
Thomas, 1994) suggesting a role for COX-2 in the adenoma-carcinoma progression 
but not from normal mucosa to adenoma. However, this remains to be tested. 
A lack of PA might be associated with PG production via an increase in 
systemic and localised inflammation as observed in physically inactive individuals 
(Woods et al.,, 2012). Specifically, IL-1β up-regulates COX-2 expression in colon 
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epithelial cancer cells in vitro (Duque et al., 2006) although a consistent link between 
systemic and localised gut inflammation has not been demonstrated in rodents or 
humans (Huffman et al., 2013; Pendyala et al., 2011). Additionally, exercise training 
in rats significantly reduces the colon mucosal gene expression of calcium-
independent phospholipase-2 (ipL-A2) (Buehmeyer et al., 2008). This could be 
important, since the phospholipase A2 (PLA2) enzyme it encodes is responsible for 
the release of arachidonic acid from phospholipids, which COX-2 converts into 
prostaglandins. Exercise could therefore limit prostaglandin production by decreasing 
the PLA2-dependent supply of arachidonic acid.  
The single randomised controlled trial in humans investigating an increase in 
PA and changes in colonic inflammation found that a 12 month aerobic exercise 
programme had no effect on colon PG levels (which are elevated in adenoma and CC 
patients (Pugh and Thomas, 1994)) in untrained polyp patients (Abrahamson et al., 
2007). However, this does not completely rule out a role for exercise in cancer 
prevention via an effect on PGs. Indeed, whilst mucosal PGs were unaffected, this 
was measured in only one biopsy and it has been shown that COX-2 expression is 
highly variable throughout the colon (Wiese et al., 2003), which the authors of the 
study acknowledge could have masked any exercise-induced changes (Abrahamson et 
al., 2007). Also, the range of PGE2 concentrations in individual biopsies recorded by 
Abrahamson and colleagues had enormous variation. In male controls, for instance, 
the mean was 1,143 pg/mg, but the range was 61-7,803 pg/mg (Abrahamson et al., 
2007). Given that the importance of PGE2 and COX-2 seems to be more apparent in 
adenoma to carcinoma progression as opposed to polyp risk (Burn et al., 2011; Pugh 
and Thomas, 1994) it is questionable whether PGE2 is a suitable marker for the 
effectiveness of an intervention designed to reduce adenoma incidence. This could 
partly explain why the association between PA and reduced incidence of adenoma is 
stronger for larger, more advanced polyps (Wolin et al., 2011).   
1.5.6.2b Cytokines 
 
Localised inflammation is a facet of the colon tumour microenvironment (McLean et 
al., 2011), and inflammatory bowel disease (IBD) is unequivocally linked with CC 
risk (Terzic et al., 2010). Limited evidence in rodents has suggested that such 
localised inflammation might be amenable to exercise training. Indeed, in aged mice, 
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reduced expression of TNF in intestinal lymphocytes has been observed after 4 
months of daily wheel running (~4 km per day) (Packer and Hoffman-Goetz, 2012).A 
lifestyle intervention in humans that has significantly reduced gut inflammation was 
achieved by Pendyala and colleagues, via very low calorie diet induced weight loss in 
obese women (Pendyala et al., 2011). Since IBD increases CC risk, and obesity is a 
risk factor for CC and adenoma (Comstock et al., 2014a; Ning et al., 2010; Omata et 
al., 2013), it is noteworthy that substantial reductions in gut inflammation can be 
achieved through a change in energy balance. This finding provides evidence that 
rapid weight loss in obese persons could mitigate colon inflammation, which in turn 
might reduce CC risk. Ongoing work is investigating whether sustained weight loss 
affects future adenoma risk. For example, in the BeWEL study, overweight adenoma 
patients randomised to a weight loss intervention lost a mean of 3.5 kg, or 3.9% of 
body weight, over 12 months, which resulted in significant improvements in blood 
pressure, blood glucose and glycated haemoglobin concentration (Anderson et al., 
2014). The results of this trial with respect to future adenoma risk are awaited.  
A role for localised inflammation in DNA methylation and CC is clear. For example, 
inflammatory bowel diseases (IBD) such as ulcerative colitis (UC) and Crohn’s 
disease increase risk of CC by 2-3 fold (Terzic et al., 2010). Localised inflammation is 
a hallmark of colorectal tumours (McLean et al., 2011), and it accelerates normal age-
related DNA methylation in the colon (Issa et al., 2001; Lobaton et al., 2014). 
Although the mechanism of action is not clear, it has been observed in vitro in CRC 
cell lines that inflammatory stimuli increase DNA methyltransferase (DNMT) activity 
(Foran et al., 2010; Xia et al., 2012). 
Regular PA has been frequently associated with lower levels of some serum 
inflammatory cytokines and a relative increase in anti-inflammatory cytokines in 
older persons; whereas the converse is found with physical inactivity (Brinkley et al., 
2009; Cesari et al., 2004; Colbert et al., 2004; de Gonzalo-Calvo et al., 2012b; 
Geffken et al., 2001; Jankord and Jemiolo, 2004; King et al., 2003; McFarlin et al., 
2006; Reuben et al., 2003; Verdaet et al., 2004) and in chronic disease states 
(Brinkley et al., 2009). Interestingly, in randomised exercise intervention studies in 
disease-free sedentary middle aged and older persons, there is inconsistent evidence 
of an effect on inflammatory biomarkers (Woods et al., 2012). Given that 
inflammatory cytokine concentrations are resilient to abrupt (1 wk) changes in PA 
habits (Lund et al., 2011a), it might be that any subtle effects of PA on chronic 
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inflammation take place over many years, masking any effects of increased PA in 
intervention studies. In addition, it could be that levels of inflammation in 
epidemiological studies reflect disease states which impact upon PA participation, 
confounding the associations with PA. Another possibility is that PA induces changes 
to the inflammatory methylome, which regulates production of inflammatory 
cytokines in response to a stimulus (Fitzpatrick and Wilson, 2003; Miranda and Jones, 
2007).  
1.5.7 Which mechanisms have the best evidence? 
 
Overall, the epidemiological and randomised trial evidence is limited that PA, 
independent of diet and fat mass, over the life course affects GITT, bile acid 
production, IGF-1, and adipokine secretion. However, the epidemiological evidence is 
convincing that PA over the life course beneficially affects chronic inflammation and 
insulin sensitivity. A chronic lack of PA over the life course induces numerous well-
characterised cardiovascular and metabolic perturbations (Blair, 2009), which could 
plausibly impact cancer risk in the ageing gut via DNA methylation. With respect to 
CC, there is abundant evidence that age-related DNA methylation has a pivotal role to 
play in the gut ageing process and possibly CC risk (Ahuja et al., 1998; Bailey et al., 
2014; Belshaw et al., 2008; Belshaw et al., 2010; Chan et al., 2002; Esteller et al., 
2001; Horvath, 2013; Issa et al., 2001; Issa et al., 1994; Issa et al., 1996; Silviera et 
al., 2012; Tapp et al., 2013). To date, only one study in rodents has demonstrated that 
hyperinsulinaemia might induce DNA methylation in peripheral tissues (Plagemann et 
al., 2010), but this has not yet been demonstrated in humans. On the other hand, 
inflammatory stimuli are known to induce aberrant DNA methylation in a range of 
human tissues (Niwa and Ushijima, 2010). Equally, there is plentiful evidence that 
chronic inflammation, particularly cytokine expression, is regulated by DNA 
methylation (Fitzpatrick and Wilson, 2003).  
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1.6 Can physical activity beneficially affect DNA 
methylation patterns in older persons at risk of 
colon cancer? 
 
Recent evidence has pointed to a role of exercise in affecting global and gene-specific 
CGI methylation in a range of tissues. Transient DNA hypomethylation is a means of 
increasing the expression of genes associated with exercise metabolism (e.g. citrate 
synthase and pyruvate dehydrogenase kinase) during exercise in muscle tissue (Barres 
et al., 2012). In addition, increased methylation of long interspersed repetitive 
elements on the genome (LINE-1: a surrogate of global DNA methylation) was 
associated with higher levels of physical activity in the Sister Study cohort (White et 
al., 2013). Furthermore, there was a trend toward increased LINE-1 methylation with 
increasing PA as measured by accelerometer in the North Texas Healthy Heart Study, 
despite the overwhelmingly sedentary nature of the study population (~70% 
physically inactive) (Zhang et al., 2011). Conversely, increased PA was associated 
with decreased global methylation as determined by Luminometric Methylation Assay 
(LUMA) in a cohort of elderly Swedish men (Luttropp et al., 2013). However, the 
LUMA assay is an inappropriate measure of global methylation as it does not 
interrogate hypermethylated regions of the genome, which might explain the 
conflicting result.  
With regard to gene-specific methylation, it has been documented that 6 
months of aerobic exercise training was associated with increased methylation of ASC 
(Apoptosis-associated Speck-like protein with CARD domain), which encodes a 
protein that is responsible for the conversion of the inflammatory cytokine interleukin 
1β (IL-1β) from its inactive form, in the serum of men aged 40-87 (Nakajima et al., 
2010). In gastric cancer patients, the methylation of CACNA2D3 in tumour samples 
was inversely associated with physical activity level (Yuasa et al., 2009). In addition, 
aberrant methylation of the ‘gatekeeper’ APC (Adenomatous Polyposis Coli) gene 
implicated in the development of breast and colon cancer, was inversely correlated 
with 5-year physical activity levels of women aged 43 ± 7 yrs in benign breast 
biopsies (Coyle et al., 2007). More recent work has identified that methylation of the 
breast cancer tumour suppressor gene L3MBTL1 in serum is reduced by 6 months of 
exercise training in breast cancer survivors, which was associated with improved 
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disease prognosis and survival (Zeng et al., 2012). One group demonstrated that three 
hours of high-intensity aerobic exercise per week for six months in 23 previously 
sedentary middle-aged men with or without a family history of type 2 diabetes 
affected methylation status of 134 genes in muscle and >7,500 genes in subcutaneous 
adipose tissue (Nitert et al., 2012; Ronn et al., 2013). In overweight, premenopausal 
women, it has also been shown that cardiorespiratory fitness and/or minutes per week 
of PA are associated with reduced gene-specific and overall methylation of 45 CGIs in 
known breast cancer suppressor genes in saliva (Bryan et al., 2013). Furthermore, 
voluntary treadmill running for 12 weeks was associated with a decline in betaine-
homocysteine S-methyltransferase-2 (BHMT2) gene expression in rat colon 
(Buehmeyer et al., 2008). This raises the possibility that exercise alters methyl group 
availability, which might impact colon CGI methylation. Taken together, this suggests 
that PA has the capacity to alter CGI methylation in tissues distant from the exercising 
skeletal muscles, and in genes known to be implicated in CC development and 
inflammation. With this in mind, it is possible that PA can induce changes in age-
related CGI methylation, particularly in inflammation-related genes, which might be a 
means by which it affects CC risk.  
 
1.7 How much physical activity is required to 
demonstrate a change in DNA methylation? 
 
There are currently no longitudinal studies in the extant literature examining changes 
in DNA methylation patterns with changes in PA. It would be of great interest if PA 
data and genetic material from a previous cohort was available for such an 
investigation. Furthermore, only two non-randomised, and no randomised, trials have 
explored how much physical activity is necessary to induce a significant change in 
DNA methylation in target tissues. One of which was a six-month walking 
intervention in an aged Japanese cohort (142 men, 294 women, mean age 65 ± 7 
years). The exercisers (n = 274) completed sessions of interval walking (3 minutes 
40% VO2 max; followed by 3 min at 70% VO2 max for several sets) for a mean of 
52.2 ± 18.5 minutes per day on 3.9 ± 1.2 days per week. Compared with the control 
group, methylation of ASC in peripheral blood leukocytes was 1% greater (Nakajima 
et al., 2010). However, whilst the results were intriguing there was no evidence of 
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between-group matching or balancing, nor were the PA levels of the control group 
recorded. Also, the blood samples were taken only after the completion of the 
intervention. It is therefore distinctly possible that the between-group differences in 
ASC methylation at the end of the intervention were present to begin with.  
 The second intervention was reported in two publications in 2012-2013 (Nitert 
et al., 2012; Ronn et al., 2013). 23 overweight men (BMI 28.2 ± 2.9 kg/m2; 37.3 ± 
4.4 yrs) with or without a family history of type 2 diabetes had a fat biopsy from the 
right thigh, and a muscle biopsy from the vastus lateralis, before and after a six-month 
high-intensity aerobic exercise intervention. The intervention consisted of a one hour 
spinning class and two hour-long aerobics sessions per week, with a mean of 1.8 
sessions per week being attended. DNA was bisulphite-modified and subjected to 
Illumina 450K array. In adipose tissue, 45 CpGs in 21 genes were differentially 
methylated after the programme, including FTO and KCNQ1, which are both 
implicated in obesity (Ronn et al., 2013). In muscle tissue, differential methylation 
was observed at 134 genes, including reduced methylation of THADA, RUNX1, 
MEF2A and NDUFC2 (Nitert et al., 2012). In each case of differential methylation, 
there was a concomitant change in mRNA expression in the associated gene i.e. 
greater methylation was observed with reduced expresssion and vice-versa (Nitert et 
al., 2012; Ronn et al 2013).  
 It might be argued that a similar intervention to Nitert and colleagues would be 
sufficient to induce changes in DNA methylation patterns in an aged cohort at risk of 
colon cancer. However, the age of those at greatest risk of the disease is typically > 55 
years. It is questionable that such a vigorous regimen would be suitable for this group, 
given that a recent report indicated that two-thirds of health service users aged over 65 
in parts of the United Kingdom are living with more than one comorbidity (Barnett et 
al., 2012). It is arguably of greater relevance to investigate whether long-term changes 
in more moderate activities could induce changes to DNA methylation patterns in an 
older persons at risk. There is a need for longitudinal and randomised trial evidence in 
this arena. 
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1.8 Rationale for present investigations 
 
There is a distinct lack of longitudinal and randomised trial data regarding changes in 
PA and concomitant changes in DNA methylation patterns in persons at risk of CC. 
As such, this series of studies will seek to fill that gap in knowledge to better 
understand the relationship between PA and DNA methylation. To this end, this series 
of studies will attempt to discern whether a change in PA, in a longitudinal and 
randomised trial setting, can affect DNA methylation patterns in older persons who 
might be at elevated risk for colon cancer. Since it is evident that these patterns differ 
by tissue type (Rakyan et al., 2008; Byun et al., 2009; Slieker et al., 2013; Lokk et al., 
2014) the best efforts will be made to interrogate the source tissue i.e. colon epithelia. 
Where this is not possible, surrogate epithelial tissues will be utilised, and where that 
is not possible peripheral blood will be collected instead. Furthermore, these 
investigations will use in vitro models of colon epithelia which will be treated with 
serum before and after a short-or-long term exercise intervention. This will help 
provide insight as to what might be occurring at the level of the colon in response to 
systemic changes brought about by exercise when biopsy material from participants is 
not-available.
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Chapter 2 
General Methods 
 
This section details the general methods used over the course of the investigations 
presented in this thesis based at the Norfolk and Norwich University Hospital 
(NNUH) University of East Anglia Exercise Physiology Laboratory and the Institute 
of Food Research (IFR). Where appropriate, abridged versions of the detailed 
methods presented here can be found within the ensuing chapters.  
 
2.1 Participants  
 
Participants in the intervention studies detailed in Chapters 5 and 6 were generally 
aged between 50 and 75, and recruited via nurse referral, direct contact with the 
research team at the Norfolk and Norwich University Hospital, or via online and 
printed flyers placed at the University of East Anglia, Norfolk and Norwich 
University Hospital, Norwich Evening News, and sent via the University of East 
Anglia alumni association. All methods of recruitment received approval from the 
Norfolk NHS Research Ethics Committee (REC) and the University of East Anglia 
School for Medicine and Health Sciences Research Ethics Committee where 
appropriate. All members of the research team who had direct contact with patients 
and participants obtained an enhanced CRB, were Good Clinical Practice (GCP) 
trained and had undertaken site-specific courses in Information Governance and Data 
Protection. All members also obtained a Research Passport for activities based on 
hospital premises. 
All participants who had consented to taking part in the research studies after 
reading the provided Patient/Participant Information Sheet attended an information 
session at the Clinical Exercise Science laboratory. Here, the team ensured that 
participants understood the demands of taking part and were encouraged to ask 
questions regarding the research. Once the research team and participant were 
satisfied that they wished to continue, both parties signed two copies of an approved 
consent form. The participants were reminded that they were free to withdraw from 
the study without giving reason.     
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2.2 Tissue collection 
2.2.1 Colonoscopy referral process 
 
Patients were referred for flexible sigmoidoscopy or colonoscopy via their General 
Practitioner due to unexplained bowel symptoms or through the National Bowel 
Cancer Screening Programme. Briefly, patients over the age of 60 registered with the 
NHS were offered to take a home-based faecal occult blood test (FOBT). If occult 
blood was detected in 5-6 instances over the course of three separate bowel 
movements, the patient was invited for a consultation with a bowel cancer screening 
nurse at the Gastroenterology Department at the NNUH. At this point, the screening 
nurse provided materials regarding the research study, including a Patient Information 
Sheet and Patient Consent Form for registration of interest and provision of contact 
details. These details were collected by the research team and the potential 
participants contacted (typically by telephone) by the research team. Verbal interest in 
taking part was confirmed, with the view to provide written informed consent for the 
collection of research biopsies with a member of the research team present prior to 
colonoscopy. 
2.2.2 Colon biopsies 
 
Approximately twenty-four hours before the procedure, patients were instructed to 
take the osmotic laxative Klean-Prep® (Helsinn Healthcare S.A., Lugano, Ticino, 
Switzerland) according to manufacturers’ instructions. On occasion, some participants 
were instructed to take Picolax® (Ferring Pharmaceuticals Ltd, West Drayton, Middx, 
UK). The preparation method was recorded by the research team. Written informed 
consent for the collection of research biopsies was obtained on the day of 
colonoscopy, prior to preparation of the patient for the procedure. A member of the 
research team was present in the theatre with the clinical staff. Most patients 
requested a sedative but others declined. The endoscopist screened the entire bowel. 
Where polyps were detected by the endoscopist at any point in the bowel, they were 
removed via snare and/or cauterisation. If this was the case, five pinch biopsies (~2-5 
mm in diameter) were obtained from the sigmoid colon, at least 10 cm from any polyp 
margin. Where abnormal growths in the lining of the colon that could not be 
Chapter 2 General Methods 
39 
 
definitively identified as large polyps or cancer were found, research biopsies were 
taken pending histological confirmation. Two of these were placed in 1 ml of 
RNAlater® (Life Technologies), one was placed in 1 ml 10% formalin, one was 
placed in Carnoy’s fixative (75% EtOH, 25% acetic acid) and one was frozen on dry 
ice. The samples in RNAlater® and Carnoy’s fixative were refrigerated for 48 hours 
to allow full fixation, after which the former was stored at -75 °C and the latter 
transferred into 1 ml 70% EtOH and refrigerated at 4 °C. Formalin-fixed samples 
were stored at 4 °C, and frozen samples stored at -75 °C. Where the bowel was not 
sufficiently clean to investigate the epithelium and could not be adequately cleaned 
with saline solution in situ, the patient was invited to attend another colonoscopy. The 
investigation was generally very well-tolerated and lasted from 45 to 80 minutes. 
2.2.3 Blood and buccal cells 
 
On experimental days where human tissue collection occurred, all participants arrived 
at the Clinical Exercise Science laboratory after an overnight fast and having refrained 
from moderate-vigorous PA for 72 h, and from consumption of alcohol for 24 h. 
Venous blood was obtained by venepuncture of the left or right antecubital vein by a 
trained phlebotomist. Venous blood was transferred to serum collection tubes using 
the Vacutainer® technique (Beckton, Dickinson and Company, Franklin Lakes, NJ, 
USA), inverted gently several times and allowed to clot for 30 min at ambient 
temperature. They were then centrifuged at 3600 rpm at 4 °C for 15 min (Thermo 
Fisher Scientific 1-SR Multifuge, Thermo Fisher Scientific, Waltham, MA, USA). 
Serum and plasma was extracted, pipetted in 200 µl aliquots into 1.5 ml Eppendorf 
tubes and frozen on dry ice. Buccal cells were collected using an Epicentre® Catch-
All™ Sample Collection Swab (Cambio Ltd, Cambridge, Cambs, UK) according to 
the manufacturer’s instructions and stored at -20 °C.  All samples were subsequently 
transferred on dry ice to the Institute of Food Research and stored at -75 °C.  
  
2.3 Anthropometric measures    
 
Height (m) and mass (kg) were measured using a calibrated stadiometer and balance 
(Seca 711, Seca UK, Birmingham, UK). Resting blood pressure (DINAMAP v1000, 
GE Healthcare, Bucks, UK) was taken after the participant was in a semi-supine 
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position for five minutes, was recorded and body composition obtained via 
bioelectrical impedance analysis (AKERN BIA 101, SMT Medical GmbH & Co., KG, 
Germany) and integrated software (BodyGram Pro 3.0, SMT Medical GmbH & Co., 
KG, Germany).  
 
2.4 Cardiorespiratory fitness 
 
Maximal aerobic capacity ( ?̇?𝑂2 𝑚𝑎𝑥 ; 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛
−1 ) was determined using a 
Medgraphics™ Ultima Cardio2 suite (Medical Graphics Corporation, St. Paul, MN, 
USA). Prior to the test, the unit was calibrated according to manufacturers’ 
instructions. In short, the system was switched on and allowed to warm up and 
stabilise for ~40 min. In the software, the vacuum pump was switched on and allowed 
to warm up for two minutes until the ‘READY’ sign was displayed. Calibration of 
expired and inspired air volume was performed using a known volume of room air (3 
litres) at ambient temperature, pressure and humidity, using a syringe moved at 
progressively slower speeds to simulate breathing. This was connected to the unit via 
bi-directional Pitot tubing and flow sensor. The volume of air detected by the flow 
sensor was accurate to true volume to ± 3% or 50 ml, whichever was greater.  
Calibration failed if the volume detected deviated by ± 2% from the syringe volume. 
Air composition was calibrated against supplied calibration gas (12% 𝑂2, 5% 𝐶𝑂2) 
and reference gas (21% 𝑂2, 0% 𝐶𝑂2) with cylinders opened and set to 5 psi. It was 
ensured that the same Pitot tubing and flow sensor used for calibration was also used 
for testing. All tests that required a follow-up measurement utilised a mouthpiece and 
nose-clip apparatus to ensure standardisation between tests.  
Participant information including name, gender, age, ethnicity and trial 
number was recorded and imputed into the software. Height (m) and mass (kg) was 
measured using a calibrated stadiometer and balance (Seca 711, Seca UK, 
Birmingham, UK) immediately prior to the test, and 10 lead ECG attached by an 
accompanying medical professional. The research team explained the nature of the 
test to the participant, emphasising the need for a maximal effort, using the Borg scale 
of perceived exertion (Borg, 1970) and demonstrating how to insert the mouthpiece. 
Cardiorespiratory fitness (CRF) was measured using a 20-watt incremental ramp 
protocol on an electrically braked cycle ergometer (Lode Excalibur Sport, Lode B.V. 
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Groningen, NL) or with a Balke graded treadmill protocol. The cycle protocol was 
used for the participants in Chapter 5 of this thesis, whose mean age was 68.5 years 
with several suffering from musculoskeletal ailments that would have made a 
treadmill protocol uncomfortable, if not intolerable. The treadmill protocol was used 
for the younger (mean age 55 years) and more physically active participants in 
Chapter 6 of this thesis, in preparation for the treadmill exercise session on the study 
days. Briefly, the ergometer test started with a 2 min ‘freewheel’ period against no 
resistance so that the participant was accustomed to the protocol. On the treadmill, 
approximately 2 minutes was spent selecting a comfortable brisk walking/running 
speed which the participant could maintain for the duration of the test. Thereafter, the 
resistance/gradient increased every minute by 20 watts until ?̇?𝑂2 𝑚𝑎𝑥  or volitional 
exhaustion was reached. The result was accepted if the respiratory exchange ratio 
(RER) was > 1.15 and a plateau in ?̇?𝑂2 on the graphical and numerical displays were 
evident. Where appropriate, approximate attainment of age-predicted maximum heart 
rate was also used as a criterion, but not when participants were taking medication 
that could affect heart rate (e.g. beta-blockers). During the test, a continuous 10 lead 
ECG trace (Mortara XScribe 5, Mortara Dolby UK Ltd, Stirling, UK) was monitored 
by the medical professional, and the test stopped immediately where any 
abnormalities arose during the exercise bout. The test ceased once the participant 
reached their ?̇?𝑂2 𝑚𝑎𝑥  and/or was unable to continue.  The medical professional 
continued to monitor the ECG trace to ensure that any abnormalities did not manifest 
in the post-exercise epoch. Participants then had the opportunity to shower and 
change. 
  
2.5 Current physical activity 
 
Objective free-living PA level was assessed over 7 days using accelerometry 
(ActiGraph® GT3X, ActiGraph Corps, Pensacola, FL, USA). The small unobtrusive 
accelerometer was worn on the hip and collected data including estimated activity 
counts, step counts, minutes of MVPA per day and per week, bouts of MVPA of ten 
minutes or more, and total estimated exercise energy expenditure. Data collection 
occurred at one-minute epochs. Wear time was considered sufficient if it met 
standardised criteria i.e. at least 10 hours of wear time on at least five days including 
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one weekend day by an inbuilt algorithm (Choi et al., 2011) and visually examined by 
the researcher to ensure that days of data collection corresponded to the activity diary 
provided. Data was analysed using integrated software (ActiLife version 6.9.1, 
ActiGraph Corps, Pensacola, FL, USA). The activity count cut off points used in all 
intervention studies is displayed in Table 2.1. 
 
Table 2.1 Actigraph physical activity accelerometer counts per ten-minute bout and 
corresponding estimated activity intensity. 
 
Activity count range Estimated activity 
intensity 
≤ 100 Sedentary 
101 – 759 Lifestyle 
760 – 1952 Light 
1953 – 5724 Moderate 
5725 – 9498 Vigorous 
≥ 9499 Very vigorous 
 
Self-reported PA was assessed using a seven-day physical activity diary completed by 
the participants. Participants were instructed to record time spent in all physical 
activity behaviour during all waking hours, including sitting, walking, chores, and 
leisure-time PA. Participants were also provided with the Borg scale of perceived 
exertion (Borg, 1970) to complement the record, to aid the researchers in calculating 
activity intensity. The intensity of physical activities in metabolic equivalent of task 
(MET) was determined using the Compendium of Physical Activities (Ainsworth et 
al., 2000). ‘Moderate’ activities were deemed to be > 3 METS, and ‘vigorous’ 
activities > 6 METS. Amount of exercise in MET-hours per week was calculated by 
multiplying hours and intensity of specific activity undertaken. Self-report PA was 
also assessed using the International PA Questionnaire (IPAQ) (Friedenreich et al., 
1998) and the Godin Leisure Time Exercise Questionnaire (Boyle et al., 2015; Godin 
and Shephard, 1985). Both questionnaires were self-administered and use a 7-day 
recall period. The IPAQ is designed to measure four domains of PA: 1) Job-related; 2) 
Transportation; 3) House work; and 4) Recreation, sport and leisure-time. An 
additional question asks for the time spent sitting. The validity of the IPAQ has been 
rated as acceptable for the different activity domains (Friedenreich et al., 1998). The 
Godin Leisure Time Exercise Questionnaire is a short four-item questionnaire that 
assesses the number of times that strenuous, moderate or mild exercise was performed 
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for more than 15 min over the last 7 days. Research team members read aloud the 
questionnaire questions verbatim at follow-up visits to maintain consistency, with 
participants providing a verbal response. The questionnaires took approximately 30 
minutes to complete.  
 
2.6 Historical physical activity 
 
Historical physical activity was assessed using the Historical Adulthood Physical 
Activity Questionnaire (HAPAQ) (Besson et al., 2010).  In sum, the questionnaire 
operates by allowing participants to recall PA behaviour over several decades by 
‘pegging’ those memories to significant world and life events in a ‘Life Calendar’. 
Uniquely, this approach has been validated against objectively measured PA via 
accelerometer (Besson et al., 2010) unlike other questionnaires which often exhibit 
poor correlation and agreement with actual PA (Boyle et al., 2015). Based on the 
sample (incomplete) Life Calendar provided by Besson and colleagues in their 
original work (Besson et al., 2010) the author updated the Calendar to encompass life 
and historical events for the potential eldest participant (75 yrs) from the age of 21 
years. Participants completed the ‘Life Calendar’ section (which was not analysed by 
the researcher) followed by the formal HAPAQ questionnaire in line with the original 
authors’ instructions. Similarly to previous questionnaires, the questions were asked 
verbatim with the researcher recording the response. A PA ‘prompt card’ was also 
used to identify the specific types of occupational or leisure time PA performed by the 
participants.  In total this questionnaire took between 45 and 80 minutes to complete.  
    
2.7 Preparation of samples for methylation analysis 
 
2.7.1 Buccal swabs 
 
Buccal swabs were defrosted on ice, placed in 500 µl of DNA extraction buffer (0.2M 
Tris, 0.25mM EDTA, 0.5% SDS, pH 8.5) with 5 µl proteinase K (20 mg/ml) and 5 µl 
RNAse A (10 mg/ml: Sigma Aldrich) in a 1.5 ml Eppendorf and incubated in a water 
bath at 50 °C for two hours. Upon removal, buccal swabs were pressed firmly against 
the sides of the Eppendorf to release as much of the solution as possible. 500 µl 
phenol-chloroform (Sigma Aldrich) was added to the clear extract under a fume hood, 
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shaken vigorously until a homogenous mixture was formed (~ 1 minute) and 
centrifuged at 13.2 x 103 RCF for five minutes. The upper, aqueous phase was 
removed with a pipette and added to 500 µl chloroform, shaken vigorously, and the 
homogenate again centrifuged at 13.2 x 103 RCF for five minutes. The DNA was 
precipitated by adding the upper aqueous phase to 500 µl iPrOH and 50 µl 3M 
NaOAc (pH 5.5). This was mixed by flicking and centrifuged at 13.2 x 103 RCF at 4 
°C for 30 min. The supernatant was removed carefully by pipette and discarded, 
leaving the DNA pellet undisturbed. 500 µl of ice-cold 70% EtOH was added to the 
pellet, mixed by flicking and centrifuged at 13.2 x 103 RCF for 10 minutes. The 
majority of supernatant was then removed by pipette, and the pellet allowed to air-dry 
overnight. This was then resuspended in 20 µl TE (10 mM Tris-HCl, 1 mM EDTA, 
pH 8.0). The amount of DNA was then quantified by NanoDrop1000 
Spectrophotometer (Thermo Fisher Scientific).  
2.7.2 Colon biopsies 
 
Genomic DNA was extracted from frozen biopsies using the Genelute Mammalian 
Genomic DNA Kit (Sigma-Aldrich Company Ltd, Gillingham, Dorset, UK) according 
to manufacturers’ instructions. The biopsies were placed in 180 µl of cell lysis 
solution for tissue and 20 µl Proteinase K and incubated in a water bath (Grant 
SUB14, Grant Instruments, Cambridge, Cambs UK) at 55 °C for ~ 36 hours until fully 
digested, leaving a clear solution. 20 µl of provided RNAse A was added to each 
solution, vortexed and left to incubate at room temperature for 15 min. 200 µl of cell 
lysis solution was added, and incubated for 10 min at 70 °C. 200 µl of 100% EtOH 
was added and mixed by vortexing, and the solution transferred to a binding column 
and centrifuged for one minute at 13.2 x 103 RCF. This was followed by two wash and 
centrifugation steps using the wash solution provided, and centrifugation at 13.2 x 103 
RCF for five minutes to dry the column. DNA was eluted in 200 µl of elution solution 
and quantified by NanoDrop1000 Spectrophotometer (Thermo Fisher Scientific).    
2.7.3 Bisulphite modification 
 
DNA (~ 100 ng) was bisulphite-modified using an EZ 96 DNA Methylation-Gold™ 
Kit (Zymo Research Corp, Irvine, CA, USA) according to the manufacturer’s 
instructions. The kit converts >99% of unmethylated cytosines to uracil, with 75% 
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DNA recovery. The protocol consists of a conversion/sulphonation step, a binding 
step, and two wash steps either side of a desulphonation step prior to elution. ~ 100 ng 
of DNA sample (made up to 20 µl with RNAse free water) was added to a 96-well 
conversion plate containing 130 µl of conversion reagent, mixed by pipetting up and 
down, sealed, and placed on a 96-well PCR block for 10 minutes at 98 °C, 2.5 hours 
at 64 °C, and stored at 4 °C for 18 hours. This comprised the sulphonation and 
deamination step, where free cytosine was converted to cytosine sulphonate through 
the addition of a sulphonate group to the 2 – carbon position, followed by bisulphite-
mediated deamination to form uracil sulphonate. The samples were then transferred to 
a supplied 96-well binding plate, containing 600 µl of binding buffer per well, and 
placed on top of a collection plate. This was covered and centrifuged at 2.25 x 103 
RCF for five minutes (Eppendorf 5804R). The flow-through was discarded, 400 µl of 
wash buffer added to each well of the binding plate, and the centrifugation repeated. 
Afterwards, 200 µl of desulphonation buffer was added to each well and allowed to 
stand at ambient temperature for 20 minutes. This process cleaves the sulphonate 
group from the 2 – carbon position, leaving uracil. This was then centrifuged and the 
flow through discarded. Two more wash steps were completed by adding 400 µl to 
each well, and centrifuging for five minutes and ten minutes, discarding the flow-
through each time. The binding plate was then placed on a 96-well plate (Thermo 
Fisher Scientific) and the converted DNA was eluted with 40 µl of elution buffer per 
well. This was allowed to stand for 15 minutes, and centrifuged for five minutes. The 
eluted DNA was stored at - 20 °C until analysis. 
 
2.8 Methylation analyses  
2.8.1 Combined bisulphite restriction analysis (COBRA) 
and gel electrophoresis 
 
This method was used to quantify the extent of DNA methylation in bisulphite-
modified DNA extracted from buccal cells and colon biopsies as described previously. 
Gene-specific DNA methylation was measured using combined bisulphite and 
restriction analysis (COBRA) and subsequent enzyme digestion and gel 
electrophoresis (Xiong and Laird, 1997). Gene-specific primers free of CpGs were 
designed so as to maintain specificity of the primer to the target sequence after 
Chapter 2 General Methods 
46 
 
bisulphite modification (Table 2.2). For the buccal and biopsy bisulphite-modified 
DNA, reactions were performed in volumes of 5 µl, comprising 1.5 µl of sample, and 
3.5 µl of master mix (2.5 µl HotStarTaq (Qiagen, Hilden, Germany), 0.5 µl bovine 
serum albumin (BSA; 1 mg/ml-1) (Sigma-Aldrich), 0.05 µl MgCl2 (0.5 mM)(Qiagen), 
0.01 µl of both forward and reverse primer at 4 pmol concentration (Sigma-Aldrich), 
and RNAse-free water (Qiagen) up to 5 µl). Master mix batches were made up to 
110% of the volume required and dispensed and mixed with samples using a PIRO® 
robot (Dornier-LTF GmbH, Lindau, Germany) into a 384 well PCR plate (Life 
Technologies). Three control samples of unmethylated DNA, methylated DNA and 
RNAse free water (Qiagen) were included in each sample batch. This was sealed, 
mixed again by vortexing, centrifuged, and placed in a 384 well PCR block (Bioer 
GenePro, Binjiang, China). The COBRA PCR consisted of a 15 minute ‘hot start’ at 
95 °C, followed by 40 cycles of denaturation at 95 °C for 30 s, annealing for 30 s and 
extension at 72 °C for one minute. A final extension step of 72 °C for five minutes 
was also included. After amplification, samples were EtOH-precipitated by adding 1 
part NaOAc (pH 5.5) to 25 parts EtOH in volumes of 13 µl per sample. This was 
mixed and centrifuged at 2.25 x 103 RCF at 4 °C for 30 min. The supernatant was then 
removed by removing the seal and inverting the plate onto a clean paper towel, and 
centrifuging at 50 RCF for ten seconds. 25 µl of 70% EtOH was added to each 
(invisible) pellet and centrifuged for five minutes at 2.25 x 103 RCF. The supernatant 
was removed using the method described above, and the pellets allowed to air-dry 
overnight. 10 µl of restriction digest solution was added to each sample pellet, 
containing 0.1 µl restriction enzyme (1-2 units) (New England Biolabs, Ipswich, MA, 
USA) 1 µl of 10 x cut smart buffer (New England Biolabs, Ipswich, MA, USA) and 
8.9 µl of RNAse-free water. This was incubated in a 384 well PCR block for > 4 
hours to ensure full digestion. Enzymes and restriction digest temperatures for each 
gene can be found in (Table 2.2). The enzyme is specific for a base pair sequence 
containing CpGs (i.e. methylated CpGs unaffected by bisulphite modification), thus 
cleaving methylated sequences into two smaller fragments, whilst leaving 
unmethylated sequences unaffected. After digestion, the samples were centrifuged and 
refrigerated until use. 
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Table 2.2 Gene panel with combined bisulphite restriction analysis (COBRA) primers 
and corresponding restriction enzymes  
 
Gene COBRA primers Tm Enzyme (incubation 
temperature) 
Fragment sizes 
(unmethylated
methylated) 
 
SOX17 
 
F:GGGGATATGAAG
GTGAAG 
R:CACCCAACATCT
TACTCAACT 
 
 
61 
 
BstU1 (60) 
 
193, 135+58 
WIF1 F:GTGATGTTTTAGG
GGTTT 
R:ACCTAAATACCA
AAAAACCTA  
53 Hinf1 (37) 413, 328+85 
 
BHMT2 
 
F:GGGGTTAAGAAG
GTGAGTTT 
R:AACCTCAATTTC
CTCACCTAT 
 
57 
 
BstU1 (60) 
 
282, 245+37 
 
APC 
 
F:GTTAGGGTTAGG
TAGGTTGT 
R:CCATAATAACTCC
AACACCTA  
 
 
59.5 
 
Sau3A1 (37) 
 
267, 166+101 
 
 
 
TNF 
 
F:GGAAGTTAGAAG
GAAATAGATTATAG
ATT 
R:ACAAACATCAAA
AATACCCCT 
 
58 
 
Hinf1 (37) 
 
187, 138+49 
 
IL10 
 
F:AGTTAGTAAGGA
GAAGTTTTGGGTAT 
R:CTCCTCCTTCTCT
AACCTCTCTAA 
 
59 
 
HpyCH41 (37) 
 
331, 237+94 
 
 
HPP1 
 
F:AGAGTTTTTTTTT
TATGGTAGTAGTT 
R:ACTCCCACAACA
CCATAACTA 
 
56 
 
Taq1 (65) 
 
291, 182+109 
 
IL6 
 
F:GTTAAGATATGTT
AAAGTGTTGAGTT 
R:CTCAAACATCTC
CAATCCTA 
 
56 
 
HpyCH41 (37) 
 
299,141+158 
ASC F:GGAGGGGATTAA
GGGTGTAGTAA 
R:AAATCTCCAAAT
AAAAACTAACCAA
CTTA 
 
59 
 
BssHII (50) 372, 188+184 
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Gel electrophoresis was performed using the polyacrylamide ‘mega-gel’ method 
described previously (Wang et al., 2003). A high-throughput vertical mega gel stand 
(C.B.S Scientific, San Diego, CA, USA) was assembled according to the 
manufacturer’s instructions. The rounded borosilicate back plate was sealed, with 
spacers and an accompanying gel wrap plate placed on top. This was secured by eight 
clips and stood upright. 5X Tris-borate-EDTA (TBE) stock buffer (4 g Tris; 37.5 g 
boric acid, 4.68 g EDTA made up to 1 l with deionised water) was made up, and 100 
ml stock was added to 900 ml deionised water to make 0.5X TBE. 40 ml of 0.5X TBE 
was mixed with 30 ml of acrylamide (Sigma-Aldrich) and 130 ml deionised water in a 
conical flask. 100 mg of ammonium persulfate (APS) (Sigma-Aldrich) dissolved in 1 
ml deionised water and 250 µl tetramethylethylenediamine (TEMED; Sigma Aldrich) 
was then added and mixed briefly by swirling. This solution was poured smoothly 
between the glass plates, rapping the apparatus to remove air bubbles where 
necessary. A 100-well comb was then inserted and the gel left to set for ~30 min. 1 µl 
of 5X Loading Dye (Bioline Reagents, London, UK) was added to each completed 
enzyme digestion, centrifuged, and left to stand for five minutes. During this time, the 
clips were removed from the gel plate sandwich and attached to the stand with 
gaskets. The upper and lower reservoirs were filled with 0.5X TBE running buffer 
such that the gel wells were covered and the bottom of the gel was submerged (NB 
the lower reservoir was filled before inserting the gel sandwich to avoid formation of 
air bubbles). The gel comb was removed and wells cleared of any debris by pipetting 
~ 20 µl of reservoir buffer into each one.      
 Dyed samples were loaded left-to-right with a multi-channel pipette. Two 
wells were left blank in the centre of each gel to avoid cutting through samples. 1 µl 
of HyperLadder™ IV (100 bp) standard (Bioline Reagents) was loaded into the final 
well after the controls. The gel was run at ~ 200V (Biometra Standard Power Pack 
P25, Biometra GmbH, Göttingen, Germany) for 1 hour 45 minutes. When the run had 
completed, the gel was separated from the wrap plates and sliced in half. Both gels 
were folded, placed into ~ 250 ml of TBE running buffer in a large, shallow container, 
and unfurled. 10 µl of 100 x SYBR Green reporter dye (Life Technologies) was added 
to the buffer and agitated to ensure even distribution. The gels were placed on an 
orbital shaker for > 1 hour and allowed to stain. After staining, the gels were inserted 
into a PharosFX Molecular imager (Bio-Rad Laboratories Ltd, Hemel Hempstead, 
UK) and visualised with QuantityOne Software (Bio-Rad Laboratories). The protocol 
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‘Nucleic Acid Stain - SYBR Green’ was selected, and DNA fragments observed at 
530 nm. A high quality TIFF image (50 µm resolution) was acquired and analysed 
using the TotalLab programme (Non-linear dynamics, Newcastle-upon-Tyne, UK). In 
the 1D analysis suite, lanes were created and sized manually. Background subtraction 
was performed using the rolling ball method and bands detected automatically. Where 
appropriate, the pixel position of the band was moved so that it corresponded with the 
peak signal intensity. These were checked against the standard and methylated and 
unmethylated control DNA, which had also been bisulphite-modified, to ensure the 
correct fragment size. The volume of the bands detected in each lane was calculated, 
and percentage methylation derived by dividing 100 by the total volume of all three 
bands, and multiplying by the total volume of the methylated fragments.  
2.8.2 Quantitative methylation-specific PCR (QMSP) 
 
2.8.2.1 Preparation of Standard plasmids for QMSP assay 
     
Control DNA consisting of a mixture of DNA from the HCT-116, DLD-1, HT-29 and 
Caco-2 cell lines (American Type Culture Collection (ATCC), Manassas, VA, USA) 
was bisulphite-modified. After optimisation of COBRA primers, 0.5 µl of sample was 
PCR amplified (10 µl reaction volume) and diluted to 100 µl with RNase free water 
(Qiagen). 1 µl of this product was used to optimise the methylation-specific primers. 
0.5 µl of the product was ligated into pCR 2.1 vector and inserted into TOP10 e-coli 
cells (Life Technologies). Colonies were resuspended in RNase free water and 
screened by PCR using methylation-specific primers. Suspensions containing correct 
clones identified by gel electrophoresis were cultured and purified using a QiaPrep 
mini kit (Qiagen). Purified DNA was quantified using a NanoDrop spectrophotometer 
(Thermo Fisher Scientific), and 50 ng of sample made up to 5 µl RNase free water 
was sequenced using a BigDye terminator cycle sequencing kit (Life Technologies) 
and an ABI 3100 Avant sequencer (Applied Biosystems®, Life Technologies).  
Methylated fragments were released from purified DNA by restriction digest 
using HindIII and Spe1, and unmethylated fragments released using HindII and Xba1. 
These were purified from agarose gel as above and ligated using Quick Ligase and 
inserted into TOP10 e-coli cells (Life Technologies). Colonies were picked and 
resuspended, plasmids were PCR amplified using M13 primers (Sigma Aldrich), 
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screened and purified from agarose gel and quantified as described previously. 
Standards were created by adding purified plasmid DNA to 100 µl of EB at a 
concentration of 1 ng/µl (first standard) and serially diluted ten-fold to make four 
standards. These were frozen at -75 °C until use.  
2.8.2.2 QMSP assay 
 
DNA from peripheral blood leukocytes was isolated by the Cardiovascular Health 
Study team and shipped to our laboratory on dry ice. ~ 500 ng of DNA was bisulphite 
modified (see 3.7.3 Bisulphite modification). 1.5 µl of sample, methylated and 
unmethylated control DNA, and water, was PCR amplified using a COBRA protocol 
in a 384 well PCR block (see 3.8.1 Combined bisulphite restriction analysis 
(COBRA) and gel electrophoresis). The PCR product was diluted with 20 mM Tris-
HCl to a concentration ~ 1.6 x 10-3 of the original (i.e. 1 µl diluted in 25 µl Tris-HCl, 
and repeated).  
1.5 µl of diluted sample and four plasmid standards were added to a master 
mix containing 2.5 µl Immomix, 0.5 µl BSA (0.5 mg·ml-1), 0.2 µl MgCl2 (0.5mM), 
0.1 µl ROX reference dye, 0.03 µl 100 x diluted SYBR Green, 0.01 µl forward and 
reverse methylation-specific primers (both 4 pmol/l) (Table 2.3), made up to 5 µl with 
RNase free water, in triplicate. This was RT-PCR amplified in a Viia™ 7 Real-Time 
PCR System (Applied Biosystems) using the following protocol: 10 minute ‘hot start’ 
at 95 °C, followed by 40 cycles of denaturation at 95 °C for 30 s, annealing for 30 s 
and extension at 72 °C for 30 s. The plate was read during the extension step. The 
cycle threshold (CT) was detected automatically but adjusted manually where 
necessary and the results exported to a .csv file. Means were calculated for each 
triplicate and outliers eliminated. The mean CT of each triplicate standard was plotted 
against the expected number of log copies. The equation of the fit line (y = mx + c) 
was used to calculate the inverse log copy number for the mean of triplicate samples 
(i.e. 10^ (mean CT – c) / - m)). This was performed for both the methylated and 
unmethylated reactions. Percentage methylation was calculated using the formula 100 
× M copies / (U copies + M copies). The experimental work for the QMSP assay was 
performed by Dr Wing Leung. 
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2.9 Cell culture experiments 
2.9.1 Cell handling 
 
All reagents were warmed to 37 °C and sprayed with 70% EtOH before use. All 
experiments were conducted in a Herasafe™ Class II Biological Safety Cabinet 
(Thermo Fisher Scientific). Colorectal cancer cell lines (HT29, Caco-2, LoVo and 
HCT-116; American Type Culture Collection (ATCC), Manassas, VA, USA) stored at 
-196 °C were placed on dry ice and thawed by gently mixing with 1 ml of Gibco® 
Dulbecco’s Modified Eagle Medium F12 + GlutaMAX™ (DMEM/F12 + 
GlutaMAX™, Life Technologies Ltd, Paisley, UK) supplemented with 10% foetal 
bovine serum (FBS) and 1% penicillin-streptomycin solution (PS; Sigma-Aldrich 
Company Ltd, Gillingham, Dorset, UK). This was added to 5 ml of DMEM/F12 in a 
T25 Nunc™ cell culture flask (Thermo Fisher Scientific) and cells were allowed to 
adhere in an incubator for 24h at 37 °C and 5% 𝐶𝑂2 (RS Biotech Galaxy S+, CMS 
Scientific, West Lothian, Scotland, UK).  
Cells were passaged by removing the DMEM/F12, rinsing with ~ 3ml of 
chilled sterile phosphate buffered saline (PBS), adding 3 ml of 0.05% Trypsin-EDTA 
solution (Life Technologies) and incubating for 5-10 min until cells had were no 
longer adherent. The solution was then transferred into 7 ml of fresh DMEM/F12 in a 
15 ml Falcon™ conical collection tube (Thermo Fisher Scientific) and centrifuged at 
ambient temperature at 300g/1179 rpm for 4 min (Heraeus™ Labofuge™ 400; 
Thermo Fisher Scientific). The supernatant was poured off, and the remaining cells 
resuspended thoroughly in 10 ml of fresh DMEM/F12. 2ml of this resuspension (or 1 
ml in the case of HCT-116 which proliferate more quickly than the other cell lines) 
was added to 10 ml of fresh DMEM/F12 in a Nunc™ T75 and incubated. Media was 
replaced every 2-3 days and cells passaged every 5-8 days when they had reached 
80% confluence. All experiments were performed within 10 passages.  
2.9.2 Cell seeding 
 
For preparation of cells for treatment, the passage procedure was halted at the 
resuspension step once the cells had reached 80% confluence. Here, the number of 
cells present in the 10 ml resuspension was estimated by extracting 20 µl and 
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manually counting the number using a haemocytometer, microscope and click-
counter. The numbers of cells in each quadrant were counted twice, with the average 
number taken to represent the number of cells present per 0.1 µl. This was then 
multiplied by 1 x 10 6 to return the total number of cells in the suspension. 30 ml of 
solution was made up with a mixture of fresh DMEM/F12 containing FBS and PS and 
cell resuspension, such that ~ 10,000 cells per 100 µl were present (e.g. in a 10 ml cell 
resuspension containing 1.4 x 107 cells, 2.14 ml was added to 27.86 ml of fresh 
media). This cell density was used for Caco-2, HT-29, and LoVo cells. Owing to the 
more rapid proliferative capacity of HCT-116 cells (Ahmed et al., 2013), the cell 
density was halved (i.e. 5000 cells per 100 µl). These were gently mixed in a 50 ml 
Falcon tube by a motorized pipette (Eppendorf Easypet™, Hamburg, Germany). 
Plates were seeded by adding 100 µl of the mixture per well. To maintain an even 
distribution of cells in the mixture, the tube was swirled gently after every six wells, 
and inverted gently after each plate. Vigorous mixing was avoided to prevent foaming. 
All plates were seeded for 24 hours in an incubator set at 37 °C and 5% 𝐶𝑂2 
concentration (RS Biotech Galaxy S+, CMS Scientific, West Lothian, Scotland, UK).  
2.9.3 Cell proliferation assay (WST-1) 
 
The water soluble tetrazolium salt (WST-1) assay (Roche Daignostics Corporation, 
Indianapolis, IN, USA) works on the principle that the glycolytic product, 
nicotinamide adenine dinucleotide phosphate ( 𝑁𝐴𝐷𝑃 + ), cleaves the salt into a 
yellow formazan dye. The amount of dye produced is therefore proportional to 
cellular metabolic activity and is an accurate proxy measure of the number of viable 
cells. Optimisation work with FBS control serum demonstrated that proliferation of 
cell lines was in its exponential phase after three hours. Cells were therefore incubated 
for three hours before assay. 3 ml of cell proliferation reagent WST-1 (Roche 
Diagnostics Corporation, Indianapolis, IN, USA) was thawed from - 20 °C and mixed 
with 30 ml DMEM/F12. The media from each well of a 96 well plate (Nunc™, 
Thermo Fisher Scientific) was removed with a multi-channel pipette and replaced 
with 100 µl of DMEM/F12 + WST-1. An additional well which had remained free of 
cells and media during incubation was filled with 100 µl of DMEM/F12 + WST-1 to 
act as a negative control. The time of complete replacement of media on each plate 
was recorded. The plates were then incubated for three hours at 37 °C and 5% 
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𝐶𝑂2.The colorimetric assay was performed with a microplate reader using a single 
read Endpoint protocol (Bio-Rad Benchmark Plus, Bio-Rad Laboratories, Hercules, 
CA, USA). Dual absorbance was set between 450nm and 690nm as per 
manufacturers’ instructions, with a five second mix time at medium speed prior to 
plate read. Approximately two minutes was allowed between plate reads so each plate 
received three hours of incubation before analysis. Mean absorbance of replicate 
sample wells and the six control wells treated with FBS on the same plate was 
calculated. The absorbance of the negative control was subtracted, and the results 
expressed as a percentage of the FBS control.   
2.9.4 Gene expression from cultured cells 
 
RNA was isolated from cultured cells in 24 well plates (Nunc™, Thermo Fisher 
Scientific) using an Isolate II RNA Mini Kit (Bioline) according to manufacturers’ 
instructions. Cell culture media was removed, and 350 µl RLY lysis buffer and 3.5 µl 
beta-mercaptoethanol (β-ME; Sigma Aldrich) was added to each well and left for five 
minutes. The lysate was extracted and passed through a filter column by 
centrifugation at 13.2 x 103 RCF. 350 µl 70% EtOH was added to the lysate and 
mixed. This was centrifuged at 13.2 x 103 RCF in a binding column and desalted by 
centrifugation with 350 µl membrane desalting buffer (MEM). DNA was digested for 
15 min at ambient temperature by adding 100 µl pre-prepared DNA reaction buffer to 
the centre of the membrane. Three wash steps were performed and RNA eluted in 60 
µl RNase free water (Qiagen) and quantified by NanoDrop Spectrophotometer 
(Thermo Fisher Scientific). 
4 µl (~ 200 ng) of eluted RNA was placed in a 96-well PCR plate (Thermo 
Fisher Scientific) and added to 4 µl qScript™ cDNA Supermix (Quanta Biosciences, 
Gaithersburg, MD, USA) and made up to 20 µl with RNase free water (Qiagen). The 
contents were sealed, vortexed and centrifuged at 2.25 x 103 RCF for one minute. The 
samples were then reverse-transcribed in a 96-well PCR block (Biometra T-Gradient, 
Biometra GmbH, Göttingen, Germany) with the following steps: 25 °C for five 
minutes, 42 °C for 30 minutes, 85 °C for five minutes, and 4 °C overnight. This was 
then diluted in 80 µl RNase free water and frozen at - 20 °C until use.   
1.5 µl of cDNA sample were added to a master mix containing 2.5 µl 
Immomix, 0.5 µl BSA (1 mg/ml-1), 0.2 µl MgCl2 (0.5 mM), 0.1 µl ROX reference 
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dye, 0.03 µl 100 x diluted SYBR Green, 0.01 µl forward and reverse primers (both 4 
pmol concentration) (Table 2.4), made up to 5 µl with RNase free water, per sample, 
in triplicate. This was RT-PCR amplified in a Viia™ 7 Real-Time PCR System 
(Applied Biosystems) using the following protocol: 10 minute ‘hot start’ at 95 °C, 
followed by 40 cycles of denaturation at 95 °C for 30 s, annealing at 60 °C for 30 s 
and extension at 72 °C for 30 s. The plate was read during the extension step. The 
cycle threshold (CT) was detected automatically but adjusted manually where 
necessary and the results exported to a .csv file. Eight genes were analysed, including 
the ribosomal DNA sequence 18S which was used as reference gene (Table 2.4). 
Mean CTs were calculated from triplicate values and outliers eliminated. Gene 
expression relative to 18S was calculated using the ∆∆CT method described 
previously (Schmittgen and Livak, 2008).  
2.9.5 Global methylation in cultured cells 
 
DNA was extracted and purified from 24 well culture plates using the phenol-
chloroform method and bisulphite-modified using the techniques described previously 
(see 3.7 Preparation of samples for methylation analysis). LINE-1 methylation, which 
has been recognized as a suitable surrogate for global DNA methylation 
(Weisenberger et al., 2005) was analysed by an adapted form of the QMSP assay 
described previously (Iacopetta et al., 2007) (see 3.8.2.2 QMSP assay), which forwent 
the COBRA PCR step. LINE-1 primer sequences can be viewed in Table 2.3.   
 
Table 2.3 Primer sequences for combined bisulphite restriction analysis (COBRA) and 
quantitative methylation specific PCR assay (QMSP). 
 
Gene COBRA primers QMSP-U primers QMSP-M primers 
 
ABCA1 
 
F:GGAAAGTAGGATTT
AGAGGAAG 
R:ATAAAAAATACAA
CAAATATCTTAAAATC 
 
 
F:TTTTTGGTTGTTGGG
AAT 
R:AAAAACACTAAACT
CAAAACTACA 
 
F:TGTTTTTGGTTGTCG
GGAAC 
R:AAAAACGCTAAACT
CGAAACTACG 
SNCG F:GTTGGGTTGAGTTA
GTAGGAGTTT 
R:AAACCCTTCTTAA
AAACATCCATA 
F:TGGTTTTTGTATTAAT
ATTTTATTGGT 
R:AAAACTAAATCTCC
CTACAAACTACA 
F:GGTTTTCGTATTAATA
TTTTATCGGC 
R:GAAACTAAATCTCC
CTACGAACTACG 
 
NOD2 
 
F:TGATGTAGTTGTTG
GGAGGATA 
R:CTCCCTTACACACC
AAACCTA 
 
F:GAGTTTTGAGTTATG
TGGTTTGGGT 
R:ATATAAACCATACAC
ACCCCAACTAATAACA 
 
F:TCGAGTTACGTGGTT
TGGGC 
R:GTATAAACCATACAC
ACCCCAACTAATAACG 
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SOD3 
 
F:GTTGTGTGTTG 
AAGGTTATTGGTT 
A 
R:ACCTTTCCAAC 
TCCTCCAAA 
 
F:TGTGGAATGGAATTT
TTGGTTT 
R:ACCTCCACCTCCTCC
CA 
 
F:CGCGGAATGGAATTT
TTGGTTC 
R:GCCTCCACCTCCTCC
CG 
 
TNF 
 
F:GGAAGTTAGAAGG
AAATAGATTATAGATT 
R:ACAAACATCAAAA
ATACCCCT 
 
F:GGTTTTGAGGGGTAT
GGGGAT 
R:CATCCTCCCTACTCC
AATTCCA 
 
F:GGTTTTGAGGGGTAT
GGGGAC 
R:ATCCTCCCTACTCCG
ATTCCG 
 
IL10 
 
F:AGTTAGTAAGGAG
AAGTTTTGGGTAT 
R:CTCCTCCTTCTCTA
ACCTCTCTAA 
 
F:TGTTATTGTGATTTA
GGAATATGT 
R:TCCTAAAAAAACAA
CTATTCTATACA 
 
F:CGTTATTGTGATTTA
GGAATACGC 
R:AATTTCCTAAAAAA
ACAACTATTCTATACG 
 
UGT1A1 
 
F:TGTGGATTGATAGT
TTTTTATAGTT 
R:CAACAATATCTTCC
CAACAT 
 
F:TGTGATATAGTTAAA
TATTAATTTGGTGTATT 
R:CTAAAACTCCACAA
CCATAACA 
 
F:CGTGATATAGTTAAA
TATTAATTTGGTGTATC 
R:CTAAAACTCCACAA
CCATAACG 
 
SERPINA5 
 
F:GGTTTAGTTGGTGG
TGTAAGGTTT 
R:AACCCCAAAACTC
TAAAATCCAT 
 
F:TGTTTGTAGGTAGGT
TTGTTGGTT 
R:AAAAACCTCCCTTT
ACAACATCA 
 
F:CGTTTGTAGGTAGGT
TTGTTGGTC 
R:AAACCTCCCTTTACG
ACATCG 
 
LINE-1 
 
n/a 
 
F:TGTGTGTGAGTTGA
AGTAGGGT 
R:ACCCAATTTTCCAAA
TACAACCATCA 
 
F:CGCGAGTCGAAGTA
GGGC 
R:ACCCGATTTTCCAAT
ACGACCG 
 
 
  
Table 2.4 Primer sequences for gene expression experiments in cultured cells. All Tm 
60 °C. 
 
Gene Forward primers Reverse primers 
 
MUC2 
 
TGTAGGCATCGCTCTTCTCA  
 
GACACCATCTACCTCACCCG 
 
COX-2 
 
CCGGGTACAATCGCACTTAT 
 
GGCGCTCAGCCATACAG 
 
Ki-67 
 
TGACTTCCTTCCATTCTGAAGA
C 
 
TGGGTCTGTTATTGATGAGCC 
 
DNMT3b 
 
TCTCCATTGAGATGCCTGGT 
 
GAGATTCGCGAGCCCAG 
 
E-Cad 
 
GACCGGTGCAATCTTCAAA 
 
TTGACGCCGAGAGCTACAC 
 
LGR-5 
 
GTTTCCCGCAAGACGTAACT 
 
CAGCGTCTTCACCTCCTACC 
 
C-Myc 
 
CACCGAGTCGTAGTCGAGGT 
 
TTTCGGGTAGTGGAAAACCA 
 
18S 
 
GTAACCCGTTGAACCCCATT  
 
CCATCCAATCGGTAGTAGCG  
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2.10 Statistical analysis 
 
All numerical values in tables and within the body text are presented as mean (SD) 
unless otherwise stated. In all figures with error bars, these are displayed as mean 
(SE), excepting the box-plots for baseline methylation data in Figure 3.2, Figure 4.4, 
and Figure 4.5, which show medians and 95% confidence intervals. For exploratory 
analysis of the longitudinal data in the first of these studies, initial investigations were 
performed using SPSS v.20 (IBM, Armonk, NY, USA). Hypothesis generation was 
conducted based on the outcome of these investigations. Subsequent to this, ANOVA-
based models were constructed and figures created using Matlab (Mathworks Inc., 
Cambridge, UK) by Dr Henri Tapp. These are detailed in Chapter 3 of this thesis. 
Analysis of the intervention data was performed using SPSS v.20 (IBM, 
Armonk, NY, USA). All ratio data was assessed for normality using the Kolmogorov-
Smirnov test. Where normality assumptions were violated, non-parametric tests were 
used. The Physical Activity and Risk of Colon cancer (PARC) trial, whose design was 
a pre-test post-test randomised group comparison, was analysed using n-way 
ANCOVA. The primary outcome measures for each test were DNA methylation status 
of target genes, self-report physical activity, accelerometer derived physical activity, 
and cardiorespiratory fitness by group allocation (control vs intervention) after 6 
months and after 12 months. The baseline value of the primary outcome measure was 
added as a covariate to correct for the potential confounding effect of group 
differences at baseline. Results from the Regular Exercise and colon cell Growth 
(ReGro) study were analysed using a repeated-measures ANOVA. Sphericity was 
assessed using Mauchley’s Test of Sphericity. Where mild sphericity was evident the 
Huyhn-Feldt correction was used for any significant F values, and Greenhouse-
Geisser corrected in cases of more severe asphericity. Where significance was 
reached, post-hoc T-tests with a Bonferroni correction were used to locate any 
differences. 
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Chapter 3 
 
Study 1: Associations between physical 
activity and differential methylation of 
genes in peripheral blood leukocytes: 
results from The Cardiovascular Health 
Study (CHS) 
 
3.1 Introduction 
 
Epigenetic mechanisms, defined as heritable changes in gene function that are not 
dependent on DNA sequence, are increasingly recognised as playing an important role 
in the development of a number of chronic diseases including colon cancer (CC) 
(Robertson, 2005). Perhaps the best understood epigenetic modification is DNA 
methylation, which affects cytosines in cytosine-guanine (CpG) dinucleotides and is 
generally associated with transcriptional repression (Robertson, 2005). DNA 
methylation patterns are established in early life and are generally stable in somatic 
cells. However, aging has been shown to induce changes to the methylation status of 
numerous genomic loci across a broad spectrum of human tissues. Importantly, the 
role of environmental stimuli as modulators of age-related DNA methylation has been 
demonstrated (Christensen et al., 2009; Talens et al., 2012; Tapp et al., 2013).  
CC is an age-related disorder whose risk is associated with several lifestyle 
factors including physical activity (PA) (Wolin et al., 2009). Numerous observational 
studies have demonstrated an inverse association between PA level and CC incidence 
and mortality (Wolin et al., 2010; Wolin et al., 2009). Increased PA, for the most part, 
beneficially modulates adiposity, blood pressure, lipid and glucose metabolism 
(Nelson et al., 2007) and has been associated with apparently beneficial effects on 
chronic inflammation in older persons (Hamer et al., 2012; Woods et al., 2012). 
However, the molecular mechanisms underpinning the long-term health benefits of 
regular PA in relation to CC risk are poorly understood.  
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Recently both the Sister Study (White et al., 2013) and North Texas Healthy Heart 
Study (Zhang et al., 2011) showed a positive association between PA and LINE-1 
methylation in leukocytes from healthy participants. LINE-1 methylation is a 
surrogate marker for global DNA methylation, which has been shown to decrease with 
ageing and CC in colon tissue (Sunami et al., 2011; Tapp et al., 2013). In addition to 
effects on global DNA methylation, studies have reported altered DNA methylation of 
genes implicated in chronic inflammation, type 2 diabetes and breast cancer in saliva, 
blood, skeletal muscle and adipose tissue after short-term exercise programmes 
(Bryan et al., 2013; Nakajima et al., 2010; Nitert et al., 2012; Ronn et al., 2013). This 
raises the question of whether age-related methylation of genes implicated in 
inflammatory processes that are linked to CC risk can be modulated by healthy 
lifestyle behaviours, such as regular PA, in later life. 
Given the potential role of habitual PA in modifying CC risk, and evidence of 
changes in DNA methylation patterns following short-term exercise interventions, the 
methylation status of genes known to be implicated in chronic inflammation, together 
with LINE-1, was determined in leukocytes collected from a sample of older adults 
participating in the Cardiovascular Health Study (CHS) (Fried et al., 1991). 
Associations between self-reported levels of leisure-time PA collected at two clinic 
visits eight years apart and corresponding leukocyte DNA methylation were 
investigated.  
Although most studies investigating disease-specific epigenetic events have 
focused on the tissues affected, several previous studies have demonstrated age-
related epigenetic changes in DNA from whole blood cells including those involving 
twins and, therefore, implicating the environment/lifestyle in ‘driving’ epigenetic drift 
(Bjornsson et al., 2008; Boks et al., 2009; Christensen et al., 2009; Fraga et al., 2005; 
Kaminsky et al., 2009; Shen et al., 2007). Of significant importance in this respect is 
the very recent demonstration that both aging and environmental exposures linked to 
risk of diseases in other tissues are reflected by alterations to gene-specific 
methylation in blood-derived DNA (Christensen et al., 2009) indicating the utility of 
this readily-available material for investigating the impact of lifestyle on biological 
aging and the risk of associated diseases. Such analyses, despite the lack of 
availability of colon epithelia from CHS participants, could therefore provide valuable 
insight into CC risk. 
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3.2 Methods 
3.2.1 Study participants 
 
The CHS is a multisite observational cohort study designed to investigate risk factors 
for CVD in the elderly (Fried et al., 1991). The CHS recruited 5,201 participants 
during 1989/90 from Medicare eligibility lists in four U.S. communities: Forsyth 
County, NC, Washington County, MD, Sacramento County, CA, and Pittsburgh, PA. 
In 1992/93 an additional 687 African-Americans were recruited into the study. 
Participants were aged 65 or older at the baseline examination. All participants signed 
an informed consent form at entry into the study and at specified intervals during the 
course of the study. 
From 1989/90 until 1999/00, annual clinic visits were completed by study 
participants. Data were collected at these annual examinations including vital signs, 
anthropometry, medical history and behaviours, physical function, and psychosocial 
interviews. Demographics collected at baseline included age, gender, and education. 
Blood was collected and stored during most years of the study. Participants were 
evaluated for the prevalence of specific cardiovascular outcomes at baseline, 
including myocardial infarction, angina pectoris and stroke. (Mittelmark et al., 1993)  
For this study, 493 Caucasian and 50 non-Caucasian participants that completed both 
the 1991/1992 (baseline) and 1999/2000 (year 8) clinic examinations were randomly 
selected from CHS participants that provided consent to use genetic material. 
Duplicate cases were eliminated leaving a total of 540 samples used for analysis. 
3.2.2 Measurement of DNA methylation 
 
The panel of genes selected were based on their reported role in cardiovascular 
disease, and a comprehensive report is being published separately. Therefore, the 
findings will be interpreted with regard to the inflammation-related genes that could 
plausibly be involved in CC, namely TNF and IL10. Genomic DNA was isolated from 
peripheral blood leukocytes collected from the participants at clinic examinations at 
baseline and year 8. Bisulphite conversion of DNA (500 ng) was performed using the 
EZ DNA methylation Gold kit (Zymo Research) following manufacturers’ 
instructions. An adapted quantitative methylation-specific PCR (QMSP) assay 
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(Fackler et al., 2004) was used to quantify the methylation status of LINE-1 and the 
genes encoding TNF (tumour necrosis factor), SNCG (synuclein gamma), SOD3 
(superoxide dismutase 3), IL10 (interleukin 10), SERPINA5 (serpin peptidase inhibitor 
A5), NOD2 (nucleotide-binding oligomerization domain 2), ABCA1 (ATP-binding 
cassette A1) and UGT1A1 (UDP glucuronosyltransferase 1A1).  The expression of 
each of these genes is negatively regulated by DNA methylation (Belanger et al., 
2010; Christensen et al., 2009; Dokun et al., 2008; Jiang et al., 2008; Kerkel et al., 
2010; Larsson et al., 2012; Lee et al., 2013; Liang et al., 2013; Sullivan et al., 2007). 
They have also previously been shown in at least two studies to be subject to 
differential methylation in human leukocytes in response to age and/or environmental 
exposures and to play a role in cardiovascular health (Baccarelli et al., 2010; 
Bruunsgaard et al., 2000; Christensen et al., 2009; Fukai and Ushio-Fukai, 2011; 
Galluzzo et al., 2011; Gowers et al., 2011; Guay et al., 2012; Hoang et al., 2008; Juul 
et al., 2004; Kolbel et al., 2006; Oram and Vaughan, 2006; Rau et al., 2007).  The 
QMSP assay had two steps. First, PCR was used to amplify the region of interest from 
bisulphite-modified DNA independent of methylation status using COBRA primers 
that do not contain CpGs (Table 2.3). Second, two separate quantitative real-time 
PCRs were performed using the products of the first PCR as template with 
methylation status-specific (U-unmethylated; M-methylated) primers. This 
determined the copy numbers of unmethylated and methylated PCR fragments, 
calculated from standard curves from plasmids containing cloned methylated and 
unmethylated PCR fragments, to give: % methylation = 100 × M copies / (U copies + 
M copies). All assays were performed in triplicate. Methylation-specific primer 
sequences are also shown in Table 2.3. 
3.2.3 Physical activity 
 
Leisure time PA levels of the entire CHS cohort (n = 5,888) were recorded using an 
interview-based questionnaire at baseline and year 8. Participants provided 
information on the type of activity they undertook (e.g. walking for exercise, 
callisthenics, gardening), how often the activity was completed in the past two weeks, 
the duration of each bout, and the number of months per year that it was undertaken. 
The total weekly PA energy expenditure (PAEE: kcal) was calculated for selected 
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participants using the method of van Stralen (van Stralen et al., 2008) which uses the 
metabolic equivalent task (MET) score for the intensity of each activity.  
 
Weekly energy expenditure (kcal) = (MET intensity score × minutes spent in each 
activity) × (number of sessions reported in last two weeks)/2 × (number of months per 
year each activity was undertaken)/12. 
 
This calculation was performed for each activity to provide total leisure time 
PAEE/week for each participant at both time points. Change in PA (∆PAEE) was 
calculated as the difference between the two time points and then stratified into the 
following three categories: participants who increased PAEE by >500 kcal/wk (INC), 
those who decreased PAEE by >500 kcal/wk (DEC), and the remaining cohort who 
showed a nominal overall change in PAEE of <500 kcal/wk (NOC). The 500 kcal cut-
off represents approximately 2 hours of brisk walking according to the calculation of 
van Stralen (van Stralen et al., 2008). Brisk walking equates to a MET score of 3.8 
(Ainsworth et al., 2000), which in a male of average fitness aged 70-79 is perceived 
as ‘moderate’ activity (O'Donovan et al., 2010). Hence, a change in PAEE of >500 
kcal/wk represents a tangible change in PA level between baseline and year 8. 
Participants reporting dubious PAEE values (i.e. zero or >15,000 kcal/week) or with 
missing anthropometric data at either interview were excluded from the analysis, 
leaving a sample of 390 Caucasian participants comprising 253 women and 137 men 
with the following mean (SD) characteristics at baseline: women were aged 70.7 (4.0) 
years, with waist circumference 91.2 (13.2) cm and leisure time PAEE 1313 (1335) 
kcal/wk; men were aged 71.4 (4.3) years with waist circumference 97.0 (10.0) cm and 
PAEE 2226 (2209) kcal/wk. A further 31 non-Caucasian participants comprising 20 
women aged 70.3 (4.1) years, with waist circumference 93.0 (12.5) cm and PAEE 
1118 (1391) kcal/wk, and 11 men aged 70.8 (4.7), with waist circumference 99.2 (8.6) 
and PAEE 1277 (660) were also included. A flow diagram of the cohort selection 
procedure is presented (Figure 3.1). 
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Figure 3.1 Flow diagram depicting the selection of participants used for analysis.  
 
3.2.4 Statistical analysis 
 
Exploratory investigations were performed using n-way analysis of covariance 
(ANCOVA) (SPSS v19, IBM, Armonk, IL) with methylation data that did not require 
transformation (i.e. IL10 and TNF). PAEE and gender were the independent 
variables, baseline age was the covariate, and change in methylation was the 
dependent variable. On the strength of these findings, further analysis was conducted 
to find i) whether there is an association between age, gender and the extent of DNA 
methylation, in line with previous reports ii) if ageing of the participants in the study 
impacted DNA methylation and iii) whether physical activity, or a change in physical 
activity, affected the extent of age-related DNA methylation independent of other 
confounding variables.  To this end, gender differences in methylation at baseline 
were investigated using Wilcoxon-Mann-Whitney’s rank sum test, and the change 
between baseline and year 8 using a Fisher sign test. Where evidence of association 
was found, Type I analysis of variance (ANOVA) was used to explore the explanatory 
ability of PAEE in the presence of the other variables (‘age’, ‘sex’, ‘plate’, 
‘log(Wbld)’ and ‘∆Waist’), after applying logit and fourth-root transformations to the 
fractional methylation and PAEE variables, respectively. 
Total CHS cohort (n = 5,888) 
Blood samples available for baseline and year 8 (n = 5201) 
Subset randomly selected for analysis (n = 540) 
Successful bisulphite conversion and methylation analysis (n = 497)  
Complete physical activity energy expenditure (PAEE; kcal/wk) and 
anthropometric data available (n = 421) 
Caucasians (n = 
390) 
African-Americans, Native Americans, Pacific 
islanders, Hispanics, Asian Americans (n = 31) 
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Using all available data (irrespective of PAEE), associations between baseline 
methylation and age were investigated using Spearman rank correlation. The change 
in the proportion of methylation between baseline and year 8 for the eight genes and 
LINE-1 was treated as the response variable and analysed using analysis of variance, 
ANOVA. Associations between baseline methylation and age (Spearman correlation) 
were compared with longitudinal changes in methylation (Fisher’s sign test) using 
standardised z-scores, which for age were calculated as 
𝑧𝑆𝑅𝐶  =  √(𝑛 − 3) 1.06⁄ atanh(𝜌SRC) , where n and ρSRC are the sample size and 
Spearman rank correlation, respectively. 
To determine any potential impact of a change (∆) in PAEE on change in 
methylation, independent of some key variables with which it might be associated 
(age, gender, waist circumference and white blood cell count), three sets of modelling 
were conducted. First, models were constructed using the stratified ∆PAEE as a single 
explanatory categorical variable. Second, an additional five explanatory variables 
were introduced as main effects and the explanatory significance of ∆PAEE 
investigated in their presence (type I ANOVA). The five additional explanatory 
variables comprised two categorical variables and three continuous variables. The 
categorical variables were the 96-well plate batch identifier, which was treated as a 
block effect (‘Plate’), and gender (‘Sex’). The continuous variables were age at 
baseline (‘Age’), logarithmically transformed white blood cell count collected at 
baseline (‘log(Wbld)’) and change in waist circumference between baseline and year 
8 (‘∆Waist’). Third, backward elimination (using hierarchical type II ANOVA) was 
used to simplify an initial model comprising the five main effects; interactions 
between two categorical variables (∆PAEE, gender); and interactions between these 
categorical variables and the three continuous variables. Power transformation of the 
response was applied where appropriate based on Box-Cox diagnostics. Summary 
ANOVA tables of simplified models containing ∆PAEE are provided as 
supplementary material. 
Samples from the non-Caucasians were located on a single 96 well plate, and 
there was considerable heterogeneity of ethnicity therein (African-American, 
Hispanic, Native American, Pacific Islander, and Asian American). Given that 
considerable genomic variation occurs between populations (Haga, 2010) and that the 
effects of ethnicity (if any) could not be separated from the batch effects of sample 
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plates, this analysis was performed separately and provided as supplementary 
material. This highlights the need for targeted recruitment of these under-represented 
populations in future studies. 
Approximately 10% of participants showed lower levels of SERPINA5 
methylation (< 10%) compared with the rest of the group (21 – 93%). The reason for 
this was unclear, especially considering that several of the ‘low methylators’ fell into 
this category at only one time point. That this was the case suggests a failure of the 
assay might have been responsible, although this could not be confirmed. To reduce 
the risk of a Type 1 error, the ‘low methylators’ were therefore excluded from all 
analyses of SERPINA5 only. The size of the main study group and for SERPINA5, by 
gender and ∆PAEE, are summarised in Table 4.1. Statistical analysis was performed 
using Matlab (Mathworks Inc., Cambridge, UK). Significance was accepted where P 
< 0.05.  
 
Table 3.1 Size of main study group and SERPINA5 subgroup stratified by gender and 
∆PAEE: DEC, decrease of >500 kcal/wk; NOC, change of <500 kcal/wk; INC, 
increase of >500 kcal/wk. 
 
Subgroup 
sizes 
Main study group SERPINA5 subgroup 
 DEC (%) NOC (%) INC (%) DEC (%) NOC (%) INC (%) 
Females 92 (36) 122 (48) 39 (16) 79 (34) 114 (50) 37 (16) 
Males 65 (47) 49 (36) 23 (17) 57 (47) 45 (37) 20 (16) 
All 157 (40) 171 (44) 62 (16) 136 (39) 159 (45) 57 (16) 
 
 
3.3 Results 
 
3.3.1 Differences in DNA methylation by gender  
 
The methylation status of the eight genes and LINE-1 at baseline and year 8 are 
summarised in Figure 3.2 and Table 3.2. Table 3.2 also shows the differences in 
methylation at baseline between genders, and the change in methylation between 
baseline and year 8. At baseline, methylation of NOD2, SNCG and SOD3 was 
significantly greater in women, while LINE-1 was significantly less methylated.  
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Figure 3.2 Summary descriptions of DNA methylation values for the eight genes and 
for LINE-1 at baseline 
 
 
3.3.2 Associations between DNA methylation, baseline 
age and ageing 
 
The associations between DNA methylation at baseline with age were compared with 
the longitudinal changes in methylation using all the available data (497 cases, or 444 
for SERPINA5. Figure 3.3 provides strong evidence (P < 0.01) for a negative 
association between age and NOD2 methylation and a positive association with 
SERPINA5 methylation. Figure 3.3 also shows significant longitudinal changes 
between baseline and year 8 for reduced methylation of IL10, NOD2 and SNCG and 
increased methylation of TNF and SOD3. Together these observations show that for 
several genes the relationship between age and methylation changed significantly 
during the course of the study.  
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Table 3.2 Methylation levels (%) at baseline, gender differences in methylation at baseline, and change in methylation between year 8 and 
baseline. The first and third quartiles are denoted as Q1 and Q3, respectively. The lower and upper 95% confidence intervals are denoted 
L95%CI and U95%CI, respectively, and were calculated using a large sample approximation. The difference (female – male) in baseline 
methylation is denoted ΔMF-M, and was evaluated using the Wilcoxon-Mann-Whitney rank sum test. The change in methylation (year 8 – 
baseline) is denoted ΔM8-0, and was evaluated using the Fisher sign test. †: Analysis of SERPINA5 was conducted on a subgroup of 352 
individuals. 
DNA 
sequence 
Median Q1 Q3 ΔMF-M L95%CI U95%CI p-value ΔM8-0 L95%CI U95%CI p-
value 
ABCA1 44.36 30.84 57.22 -2.87 -6.98 1.43 0.211 0.174 -1.536 1.266 0.879 
IL10 21.70 14.23 32.16 1.93 -0.52 4.40 0.122 -4.397 -6.067 -3.022 9.3E-13 
NOD2 7.09 4.72 11.29 1.24 0.40 2.16 0.005 -1.938 -2.265 -1.660 1.3E-19 
SERPINA5† 64.70 56.10 70.60 -1.83 -4.35 0.55 0.139 -0.398 -1.434 0.525 0.488 
SNCG 44.05 33.64 55.53 5.69 2.39 8.92 8.19E-
04 
-2.074 -4.307 -0.899 0.004 
SOD3 96.36 94.10 98.17 1.79 1.11 2.47 5.59E-
08 
0.256 0.002 0.414 0.038 
TNF 67.96 58.94 77.27 -0.89 -3.62 1.85 0.506 2.538 0.515 3.854 0.004 
UGT1A1 94.47 92.69 95.97 -0.24 -0.73 0.27 0.357 0.029 -0.112 0.180 0.578 
LINE-1 94.68 93.39 95.60 -0.82 -1.14 -0.51 8.80E-
07 
-0.158 -0.286 0.046 0.244 
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Figure 3.3 Standardised (z) scores for effect of baseline age on DNA methylation 
(open bars) and longitudinal changes during the study on change in methylation 
(∆METH: filled bars) using Spearman’s correlation and Fisher’s sign test, 
respectively. *denotes significance (P ≤ 0.05), accepted if standardised score >1.96 or 
<-1.96.  
3.3.3 Baseline physical activity, changes in physical 
activity and associations with DNA methylation 
 
Baseline PAEE was negatively correlated with the methylation of SOD3 (P < 0.01) 
and SERPINA5 (P < 0.05) but was not a significant explainer (P > 0.05) of either 
gene’s methylation after adjusting for ‘Plate’ and ‘Sex’ (SOD3), or ‘Plate’ and ‘Age’ 
(SERPINA5). The investigation of an effect of physical activity on the change in TNF 
methylation between baseline and year 8 showed that ∆PAEE was a significant single 
explanatory variable (P = 0.0004); was significant after adjusting for the five 
additional explanatory variables (P = 0.0006); and was the most significant term (P = 
0.0007) in a simplified ANOVA model that also contained ‘Plate’ and ‘Age’; and 
‘Sex’, ∆Waist and their interaction. Figure 3.4 shows a significant increase in TNF 
methylation in NOC and INC participants compared with DEC participants. ∆PAEE 
was not a significant single explanatory variable for the change in IL10 methylation, 
but was significant after adjusting for the five additional explanatory variables (P = 
* 
* 
* 
* 
* 
* * 
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0.0377), and was moderately significant in a simplified model that also contained 
‘Plate’ (P = 0.0471).  
 
Figure 3.4. Variation in the change in DNA methylation (%) between year 8 and 
baseline for TNF and IL10 with ∆PAEE: DEC, decrease of >500 kcal/wk; NOC, 
change of <500kcal/wk; INC, increase of >500 kcal/wk. * significant difference (P < 
0.05) between DEC and remaing PAEE categories. 
 
Figure 3.4 shows that changes in IL10 methylation were negatively associated with 
increasing ∆PAEE, although the mean values for each stratum did not differ 
significantly. Figure 3.5a shows there was a positive association with the change in 
LINE-1 methylation and ∆PAEE in females, and a negative association in males, with 
the largest gender difference seen in subjects with increased ∆PAEE. An interaction 
between gender and ∆PAEE was also significant in a model for the change in LINE-1 
methylation that also contained ‘Plate’. Similarly for SNCG methylation, ∆PAEE was 
significant as an interaction with gender in a model that also contained ‘Plate’ (P = 
0.0163). Figure 3.5b shows SNCG methylation decreased more in men with increased 
∆PAEE. (P = 0.0302). ∆PAEE was a significant single explanatory variable for the 
change in SERPINA5 methylation (P = 0.0275). It was significant after adjusting for 
the five additional explanatory variables (P = 0.0123), and was significant as an 
interaction with gender in a simplified model that also contained ‘Plate’ (P = 0.0104). 
Figure 3.5c shows that SERPINA5 methylation decreased significantly in INC vs 
NOC men. ∆PAEE was not significantly associated with the changes in ABCA1, 
NOD2, SOD3 and UGT1A1 methylation.  
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(c)  
Figure 3.5 Gender-specific variation in the change in DNA methylation (%) between 
baseline and year 8 for (a) LINE-1 (b) SNCG and (c) SERPINA5 with ∆PAEE: DEC, 
decrease of >500 kcal/wk; NOC, change of <500kcal/wk; INC, increase of >500 
kcal/wk. * denotes significant difference (P < 0.05) between gender at PAEE category. 
 
 
3.4 Discussion 
 
3.4.1 Differences in DNA methylation by gender 
 
Methylation of LINE-1 repetitive elements has been shown to be a valid surrogate 
marker of the 5-methylcytosine content of the genome often referred to as global 
DNA methylation (Weisenberger et al., 2005). Decreased LINE-1 methylation, which 
is suggested to induce genomic instability, has been observed during aging (Tapp et 
al., 2013) and is associated with a number of age-related diseases including CC 
(Belshaw et al., 2010), ischaemic heart disease and stroke (Baccarelli et al., 2010) and 
also with CVD risk factors (Cash et al., 2011). Therefore, the positive association 
between increasing PAEE and increased LINE-1 methylation identified here in 
women is consistent with a role for PA in reducing the risk of developing these 
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diseases and is concordant with observations from previous studies (White et al., 
2013; Zhang et al., 2011).  
Synuclein γ, encoded by SNCG, plays a role in lipid metabolism (Millership et 
al., 2013) and shows increased expression in adipocytes from obese women (Oort et 
al., 2008). Methylation of SNCG in peripheral blood was previously shown to 
decrease with age but increase in lung tissue with smoking (Christensen et al., 2009). 
Therefore, the significance of the inverse association between increased PAEE and 
SNCG methylation in our male participants in relation to disease risk requires further 
investigation. The observed gender-specific differences for associations between 
changes in the methylation of SNCG, SERPINA5 and LINE-1 and PA are consistent 
with a previous report that indicated a differential response to environmental factors 
on DNA methylation in the colorectal mucosa (Tapp et al., 2013). The reasons for this 
are not known, but may reflect gender differences in age-related disease risk (Mosca 
et al., 2011).   
SERPINA5, also known as Protein C Inhibitor (PCI), plays a regulatory role in 
the coagulation system and has been suggested as a risk marker for acute coronary 
events (Carroll et al., 1997). However, PCI has been shown to have both pro- and 
anticoagulant properties (Rau et al., 2007), which means that its role in CVD 
pathogenesis is not clear. The functional consequence of reduced SERPINA5 
methylation in men with increased PAEE therefore requires further investigation. A 
previous study reported increased methylation of SERPINA5 in peripheral blood from 
ever versus never alcohol drinkers and in lung tissue of smokers (Christensen et al., 
2009), suggesting that decreased SERPINA5 is associated with healthier lifestyle 
behaviours.  
3.4.2 Associations between DNA methylation, baseline 
age and ageing 
  
In this study we investigated the relationship between DNA methylation in leukocytes 
and physical activity in the elderly. We showed that participant age was associated 
with DNA methylation, in agreement with previous reports (Christensen et al., 2009; 
Xu et al., 2013). Also, it was observed that DNA methylation patterns which 
correlated with baseline age were often dissimilar to those associated with 
longitudinal changes observed during the course of the study. For example, TNF 
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methylation at baseline was negatively (albeit not significantly) correlated with age, in 
agreement with a previous study that showed a significant negative correlation 
(Gowers et al., 2011). The narrow age range (65-82 years) of the participants in this 
study may explain the weaker correlation. However, a significant increase in mean 
TNF methylation in our study population over the course of the study suggests a 
reversal in the age-related decline in the methylation status of this gene. Similar 
effects were also observed for the methylation of SNCG, SERPINA5 and IL10, and to 
a lesser extent UGT1A1 and LINE-1.  We postulate that the mandatory fortification of 
foods with folic acid in the U.S. in 1996-7, which occurred after the baseline blood 
samples were collected but before the year 8 samples, might explain this effect. Folate 
is a major source of methyl groups and its availability has been shown to impact upon 
DNA methylation (Bae et al., 2014; Charles et al., 2012; Tapp et al., 2013; Wallace et 
al., 2010). Similar perturbations in leukocyte DNA methylation patterns were 
observed in the Women’s Health Study, where erythrocyte folate status was correlated 
with increased leukocyte LINE-1 methylation prior to fortification, but with decreased 
LINE-1 methylation 1-2 years post-fortification (Bae et al., 2014). Measurement of 
blood folate in the study population is therefore necessary to elucidate whether this 
contributed to our observations.  
 
3.4.3 Changes in physical activity and DNA methylation 
 
To explore the relationship between PA and DNA methylation we utilized the 
availability of participant blood samples together with physical activity data collected 
at baseline and 8 years later. This enabled an investigation of associations between 
changes in PAEE with changes in DNA methylation, while also accounting for the 
effects of age, gender, changes in waist circumference and the potential batch-related 
effects of sample plate. We identified ΔPAEE as a significant main effect in 
explaining changes in the methylation of TNF and IL10. A gender-specific interaction 
with ΔPAEE was also significant when modelling changes in SERPINA5, SNCG and 
LINE-1 methylation. These observations indicate that changes in PA are associated 
with changes in the methylation status of genes known to be associated with aging 
and inflammation, and therefore might constitute a mechanistic link between PA and 
reduced CC risk. Importantly, associations between changes in DNA methylation and 
Chapter 3 Study 1 
73 
 
changes in PAEE were independent of any time-dependent changes in waist 
circumference. This suggests that PA and central adiposity affect DNA methylation 
via independent mechanisms.  
DNA methylation plays a significant role in the regulation of gene expression; 
therefore, the association of PA with DNA methylation possibly suggests a role for the 
altered expression of the affected genes in attenuating CC risk. Potentially significant 
in this respect are the observed associations between ΔPAEE and changes in the 
methylation of TNF and IL10. There is evidence for a role of systemic inflammation 
in increasing adenoma and CC risk, and CC mortality (Comstock et al., 2014a; 
Il'yasova et al., 2005; Joshi et al., 2014; Kim et al., 2008; Zhou et al., 2014). TNF 
encodes the pro-inflammatory cytokine tumour necrosis factor alpha (TNFα) and 
TNFα expression in peripheral blood is associated with atherosclerosis in the elderly 
(Bruunsgaard et al., 2000). The cytokine interleukin 10, encoded by IL10, inhibits 
inflammatory cytokine production, including TNFα (Cassatella et al., 1993).  
Our results suggest, therefore, that an increase in PA in people of this age 
group may be associated with reduced risk of CC risk by decreasing systemic 
inflammation via the concomitant, methylation-induced down-regulation of TNF 
expression and the demethylation-induced up-regulation of IL10 expression. A similar 
association with exercise and increased methylation of a pro-inflammatory gene 
(ASC) has previously been demonstrated in older Japanese persons after a 6-month 
brisk walking exercise intervention (Nakajima et al., 2010). Aberrant methylation of 
this gene has been demonstrated to affect p53-mediated chemosensitivity in colon 
cancer (Ohtsuka et al., 2006). Overall, this suggests that changes in the methylation 
status of inflammatory genes could underpin some of the reported anti-inflammatory 
effects of exercise training in the elderly (Woods et al., 2012), which might 
consequently attenuate CC risk. 
3.4.4 Limitations 
 
One limitation of the current study is that CC precursor tissue (i.e. colon biopsies) was 
not available. Therefore, whilst there is good evidence that aberrant methylation in 
colon tissue increases risk of CC (Ahuja et al., 1998) there is limited evidence that 
altered methylation in blood impacts CC risk. Of particular relevance is the recent 
finding that age-related DNA methylation in blood is associated with earlier mortality 
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in later life (Marioni et al., 2015). It is yet to be determined whether this is also 
associated with CC risk and mortality.  
Another potential limitation of the current study is that the methylation 
analyses were performed on leukocyte DNA, which is derived from a mixed 
population of cell types. It is possible, therefore, that the associations between DNA 
methylation and PA may simply reflect an impact on the relative proportion of cell 
types. For example, aerobic fitness has been associated with a decreased relative 
proportion of senescent T-cells (Spielmann et al., 2011). Furthermore, differential 
patterns of age-related demethylation of TNF have previously been observed in 
peripheral blood leukocytes and monocyte-derived macrophages (Gowers et al., 
2011). Given the potential significance of the observed effects of PA on the 
methylation status of genes with plausible role in modulating CC risk, this warrants 
further investigation.  
In addition, the amount of PA was self-reported, which potentially introduces 
recall bias. This might, in part, explain why no associations between DNA 
methylation and PAEE at baseline were observed. Since any participant-specific recall 
bias probably remained consistent between baseline and year 8, stratifying the 
participants by ΔPAEE will have negated this. Furthermore, stratification allowed a 
more sensitive appraisal of how a tangible change in PA is associated with DNA 
methylation patterns. In this respect, our observations are in agreement with previous 
work demonstrating that changes in physical activity level over the course of an 
exercise intervention was associated with altered DNA methylation patterns in a 
variety of tissues (Bryan et al., 2013; Nakajima et al., 2010; Nitert et al., 2012; Ronn 
et al., 2013).  
It should be noted that, in this longitudinal multi-centre study, trial site was not 
included as a covariate in the model. This could plausibly introduce variation due to 
differences in demography, but perhaps more importantly this might have caused 
variation in standard operating procedures for data collection. For example, whilst 
other work in this population has suggested that measurement of waist circumference 
was performed about the umbilicus (Luchsinger et al., 2013) there is no intimation of 
standardisation between sites. This brings into question the reliability of ‘Waist’ in 
the statistical models used.  
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Another possibility is that seasonal variation might have impacted on PA 
participation at the time of the clinic visits, confounding the PA data.  Furthermore, 
one study has suggested that month of blood draw could impact on DNA methylation 
status of CC-related genes (RASSF1A and MGMT) and LINE-1 (Ricceri et al., 2014). 
A separate analysis was conducted to determine whether this was the case, and it was 
found that only one participant in the cohort attended clinic visits in opposite seasons 
(i.e. summer and winter). In addition, a change in PA participation might have 
reflected reflect a change in health status. However, a separate χ2 analysis showed 
there were no differences in categories of ∆PAEE by change in self-report health 
status, and indeed no impact of change in health status on change in methylation (see 
Appendix). Of course, this might be subject to recall bias. Equally, there was no 
difference in mean ∆PAEE between those who had an incident cardiovascular event 
over the course of the study and those who did not (see Appendix Aii). While it is not 
clear from the PAEE calculation whether the intensity of activity (i.e. moderate or 
vigorous) or time spent in these activities accounted for the associations with DNA 
methylation, it is clear that an increase in leisure time PAEE, irrespective of how this 
was achieved, was associated with apparently favourable changes to the methylation 
status of genes plausibly associated with CC risk.  
3.4.5 Conclusion 
 
In conclusion, a change in PAEE was associated with changes in the methylation 
status of several inflammation-related genes and LINE-1 in a manner that is generally 
consistent with the role of PA in modulating CC risk. The observed associations with 
PA were independent of changes in measured central adiposity, suggesting PA might 
influence the epigenome, and consequently health, by mechanisms that are 
independent of its effect on body fat. We showed that changes in PAEE of 500 kcal 
per week, equivalent to approximately 120 min of brisk walking in older people, 
(Ainsworth et al., 2000; O'Donovan et al., 2010) correlated with significant changes 
in DNA methylation. Future studies utilising the increasing availability of approaches 
for genome-wide DNA methylation analysis in other tissues will further our 
understanding of how PA modulates the epigenome and the consequential influence 
on health. 
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Chapter 4 
 
Study 2: Physical Activity and Risk of 
Colon cancer (PARC) 
 
4.1 Introduction 
 
The role of PA in modulating DNA methylation patterns is being increasingly 
recognised (Denham et al., 2014; Voisin et al., 2015). The biological ageing process is 
predicted by DNA methylation (Horvath, 2013) and strongly influenced by 
environmental factors (Christensen et al., 2009), even amongst monozygotic twins 
(Talens et al., 2012). As aberrant DNA methylation is associated with adenomatous 
polyps and CC (Belshaw et al., 2008; Esteller et al., 2001; Issa et al., 1994) it is of 
interest to determine whether PA in individuals at risk can alter DNA methylation 
patterns that are commonly linked to disease likelihood and progression. The presence 
of colon polyps suggests a perturbed epigenetic field (Belshaw et al., 2008; Chan et 
al., 2002) that might be malleable to unprompted changes in PA patterns (Figure 3.4) 
or a PA intervention (Bryan et al., 2013; Nitert et al., 2012). Previous reports have 
indicated that a six-month aerobic PA intervention is sufficient to induce changes in 
DNA methylation patterns in genes associated with metabolism and inflammation in 
blood, adipose tissue and muscle tissue (Nakajima et al., 2010; Nitert et al., 2012; 
Ronn et al., 2013). Additionally, minutes of walking achieved after 12-month low-
moderate intensity walking intervention amongst overweight premenopausal women 
was correlated with decreased methylation in genes associated with breast cancer risk 
in buccal cells (Bryan et al., 2013). It is not known whether a similar intervention in 
colon adenoma patients, who are at elevated risk for CC (Citarda et al., 2001; 
Winawer et al., 1993), could alter methylation patterns commonly associated with gut 
ageing and inflammation and hence cancer risk (Issa et al., 2001).  
As part of the UK National Bowel Cancer screening programme, patients who 
present with colon polyps have them surgically removed upon initial colonoscopic 
investigation. Results from the National Polyp Study (NPS) suggested that this 
procedure, known as a polypectomy, reduced colon cancer mortality by 53% in US 
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adults who presented with an adenoma between the years of 1980-1990 (Zauber et al., 
2012). Those with more than 6 small or more than 3 large (> 1 cm diameter) are 
invited for a follow-up colonoscopy 12 months afterward (Atkin and Saunders, 2002). 
This group of patients provide a unique opportunity to investigate any alterations in 
DNA methylation (amongst other measures) at the level the colon epithelia after a PA 
intervention, or indeed any lifestyle intervention. Since overall methylation of breast 
cancer-specific genes in buccal cells was modified by walking behaviour in 
premenopausal women (Bryan et al., 2013), the DNA methylation of this epithelial 
cell has potential for use as a surrogate marker.  
This population also provides an opportunity to investigate whether a PA 
intervention affects any serum factors that might be able to mitigate the progression of 
well-characterised in vitro models of colonic epithelia. This approach is especially 
usefully given the difficulty of obtaining colon biopsies, and can provide additional 
information as to the mechanisms by which PA could affect CC risk. Indeed, greater 
levels of PA are associated with apparently beneficial effects on serum factors that are 
linked with CC risk. For one, PA is correlated with reduced levels of pro-
inflammatory cytokines in serum in older persons (Woods et al., 2012), which is 
moderately associated with risk of CC and adenoma (Il'yasova et al., 2005; Kim et al., 
2008). In addition, PA can reduce fasting glucose and insulin (Knowler et al., 2002), 
which is also linked to CC risk (Giovannucci, 2007). There are a wide variety of CC 
cell lines for such an experiment (Ahmed et al., 2013), each with differing genetic and 
epigenetic characteristics (Table 1.2). It is of interest, therefore, to use these models 
should follow-up biopsies be unavailable.      
 
4.2 Methods 
 
4.2.1 Participants 
 
Participants were patients who had attended the Norwich and Norfolk University 
Hospital (NNUH) Gastroenterology Unit for a screening colonoscopy as part of the 
NHS Bowel Cancer Screening Programme after a positive faecal occult blood test 
(FOBT), or after direct referral for gastrointestinal symptoms by their General 
Practitioner, within the last three years. Those who presented with colon polyps upon 
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investigation were eligible to take part in the study. Inclusion criteria were i) diagnosis 
adenomatous polyps as a result of the screening colonoscopy; ii) aged 50-80 years and 
iii) physically able to partake in regular exercise. Exclusion criteria included i) no 
adenomatous polyps or diagnosis of CRC following the colonoscopy; ii) PA levels 
that meet the most recent American Cancer Society (ACS) guidelines for maintenance 
of health for at least the past 6 months (150 min/wk MVPA, in bouts of ten minutes or 
more); iii) presence or history of other co-morbid conditions which might preclude 
patients from safely undertaking regular exercise iv) presence of other colorectal 
conditions (e.g. inflammatory bowel disease) or known familial CRC syndrome; v) 
previous diagnosis of CRC; vi) inability to adequately understand written and spoken 
English, and vii) current involvement in other ongoing research. Current health and 
demographic data were captured from consenting participants using a bespoke 
questionnaire designed by the researchers. Data captured included age, gender, 
ethnicity, medication profile (type of medications, dosage level and frequency), family 
history of CRC, co-morbidities, spouse present in the home, occupation, level of 
education, alcohol consumption, smoking status and number of GP visits in the past 
year. The questionnaire was administered again after 12 months to monitor any 
changes that occurred during the trial.  
4.2.2 Recruitment  
 
Patients attending the hospital for their pre-assessment were given a study invitation 
letter, a patient information leaflet and a consent form. The form requested their 
approval for the collection of research biopsies should any polyps be found during the 
colonoscopy. On the day of their screening colonoscopy, patients returned their signed 
consent form in the presence of the researchers. A letter was also sent to their GP 
outlining their interest in the study and providing contact details if they had any 
further questions  
If the patient presented with any adenomatous polyps, a small research biopsy 
was taken from the sigmoid colon, placed in a 1.5 ml collection tube and frozen on 
dry ice. This was subsequently transferred to the Institute of Food Research and 
frozen at -80 °C until analysis. Once participants were informed of the outcome of 
their procedure by the clinical staff the researchers organised an appointment at the 
Exercise Science Laboratory at The University of East Anglia. At the appointment, the 
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researchers explained the study and gave the participant the opportunity to ask any 
questions before gaining full written informed consent.  
 
5.2.2.1 Randomisation 
 
After baseline measures were completed, participants were randomised into the 
control or intervention group and stratified by risk status. Risk status, in this instance, 
referred to the severity (number and size) of adenomas at investigation. Those with a 
more severe case were deemed ‘high risk’ by the clinical team and were invited to 
follow-up colonoscopy within 12 months; whereas those with fewer polyps and 
deemed ‘moderate risk’ were invited for follow-up after 36 months. Randomisation 
was performed using ‘R’ (R Core development team, http://www.R-project.org) by an 
independent biostatistician (Dr Jack Dainty) based at the Institute of Food Research. 
To ensure balancing between control and intervention groups, a covariate adaptive 
randomisation approach was used. The covariates were risk status, age, gender and 
BMI. These were chosen based on the probability that the severity of polyposis might 
indicate a greater epigenetic perturbation of the mucosal field, and that advancing age, 
being male and having a higher BMI have consistently been associated with increased 
risk of CC. Initially, participants were allocated randomly, and after the first five 
participants the balancing came into effect. Participants were assigned a unique code 
that blinded the researcher to their group allocation during analysis.  
4.2.3 Outcomes 
 
All biological outcome measures pertinent to this study were repeated after 6 and 12 
months. To minimise bias due to perceived expectancy, all physiological samples 
collected were coded so as to blind the researcher conducting the analysis as to the 
group allocation.  
4.2.3.1 Anthropometry 
 
Patients arrived at the Clinical Exercise Science laboratory after an overnight fast and 
having refrained from moderate-vigorous PA for 72 h, and from consumption of 
alcohol for 24 h. Height (m) and mass (kg) was measured using a calibrated 
stadiometer and balance (Seca 711, Seca UK, Birmingham, UK). Waist and hip 
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measurements (cm) were taken about the umbilicus and the widest point of the hips 
with a tape measure (Seca) three times and the mean taken. When consecutive 
measurements deviated by greater then 2 mm, a further measurements was taken such 
that all three results were within 2 mm. Resting blood pressure (DINAMAP v1000, 
GE Healthcare, Bucks, UK) was recorded in a semi-supine position after two minutes 
of resting quietly, and after participants voided the bladder body composition was 
obtained via bioelectrical impedance analysis (AKERN BIA 101, SMT Medical 
GmbH & Co., KG, Germany) and integrated software (BodyGram Pro 3.0, SMT 
Medical GmbH & Co., KG, Germany).  
4.2.3.2 Serum and buccal cell collection  
 
Serum and buccal cells were collected according to the procedures detailed in General 
Methods 2.2.  
4.2.3.3 Cardiorespiratory fitness 
 
Height (m) and mass (kg) was measured using a calibrated stadiometer and balance 
(Seca 711, Seca UK, Birmingham, UK). Maximal aerobic capacity ( ?̇?𝑂2 𝑚𝑎𝑥 ; 
𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛−1 ) was determined using a Medgraphics™ Ultima Cardio2 suite 
(Medical Graphics Corporation, St. Paul, MN, USA) using a 20-watt incremental 
ramp protocol on an electrically braked cycle ergometer (Lode Excalibur Sport, Lode 
B.V. Groningen, NL). Briefly, the test started with a 2 min ‘freewheel’ period against 
no resistance so that the participant was accustomed to the protocol. Thereafter, the 
resistance increased every minute by 20 watts until ?̇?𝑂2 𝑚𝑎𝑥 (as indicated by a plateau 
in ?̇?𝑂2 on the graphical display) or volitional exhaustion. During the test, a continuous 
10 lead ECG trace (Mortara XScribe 5, Mortara Dolby UK Ltd, Stirling, UK) was 
monitored by a medical professional, and the test stopped immediately where any 
abnormalities arose during the exercise bout. Once the participant reached their 
?̇?𝑂2 𝑚𝑎𝑥 and was unable to continue, the test finished and the participant allowed to 
‘freewheel’ against reduced resistance for as long as they deemed necessary. 
Participants then had the opportunity to shower and change and were allowed to leave 
after their resting heart rate and blood pressure has been checked. The test was 
repeated after six and twelve months, and prescribed exercise intensity in the 
intervention group adjusted accordingly.  
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4.2.3.4 Habitual physical activity 
 
Objective free-living PA level was assessed over 7 days using accelerometry 
(ActiGraph® GT3X, ActiGraph Corps, Pensacola, FL, USA). The small unobtrusive 
accelerometer was worn on the hip and collected data including estimated activity 
counts, step counts, minutes of moderate-vigorous PA (MVPA) per day and per week, 
bouts of MVPA of ten minutes or more, and total exercise energy expenditure. Data 
was analysed using integrated software (ActiLife version 6.9.1, ActiGraph Corps, 
Pensacola, FL, USA).  Self-reported PA was also assessed using the International PA 
Questionnaire (IPAQ) (Friedenreich et al., 1998) and the Godin Leisure Time 
Exercise Questionnaire (Godin and Shephard, 1985). The Godin Leisure Time 
Exercise Questionnaire is a short four-item questionnaire that assesses the number of 
times that strenuous, moderate or mild exercise was performed for more than 15 min 
over the last 7 days. 
4.2.3.5 Diet 
 
Diet was monitored at baseline and after 6 and 12 months of the intervention with a 
diet diary, which formed part of the PARC workbook. Participants had to complete the 
diary for a minimum of four week days and one weekend day. Participants were 
instructed not to change their dietary habit during the study. Diet composition was 
analysed using COMPEAT5 software.  
4.2.4 Intervention 
 
4.2.4a Active Lifestyle Programme (ALP) 
 
All participants in the Active Lifestyle Programme (ALP) attended a familiarisation 
session in the week before the trial started. They were introduced to the equipment 
available in the exercise facility (treadmill/rowing machine/cycle ergometer) and the 
various resistance/bodyweight exercises that the participants were required to 
perform. These included bicep curls, dumbbell flys, sit-ups and Theraband exercises. 
In the first 12 weeks of the study, participants attended the exercise facility on 2 d/wk 
and complete a supervised exercise session. This consisted of a ten minute warm up, 
30 minutes of aerobic exercise at 65-80% ?̇?𝑂2 𝑚𝑎𝑥 as determined by the ?̇?𝑂2 𝑚𝑎𝑥 test 
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(some participants were unable to exercise at a heart rate corresponding to 65% 
?̇?𝑂2 𝑚𝑎𝑥 for 30 min at the onset of the trial, so intensity was adjusted accordingly to 
ensure a full 30 min bout was completed) and 30 min of resistance exercise using the 
exercises described above. Sessions followed the principles of progression and 
overload such that participants continued to improve their fitness. On ≥ 3 days per 
week, participants completed home-based exercise to complement these sessions. In 
the second 12 weeks of the study, supervised exercise at the exercise facility took 
place on 1 d/wk only, and home-based exercise took place on ≥ 4 d wk.  For the 
remaining 24 weeks (for those participants recruited earlier in the study) participants 
were asked to complete ≥ 300 min of moderate to vigorous exercise per week, spread 
over ≥ 5 days. To help monitor non-supervised exercise activity, participants were 
provided with a physical activity diary with which to record the time spent, type and 
intensity of any occupational and leisure-time PA, with a copy of the 6-20 point Borg 
scale of perceived exertion (RPE; Borg, 1982) attached. Both the diary and Borg scale 
were introduced and explained to them at the initial familiarisation session. The 
research team advised that any leisure-time PA should ideally be completed at an RPE 
of 12-14, which equates to a ‘somewhat hard’ to ‘hard’ effort.  
The protocol was an adapted, less vigorous version of one used in a previous 
study of polyp patients (Campbell et al., 2007), where participants were encouraged to 
engage in 60 min of aerobic exercise at 60-85% VO2 max on six days per week. It 
was adjusted based on the assumption that the patients in the present study would be 
significantly older than those in the previous study. Indeed, the mean age of 
participants in the work of Campbell and colleagues was 55 years; whereas the 
National Bowel Cancer Screening Programme is typically offered to individuals over 
the age of 60. Secondly, a resistance exercise component was added to increase the 
variety of exercise options available, thereby increasing the likelihood of continuing 
the intervention. 
To encourage exercise participation and maintain adherence, ALP were 
provided with a bespoke PA workbook (the PARC workbook) designed by the 
researchers, which outlines suggestions for PA, and included PA logs, progress 
monitors and contact details of the researchers. The participant kept this workbook for 
the duration of the trial. Furthermore, ALP was provided with pedometers, which 
were used as a motivational tool to promote exercise (i.e. brisk walking) behaviour. To 
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promote adherence to the programme, theory-based workshops took place at the 
University of East Anglia every fortnight for the first 6 months of ALP and once a 
month for the remaining 6 months. The workshops were based upon the Self-
Determination Theory (Ryan and Deci, 2000) and covered a range of topics including 
goal-setting, benefits of regular exercise and exercise barriers. The workshops were 
designed and delivered by Liane Lewis, a member of the research team. During the 
first 24 weeks of the intervention, ALP attended one workshop every two weeks after 
a supervised exercise session, which lasted for approximately 30-45 min. A schematic 
outline of the ALP intervention is presented in Figure 4.2. 
4.2.4b Usual Care (UC) Group 
 
The UC group did not receive an intervention or any other form of advice with regard 
to lifestyle behaviours. However, they had the opportunity to take part in a limited 
number of supervised exercise sessions and received an intervention workbook at the 
end of the study. They did not receive any lifestyle advice or supervised exercise 
sessions until the end of the 12 months study period. Participants in the UC group 
undertook the baseline measures and repeated these at the same time points as ALP. 
These included a fitness test, body composition, blood samples and all questionnaires 
at 6 and 12 months. A schematic outline of UC is presented in Figure 4.1.
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Figure 4.1. Schematic diagram of Usual Care (UC)
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Figure 4.2 Schematic diagram of the Active Lifestyle Programme (ALP).
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4.2.5. DNA methylation 
 
Biopsies were collected at initial surveillance colonoscopy (baseline) and after 12 
months at a follow-up visit where possible. Biopsies were analysed for global DNA 
methylation status by quantifying the methylation of the repetitive element LINE-1, 
previously demonstrated to be suitable surrogate index of global methylation, using an 
adapted qPCR assay (Iacopetta et al., 2007). Gene-specific CGI methylation status of 
a panel of genes were also determined using combined bisulphite restriction analysis 
(COBRA) and ‘mega gel’ electrophoresis (Wang et al., 2003; Xiong and Laird, 1997) 
(see 3.8.1 Combined bisulphite restriction analysis (COBRA) and gel 
electrophoresis). Genes (ASC, IL6, IL10, TNF and TSLP) were selected based on their 
involvement in chronic inflammation, colon inflammation and their apparent 
amenability to changes in PA based on previous investigations from our laboratory 
(Chapter 4) and others (Nakajima et al., 2010). Other genes (APC, SOX17, WIF1, and 
HPP1) and LINE-1 were selected based on their involvement in age-related 
methylation of the colorectal mucosa (Belshaw et al., 2008). Another gene, BHMT2, 
was analysed based on its role in methyl group donation, and its possible amenability 
to exercise training (Buehmeyer et al., 2008).  
Briefly, primers were designed to capture an area rich in CpGs after the colon 
biopsy and buccal DNA samples had undergone bisulphite modification (Zymo 
Research Corp, Irvine, CA, USA) and amplified by PCR (see General Methods 2.8). 
The product was then EtOH-precipitated and digested with a specific restriction 
enzyme designed to cut methylated DNA fragments (Table 2.2) at a concentration of 
1% enzyme, 10% buffer and 89% RNAse free water (10 µl volume per sample) at the 
recommended temperature for ≥ 4 hours. The pool of cut and uncut fragments were 
then stained with 5 x loading dye and separated by gel electrophoresis in a high 
throughput ‘mega gel’ (C.B.S Scientific, San Diego, CA, USA). Gels were stained for 
> 1 hour with 10 µl neat SYBR Green and bands visualised with a PharosFX 
Molecular Imager (Applied Biosystems). The volume in each band was quantified 
using TotalLab software (Non-linear dynamics, Newcastle-upon-Tyne, UK) and 
percentage methylation calculated by using the formula 100 × M signal intensity/ (U 
signal intensity + M signal intensity). 
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4.2.6 Statistics 
 
4.2.6.1 Sample size calculation 
 
The sample size was based upon the numbers required to demonstrate a clinically 
important change in aberrant CGI methylation. Previous work has demonstrated that 
aberrant CGI methylation in key genes is inversely related to the progression of 
sporadic CC (Grady and Carethers, 2008; Kim et al., 2010b). Aberrant activation of 
the Wnt signalling pathway is a common pathological feature of colon carcinogenesis. 
One reason for this is that the gene encoding the lipid binding protein Wnt inhibitory 
factor 1 (WIF1) that can inhibit this pathway is frequently methylated. Therefore, the 
statistical power for the present study was based on the assumption that PA will i) 
significantly reduce the proportion of participants in whom the WIF1 gene is 
methylated in > 11% of alleles, and ii) reduce their WIF1 methylation profile by the 
equivalent of ten years of ageing. The 11% threshold was based upon data collected 
from the Biomarkers of Risk of CRC (BORICC; Food Standards Agency) study 
which indicated that 11% of participants aged between 47 – 53 have > 11% of WIF1 
alleles methylated, compared with 33% in those aged from 57 – 63 (Tapp et al., 
2013). The Cohen’s d calculation for independent samples (R Core development team, 
http://www.R-project.org) suggested that to achieve a significant reduction (P ≤ 0.05, 
80% power) of WIF1 gene methylation from 33% to 11%, in participants with > 11% 
of WIF1 alleles methylated, it was calculated that n = 124 (i.e. 62 participants per 
group) was required.  
4.2.6.2 Statistical methods 
 
Differences in gene-specific colon and buccal CGI methylation, and LINE-1 
methylation due to group allocation (ALP vs UC) after 6 and 12 months was analysed 
using a type 1 analysis of covariance (type 1 ANCOVA) with baseline methylation as 
a covariate. This method was also used to detect differences in anthropometric 
measures and accelerometer derived and self-report MVPA after 6 and 12 months, 
again using baseline values as covariates. Any possible associations between any of 
the participants’ characteristics (e.g. age, mass, CRF) and cell metabolic activity were 
explored using Pearson correlations. All tests were performed, and figures created, 
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using the Statistical Package for Social Sciences (SPSS) v.20 (IBM, Armonk, NY, 
USA). 
 
4.3 Results 
 
4.3.1 Recruitment 
 
 
In total, 736 patients were assessed for eligibility, and 31 randomised (see CONSORT 
Figure 4.3). Baseline characteristics of the participants are presented in Table 4.1. Of 
the participants, 22 completed ALP or UC for 6 months, and 13 completed 12 months.   
 
Figure 4.3 CONSORT diagram of PARC RCT 
4.3.2 Compliance 
 
Attendance at the supervised exercise sessions and workshops after randomisation 
was 62% and 53%, respectively. All participants gave advanced notice of non-
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attendance. Principal reasons for non-attendance included illness, holidays and work 
commitments. However, when participants who dropped out of ALP shortly after 
randomisation were excluded, the remaining participants attended 82% of exercise 
sessions. The combined attrition rate across ALP and UC was 29%. 
 
4.3.3 Anthropometry, cardiorespiratory fitness and 
physical activity 
 
Body weight, BMI and body fat was unaffected by group allocation at all time points. 
CRF was significantly greater in UC at baseline (Table 4.1). ALP significantly 
increased CRF after 6 months (P < 0.05); whereas no change was observed in UC 
(Figure 4.4). However, there were no significant differences between groups after 12 
months (Figure 4.5). There were group-related differences in self-report PA between 
UC and ALP after six and twelve months of the intervention. ALP significantly 
increased self-report leisure-time PA after 6 months (P < 0.05), with no change in UC 
(Figure 4.6). However, the increase in ALP was no longer significant after 12 months 
when corrected for baseline self-report leisure-time PA (Figure 4.7). According to 
accelerometry data at baseline, ALP completed significantly more moderate-vigorous 
PA (Table 4.1). The number of minutes spent in MVPA in of bouts of ten minutes or 
more did not change significantly in UC or ALP from baseline after 6 months (Figure 
4.8) or 12 months (Figure 4.9). 
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Table 4.1 Baseline characteristics of patients in the PARC randomised controlled trial. 
All values in upper portion of table presented as mean (SD). Values in lower portion 
of table denote numbers of participants with each co-morbidity. * denotes significant 
difference between groups, P < 0.05. 
 
 
Group UC  ALP  
 Females Males All Females Males All 
N 5 9 14 6 11 17 
Age 65.2 (2.7) 71.8 (1.8) 69.4 (6.3) 66.6 (1.6) 68.2 (2.7) 67.7 (3.0) 
Mass (kg) 68.5 (7.3) 89.2 (3.8) 81.8 (16.3) 81.2 (3.8) 90.9 (20.7) 87.7(17.8) 
BMI 25.6 (7.0) 28.9 (2.9) 27.7 (4.8) 30.3 (3.5) 29.8 (5.8) 30.0 (5.0) 
Body fat (%) 31.0 (8.8) 23.8 (5.5) 26.4 (7.5) 37.7 (3.8) 25.7 (7.2) 29.7 (8.5) 
Self-report 
leisure-time PA 
(MET h/wk) 
6.0 (3.3) 7.0 (3.6) 6.7 (9.4) 4.7 (4.4) 10.3 (14) 8.5 (11.8) 
Accelerometer-
derived MVPA 
(min/wk) 
132 (81) 101 (87) 112 (83)* 103 (108) 194 (128) 164 (126) 
?̇?𝐎𝟐 𝐦𝐚𝐱  
(𝐦𝐥 ∙ 𝐤𝐠 ∙ 𝐦𝐢𝐧−𝟏) 
23.7 (2.9) 25.1 (4.6) 24.6 (4.0)* 17 (3.6) 25.8 (5.8) 22.8 (6.6) 
Obesity 2 2 4 4 6 10 
Hypertension 1 2 3  3 3 
Cardiovascular 
disease 
 2 2 2 2 4 
Type II diabetes  4 4    
Pulmonary 
disease 
 1 1 2 2 4 
Family history 
of colon cancer 
2 2 4  1 1 
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 Figure 4.4 Significant (P = 0.015) difference between Usual Care (UC: filled bar) and 
Active Lifestyle Programme (ALP: open bar) in change in cardiorespiratory fitness 
(CRF, ∆ml ∙ kg ∙ min−1) from baseline to 6 months. Error bars ± 1 SE. 
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Figure 4.5 Significant (P = 0.002) difference between Usual Care (UC: filled bars) 
and Active Lifestyle Programme (ALP: open bars) in self-report leisure-time physical 
activity (PA) in metabolic equivalent of task (MET) hours per week after six  months 
when adjusted for baseline leisure-time PA . Error bars ± 1 SE. 
 
* 
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Figure 4.6 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in self-report leisure-time physical activity 
(PA) in metabolic equivalent of task (MET) hours per week at baseline and after 12 
months. No difference after 12 months by group allocation when adjusted for baseline 
leisure-time PA . P = 0.328, error bars ± 1 SE. 
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Figure 4.7 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in minutes per week spent in moderate or 
vigorous physical activity (MVPA) in bouts of ten minutes or more  according to 
accelerometer data at baseline and after 6 months. P > 0.05, error bars ± 1 SE.  
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Figure 4.8 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in minutes per week spent in moderate or 
vigorous physical activity (MVPA) in bouts of ten minutes or more according to 
accelerometer data at baseline and after 12 months. P > 0.05, error bars ± 1 SE. 
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4.3.4 Diet 
 
Details of macronutrient and some micronutrient composition of the diet recorded by 
ALP and UC participants at baseline, 6- and 12-months are displayed in Table 4.2. 
Taking part in either ALP or UC did not affect diet composition over time, nor were 
there any inter-group differences in diet composition at any time point. 
 
Table 4.2 Diet composition in PARC participants  
 
Group UC  ALP  
 Baseline 6-mo 12-mo Baseline 6-mo 12-mo 
N 14 10 7 17 12 8 
Energy (kcal) 
1697 
(576) 
2049 
(676) 
1648 
(418) 
1871 
(823) 
1584 
(705) 
1454 
(546) 
Protein (g) 65 (22) 76 (25) 63 (14) 80 (55) 66 (24) 71 (19) 
Carbohydrate 
(g) 
214 (89) 272 (100) 200 (69) 214 (93) 193 (145) 175 (98) 
Fat (g) 64 (21) 76 (29) 62 (15) 73 (47) 53 (23) 53 (22) 
Fibre 18 (10) 25 (14) 18 (11) 18 (8) 16 (9) 18 (11) 
Selenium 36 (13) 39 (16) 27 (10) 53 (67) 39 (20) 45 (19) 
Vitamin D 2.8 (4.0) 3.4 (2.0) 1.6 (0.7) 2.8 (3.1) 1.8 (1.4) 3.1 (2.5) 
Folate 240 (134) 289 (115) 234 (134) 255 (94) 257 (237) 254 (121) 
 
4.3.5 DNA methylation 
 
Summary descriptions for the extent of DNA methylation for the eight genes for 
which there was sufficient DNA to analyse in both colon and buccal cells are 
displayed in Figure 4.10 and Figure 4.11, respectively. There was no correlation 
between buccal cell and colon DNA methylation in any of the genes studied or LINE-
1. APC ASC and HPP1 were predominantly unmethylated in colon biopsies (Figure 
4.10) and IL6, HPP1, APC and ASC were found to be unmethylated in buccal cells 
(Figure 4.11). Of the remaining genes with normal distribution of methylation at 
baseline, none were associated with any of the variables in Table 5.1. There were no 
effects of sampling time i.e. baseline, 6 and 12 months on differences in DNA 
methylation. There was no difference between ALP and UC on the methylation status 
of IL10 after 6 or 12 months, after correcting for baseline methylation levels (Figure 
4.12 and Figure 4.13, respectively). There was also no difference between ALP and 
UC on the methylation status of TNF after 6 or 12 months, after correcting for 
baseline methylation levels (Figure 4.14 and Figure 4.15, respectively). Equally, there 
Chapter 4 Study 2 
98 
 
was no difference in change in methylation between ALP and UC in the remaining 
genes and LINE-1. WIF1 could not be analysed due to a lack of sufficient DNA, 
evidenced by multiple bands on the mega-gel.  
 
 
 
Figure 4.9. Summary descriptions of sigmoid colon biopsy DNA methylation values 
for seven genes and for LINE-1 at baseline. 
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Figure 4.10. Summary descriptions of buccal cell DNA methylation values for seven 
genes and for LINE-1 at baseline. 
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Figure 4.11 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in IL10 buccal cell methylation (%) at 
baseline and after 6 months. Error bars ± 1 SE. 
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Figure 4.12 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in IL10 buccal cell methylation (%) at 
baseline and after 12 months. P > 0.05, error bars ± 1 SE.  
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Figure 4.13 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) in TNF buccal cell methylation (%) at 
baseline and after 6 months. Error bars ± 1 SE. 
 
 
 
 
 
Chapter 4 Study 2 
103 
 
 
Figure 4.14 No significant difference between Usual Care (UC: filled bars) and Active 
Lifestyle Programme (ALP: open bars) TNF buccal cell methylation at baseline and 
after 12 months. Error bars ± 1 SE. 
 
4.4 Discussion 
   
4.4.1 Physical activity and cardiorespiratory fitness 
 
According to the IPAQ and Godin Leisure Time Exercise Questionnaire, ALP 
successfully increased the amount of self-report leisure-time PA to a mean of 18 MET 
hrs per week after 6 months (Figure 4.4), which was maintained after 12 months (4.5), 
although there was no significant difference between ALP and UC after 12 months 
when baseline PA was taken into account (Figure 4.5). However, this ultimately fell 
short of the 300 min/wk target set by the research team. This was accompanied by 
increases in CRF in ALP (Figure 4.6), although this was not observed after 12 months 
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(Figure 4.7). This is possibly because i) the contact time with participants in ALP was 
reduced, and ii) fewer participants completed the study to 12 months (n = 15), which 
introduces the possibility that there was insufficient power to detect differences. 
Change in CRF was unrelated to body mass, which remained stable in both groups 
(Table 4.1). Surprisingly, it was also not associated with any changes in time spent in 
bouts of moderate-vigorous PA measured via accelerometer (Figure 4.8). There are 
several possible explanations for this finding. For one, it might be that the 
accelerometer was worn during a week where less moderate-vigorous PA was 
performed, despite more time being devoted to leisure-time PA. Another reason might 
be that the accelerometer was insufficiently sensitive in detecting lower intensity PA 
in our participants. Given that the majority of our participants had very poor fitness 
for their age at baseline according to previous work (Sui et al., 2007), it is highly 
possible that very modest changes in PA behaviour resulted in substantial fitness 
gains. 
4.4.2 DNA methylation 
 
Buccal cell methylation and colon DNA methylation of all genes studied were not 
correlated at baseline. This is perhaps because age-related methylation of individual 
genes is tissue specific (Sliekerk et al., 2013; Lokk et al., 2014) and this specificity is 
still apparent in response to environmental stimuli (Christensen et al., 2009). Despite 
methylation patterns being similar across functionally similar tissues (Lokk et al., 
2014) this relationship might not extend to buccal and gut epithelia, which perform 
dissimilar roles. This heterogeneity might render surrogate gene-specific methylation 
markers unsuitable for accurately estimating methylation status of more inaccessible 
tissues such as the colon. As we could not obtain follow-up colon biopsies, we cannot 
be sure that beneficial adaptations not observed in buccal tissue also did not occur in 
the colorectal mucosa. Given the unpredictable nature of colonoscopy outcomes, and 
the considerable time between investigations after adenoma detection (1 – 3 years 
(Atkin and Saunders, 2002)) future investigations into colon DNA methylation and 
other biomarkers of risk from colon biopsies in a randomised trial setting might have 
to occur outside the auspices of the National Bowel Cancer Screening Programme.  
In contrast to the present work, other exercise studies have succeeded in 
affecting DNA methylation patterns after six months in adipose tissue and muscle, in 
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men at elevated risk of type 2 diabetes (Nitert et al., 2012; Ronn et al., 2013). 
Interestingly, the majority of DNA methylation changes in those investigations did not 
occur in CpG islands but CpG island shores distant from the promoter. Similarly, 
widespread changes in CpG island shore methylation are abundant in cancerous colon 
tissue (Irizarry et al., 2009). As the current study investigated the promoter region, 
there is a possibility that differentially methylated regions were not measured. Of the 
genes with altered CpG methylation after exercise training in adipose tissue, 39 were 
candidate genes for type 2 diabetes or obesity and involved in the metabolism of 
adipocytes, which is possibly related to the loss of fat as a result of the intervention 
(Ronn et al., 2013). In addition, the genes that displayed differential methylation in 
skeletal muscle were principally involved in pathways including insulin signalling, 
metabolism of carbohydrate, and cell signalling (Nitert et al., 2012). In both cases, the 
differences observed were plausibly linked with the morphological and functional 
changes that accompany exercise training, e.g. improved insulin sensitivity, fat 
metabolism and decreased reliance on carbohydrates for muscle fuel. Given these 
findings, it is perhaps unsurprising that we did not find any effect of ALP on buccal 
cell DNA methylation, as the dose of PA was much lower in intensity than the work of 
Ronn and colleagues, and the tissue had no direct involvement in exercise training. 
Indeed, it might be that such dramatic changes could not be achieved in the buccal 
cells or colon tissue in older persons at risk of CC given that i) it is unlikely that 
sedentary older adults will enrol on or independently maintain a programme of high-
intensity aerobic exercise and ii) the tissues have no direct involvement in exercise 
training. 
It is possible that had we measured the DNA methylation status of genes in 
peripheral blood we might have observed changes associated with exercise behaviour, 
as our group has demonstrated previously. Another example of this phenomenon was 
shown by Nakajima and colleagues, who found that compared with aged-matched 
controls, a six month moderate-intensity walking protocol in older Japanese persons 
was associated with ~ 1% increased methylation of ASC in peripheral blood 
leukocytes compared with the control group, which indicates a reversal of age-related 
methylation in the selected CpG sites of that gene (Nakajima et al., 2010) and has 
been shown to increase with age in a separate report (Christensen et al., 2009). 
However, the study was not a randomised controlled trial, nor was any information 
pertaining to balancing or matching the participants in the control and intervention 
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arms published. Therefore, it cannot be ruled out that the differences observed were 
not due to the exercise protocol. In the present study, it was found that ASC was 
typically unmethylated in both colon and buccal cells (Figure 4.10, Figure 4.11). In 
addition, the extent of DNA methylation of IL10 and TNF observed in the colon 
biopsies obtained in this study (Figure 4.10) was dissimilar to those obtained from 
blood samples in the CHS, notably for IL10. Whilst we cannot infer that this 
represents a true difference between the methylation statuses of these genes in 
different tissues, it is worth noting that the baseline anthropometric characteristics of 
both study populations were similar. Again, this suggests that any effect of increasing 
PA on DNA methylation is tissue and gene-specific.  
4.4.3 Limitations  
 
Unfortunately, the study failed to recruit the number of participants deemed necessary 
at the outset. With hindsight, a smaller-scale feasibility study, or sham recruitment, 
would have been very useful in order to better estimate the likely uptake of 
participants into the study. Not performing this was a major limitation. As a 
consequence, this is reported as a pilot study. Previous work from our laboratory has 
indicated that TNF methylation might be susceptible to changes in PA (Chapter 3). A 
post-hoc estimate of achieved power with our small sample size was conducted using 
GPower software. Using the mean (SD) difference in TNF buccal cell methylation 
from baseline to 6 months by group, (n =10 in UC; n = 12 in ALP) the post-hoc effect 
size (d) was 0.154, which translated into an achieved power (1 – beta error 
probability) of 0.0636. An a priori calculation of required sample size based on 
obtaining 80% power was 1334 (Figure 4.14). It seems that the present study was 
highly underpowered, so it is perhaps unsurprising we did not find any significant 
differences in DNA methylation with PA. It is also possible that the original target of 
124 participants would have been insufficient to detect whether PA had any effect.  
The reasons for the low recruitment are multi-faceted and are probably related 
to the study design, location and patient group. Firstly, the FOBT has a specificity of 
~50% for polyps and cancer in those who have a positive test (NHS, 2015). This is 
broadly in agreement with the number of patients who agreed to take part who were 
ineligible due to absence of adenomas at colonoscopy in the present study. n addition, 
a UK-based qualitative investigation, published after recruitment had begun, had 
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strongly suggested that most colon polyp patients did not associate polyps with CC, 
were unaware of lifestyle influences on the disease, and were not prepared to change 
behaviour to reduce risk (Dowswell et al., 2012). 
 
 
Figure 4.15 Estimated sample size required to demonstrate effect of PA on buccal cell 
TNF methylation based on achieved power in the present study 
 
More recently, an investigation in New Zealand found that <13% of polyp patients 
with a family history of CRC who responded to a health questionnaire believed that 
the disease was related to lifestyle factors (Tarr et al., 2014). This might in part 
explain the high number of refusals to take part in eligible patients contacted. This is 
an attitude that requires tackling, since the estimated conversion rate of advanced 
adenomas to carcinoma is 25 – 43% depending on age and gender (Brenner et al., 
2007b). Another potential explanation for the low recruitment rate is that the Norfolk 
and Norwich University Hospital, whilst providing hospital services for 
approximately 995,000 persons, does so for the largely rural Norfolk and Waveney 
catchment area, regions of which have some of the lowest population densities in 
England. As such, many participants were unable to commit to ALP due to travel 
difficulties.  
Previous intensive lifestyle interventions have recruited larger numbers of 
participants from this patient group. For example, a 12-month exercise study based in 
Washington State, U.S.A, recruited 202 patients with a history of colon adenoma 
(McTiernan et al., 2006). However, this was achieved by sending invitations to 9,828 
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potentially eligible participants and utilised four health centres, with complimentary 
gym memberships provided. Even then, the actual recruitment rate was 2.1%, which 
was less than that of the present study (4.2%). Another year-long study, which focused 
on weight loss of 7% body weight in overweight polyp patients, achieved a 
recruitment rate of 33% from an initial pool of 997 (Anderson et al., 2014). Unlike the 
present study, this was achieved in a multicentre setting over 17 months. Also, the 
study required far less contact time with the research team (5.25 hrs per participant), 
which probably made taking part more palatable despite the demands of the 
intervention. 
Furthermore, the attrition rate for this study was 29%. This is considerably 
greater than that seen in similar exercise intervention studies in cancer survivors, 
which typically report approximately 10% drop-out (Bisschop et al., 2015). This is 
possibly because cancer survivors might be more motivated to continue with such an 
intervention. Certainly, although the participants in the current study were polyp 
patients, with some suffering from other chronic disease, they were cancer-free. A 
comparable attrition rate (35%) was observed in cancer-free physically inactive 
Australians aged > 66 during a six-month randomised walking and resistance training 
intervention (Jancey et al., 2007). The only previous randomised exercise study in 
colon polyp patients failed to publish drop-out rates (McTiernan et al., 2006), so it 
remains unclear whether the present investigation experienced a greater or lesser 
extent of attrition than might be expected. 
Another limitation was that the groups were not balanced in terms of CRF and 
baseline PA (Table 4.1). It was envisaged that the participants would follow similar 
physical activity patterns, in that they would all be sedentary. However, there was 
considerable heterogeneity in their PA behaviour patterns. This could plausibly have 
affected baseline DNA methylation, as minutes per week of PA and CRF have been 
associated with differential DNA methylation of buccal cell DNA in a previous report 
(Bryan et al., 2013). This was an oversight, and if the experiment were to be run again 
PA and CRF would form part of the randomisation strategy. 
In addition, whilst participants recorded their diet and were asked not to alter 
their dietary habit, it was not controlled. This could have had a profound effect on 
DNA methylation patterns, as it has been demonstrated that age-related DNA 
methylation in the rectal mucosa is inversely correlated with Vitamin D and selenium 
intake, but positively correlated with folic acid intake (Tapp et al. 2013). Folate is a 
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methyl group donor and can profoundly affect DNA methylation (Bae et al., 2014; 
Charles et al., 2012; Tapp et al., 2013; Wallace et al., 2010). Whilst there were no 
significant differences in self-reported consumption of these micronutrients by group 
or over time (Table 4.2) it cannot be ruled out that they did not change. 
Finally, peripheral blood leukocyte samples were not collected from the 
participants, which meant that we did not investigate whether the associations that 
were observed in our previous work in the CHS cohort could be replicated in a 
randomised trial. Whilst it is uncertain whether any changes in these cells are a proxy 
marker for colon DNA methylation patterns, this was perhaps a missed opportunity. 
4.4.4 Conclusion 
 
In conclusion, this study has demonstrated that the recruitment of adenoma patients to 
exercise intervention studies presents numerous challenges, which might render 
intensive exercise-based methods to decrease CC-specific risk in this group 
ineffectual. Secondly, there is little correlation between the methylation status of the 
inflammation and CC-risk specific genes in buccal and colon tissue analysed in this 
study, which suggests that buccal cell methylation might not be a suitable biomarker 
of CC-specific risk. Furthermore, there was no impact of a six-month to one-year 
aerobic physical activity programme on buccal cell methylation patterns. However, 
since the study was underpowered it is not possible to draw any definitive 
conclusions.  
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Chapter 5 
 
Study 3: The Regular exercise and colon cell 
growth (ReGro) study: Does cardiorespiratory 
fitness and physical activity participation in 
older men affect growth of colon cancer cells 
in vitro? 
 
5.1 Introduction 
 
Obtaining colon biopsies from persons at risk of CC in the context of a randomised trial 
presents numerous challenges. An alternative to obtaining colon biopsies can be found in cell 
line work, where at least 24 distinct types of colorectal cancer cell are used for research 
purposes (Ahmed et al., 2013). Physical activity (PA) and cardiorespiratory fitness (CRF) 
have been inversely associated with risk of breast, prostate and colon cancer CC, and overall 
cancer mortality based on strong observational evidence (Evenson et al., 2003), although 
there is no evidence from randomised trials. The mechanisms behind this phenomenon are 
not well understood, but are chiefly attributed to PA-induced alterations in chronic 
inflammation, immune function, hormonal concentrations and oxidative stress (Friedenreich 
et al., 2010a; Gleeson et al., 2011). These purported effects of PA on cancer risk and 
progression can be investigated through in vitro models. This method has demonstrated that 
growth of the prostate cancer cell line LNCaP is potentially susceptible to alterations in 
energy balance. For example, a two-week intensive Pritikin diet and exercise programme 
resulting in weight loss in obese men inhibited growth of LNCaP by 30% compared with 
baseline (Ngo et al., 2002). Incubation in serum from long-term (14 y) adherents to the 
Pritikin programme reduced cell growth by a further 14% (Ngo et al., 2002). Furthermore, it 
was found that serum from obese men also induced LNCaP proliferation compared with lean 
individuals who had not followed the Pritikin regimen (Leung et al., 2004). The authors 
attributed this to a reduction in insulin-like growth factor-1 (IGF-1) and an increase in its 
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binding protein IGFBP-3, which was confirmed to affect LNCaP growth in a related study 
(Ngo et al., 2003).  
The findings from Ngo and colleagues must be viewed with caution since the most 
likely explanation for altered IGF-1 and IGFBP-3, resulting in reduced cell growth after two 
weeks was energy restriction rather than a change in diet and exercise patterns. Acute energy 
restriction has long been known to induce this effect (Thissen et al., 1994), and importantly 
this does not translate to reductions in IGF-1 or IGFBP-3 in the long term in the absence of 
malnutrition (Belobrajdic et al., 2010; Fontana et al., 2008). Moreover, the long-term 
adherents to the Pritikin programme were of normal weight, which confounds any 
comparison with the obese men in that study. Indeed, obesity is associated with higher free 
concentrations of these hormones (Nam et al., 1997) so any differences cannot be reliably 
attributed to diet and exercise.  
More recent work has shown that pooled serum taken from the femoral artery in ten 
healthy young men after 60 min of cycling exercise at 50-65% ?̇?𝑂2 𝑚𝑎𝑥  reduced LNCaP 
growth by 31% compared with incubation in serum taken prior to exercise (Rundqvist et al., 
2013). This might, in part, be related to the inflammatory response to exercise. An acute bout 
of exercise induces changes in some inflammatory biomarkers. Notably, IL-6 has been 
demonstrated to be elevated four-fold after thirty minutes of moderate intensity treadmill 
exercise in the serum of trained runners (Ostrowski et al., 1998) and two-fold after 40 
minutes of moderate cycling exercise in sedentary, middle aged men (Mendham et al., 2011). 
his is also associated with an increase in the anti-inflammatory cytokine IL-1ra in lean men 
immediately after 60 min of moderate intensity running (Peake et al., 2005; Scott et al., 
2011), which peaks approximately 1 hr after exercise (Ostrowski et al., 1998; Peake et al., 
2005; Scott et al., 2011). After high-intensity interval running in active males a transient 
increase in the pro-inflammatory mediator IL-8 is also observed (Croft et al., 2009). In 
addition, a high-intensity continuous bout of running (60 min, 85% 𝑉𝑂2𝑚𝑎𝑥 ) induces 
increases in the anti-inflammatory cytokines IL-1ra and IL-10 in endurance-trained men, 
which again peaks 1 hr after exercise (Peake et al., 2005). Since inflammatory markers are 
modulated by PA, and chronic inflammation is associated with CC risk (Caruso et al., 2004; 
Franceschi et al., 2000a; Il'yasova et al., 2005), this could be a mechanism by which a single 
bout of exercise mitigates cell growth in vitro.  
Combined, the results of these studies lend partial support to the hypothesis that PA 
participation could induce biologically relevant changes in serum that affects the proliferative 
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capacity of one type of malignant cell. To the author’s knowledge, this hypothesis is yet to be 
tested in CC cell lines using serum from participants who have partaken in regular moderate-
vigorous PA (MVPA) over many years and who have excellent CRF, those who have a 
sedentary lifestyle, and those who have recently taken up a programme of MVPA. It is also 
not known whether a single bout of exercise can affect the capacity of serum to retard CC cell 
line growth.  
Therefore, to examine whether serum-induced growth of CC cells is modulated by 
long-term MVPA, CRF or a single bout of exercise, we sought to recruit older men free of 
metabolic or cardiovascular disease with varying CRF. We also aimed to investigate whether 
a single bout of exercise could affect growth of these cells, as has been demonstrated in the 
LNCaP cell line (Rundqvist et al., 2013). Therefore, given the negative association between 
MVPA and CRF on CC risk and mortality (Wolin et al., 2009), the aim of this pilot study (the 
Regular Exercise and colon cell GROwth study: ReGro) was to investigate whether serum 
from long-term MVPA participants and with excellent CRF affects growth of CC cell lines, in 
the fasted state and after a single bout of exercise, compared with disease-free controls. To 
test the hypothesis that recently changing exercise behaviour might influence serum 
composition that could also meaningfully affect cell growth, a population previously 
recruited to a randomised exercise trial in our laboratory was used. Twenty male participants 
from the PARC RCT (Chapter 4) provided serum at baseline, and after 6 months of taking 
part in the supervised exercise portion of the study. These samples were used to treat CC cell 
lines to determine whether the ALP intervention influenced the ability of serum to inhibit cell 
growth.  
 
5.2 Methods 
 
5.2.1 Study design 
 
This investigation was split into two components. The first of which was a repeated 
measures, counterbalanced, crossover design in older men free of metabolic and 
cardiovascular disease (the ReGro study, Figure 5.1). Participants were randomly allocated to 
either exercise followed by rest group (Group 1: EX-REST) or vice-versa (Group 2: REST-
EX). Randomisation was completed by a member of the Biostatistics team at the Institute of 
Food Research (Dr Jack Dainty). Participants were assigned a unique code which blinded the 
researcher as to their group allocation and time of sampling during analysis. The second was 
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a randomised controlled trial of MVPA participation in older colon adenoma patients (Figure 
4.1, 4.2). A detailed description of the PARC intervention study can be found in Chapter 4.2 
Methods. Briefly, adenoma patients were randomly assigned to either the Active Lifestyle 
Programme (ALP; a six-month predominantly aerobic exercise intervention) or UC (Usual 
Care).   
 
5.2.2 Participants 
 
Twenty male volunteers free of known cardiovascular or metabolic disease and with no 
history of malignancy were recruited via paper and online flyers placed on the Norwich 
Research Park, the Norfolk and Norwich University Hospital, and in the Norwich Evening 
News. The baseline characteristics of the participants can be found in Table 5.1. Recruitment 
of the PARC participants was completed via the Norfolk and Norwich University Hospital 
(see 4.4.1 Participants and 4.2.2 Recruitment). The baseline characteristics of these 
participants can be viewed in Table 5.2. 
 
5.2.3 Cardiorespiratory fitness 
 
Maximal aerobic capacity ( ?̇?𝑂2 𝑚𝑎𝑥 ; 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛
−1 ) in the ReGro participants was 
determined using a Medgraphics™ Ultima Cardio2 suite (Medical Graphics Corporation, St. 
Paul, MN, USA) with a Balke graded treadmill protocol. A comfortable running/brisk 
walking speed was selected for each participant (5.5 - 9 kph) and gradient increased by 1% 
every minute until volitional exhaustion or ?̇?𝑂2 𝑚𝑎𝑥 was achieved. This was considered to 
have occurred if a plateau in ?̇?𝑂2  was evident on the graphical display, respiratory exchange 
ratio (RER) was at least >1.15, and age-predicted maximum heart rate was attained. A real-
time 10 lead ECG trace was monitored by a medical professional to ensure safety both during 
and after completion of the test. Owing to the reduced physical capacity of the PARC 
participants, a cycling protocol was used instead (see 4.2.3.3 Cardiorespiratory fitness). 
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5.2.4 Current physical activity 
 
Current PA for both sets of participants was assessed using a self-report diary on which 
participants were instructed to list all occupational and recreational PA for a minimum of 7 
days. In addition, objective free-living PA level was assessed over this period using an 
accelerometer worn about the right hip (ActiGraph® GT3X, ActiGraph Corps, Pensacola, 
FL, USA). The small unobtrusive accelerometer was worn on the hip and collected data 
including estimated activity counts, step counts, minutes of MVPA per day and per week, 
bouts of MVPA of ten minutes or more, and total estimated exercise energy expenditure. Data 
was analysed using integrated software (ActiLife version 6.9.1, ActiGraph Corps, Pensacola, 
FL, USA). Data for both ReGro and PARC participants is displayed in Table 5.1 and 5.2, 
respectively. The activity count cut off points used are displayed in Table 2.1. 
5.2.5 Historical physical activity in ReGro participants  
 
For ReGro participants, historical physical activity was assessed using the Historical 
Adulthood Physical Activity Questionnaire (HAPAQ) (Besson et al., 2010).  Participants 
completed the ‘Life Calendar’ section (which was not analysed by the researcher) followed 
by the formal HAPAQ questionnaire in line with the original authors’ instructions. A PA 
‘prompt card’ was also used to identify the specific types of occupational or leisure time PA 
performed by the participants. The number of years the participants spent with the present 
physical activity pattern, according to accelerometer and PA diary, against which the HAPAQ 
has been validated (Besson et al., 2010), can be viewed in Table 5.1.     
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Figure 5.1 Study design for ReGro
Meeting at 
UEA 
Baseline 
measures and 
randomisation 
Group 1 
Exercise (45 min treadmill 
exercise, 60 min rest)  
Rest (105 min rest) 
Group 2 Rest (105 min rest) 
Exercise (45 min treadmill 
exercise, 60 min rest)  
Blood sample Blood sample Blood sample Blood sample 
Standardised 
breakfast 
Standardised 
breakfast 
1-2 weeks 1-2 weeks 4 day rest 
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5.2.6 Study days 
 
Participants arrived at the Clinical Exercise Science laboratory after an overnight fast and 
having refrained from moderate-vigorous physical activity for 72 h, and from consumption of 
alcohol for 24 h. On one of the visits, participants had resting blood pressure (DINAMAP 
v1000, GE Healthcare, Bucks, UK), height, mass, and body composition recorded via 
bioelectrical impedance analysis (AKERN BIA 101, SMT Medical GmbH & Co., KG, 
Germany) and integrated software (BodyGram Pro 3.0, SMT Medical GmbH & Co., KG, 
Germany). 20 ml of venous blood was taken from a vein about the cubital fossa using the 
Vacutainer® technique in serum collection tubes (Beckton, Dickinson and Company, 
Franklin Lakes, NJ, USA). The tubes containing whole blood were inverted gently several 
times and allowed to clot for 30 min at ambient temperature. They were then centrifuged at 
3600 rpm at 4 °C for 15 min (Thermo Fisher Scientific 1-SR Multifuge, Thermo Fisher 
Scientific, Waltham, MA, USA). Serum was extracted, pipetted into 1.5 ml Eppendorf tubes 
in 500 µl aliquots and frozen on dry ice. Each tube was given a 4 digit code which blinded 
the researcher to the participant identity and time of sampling. Serum samples were then 
stored at -75 °C at the Institute of Food Research. 
Immediately afterwards the first blood sample had been taken, ReGro participants 
consumed a standardised breakfast. The rationale for providing a standardised breakfast was 
based on initial ethical review, where it was suggested that refreshments should be provided 
to the participants after the exercise bout. Secondly, it was envisaged that several of the 
participants would be unaccustomed to sustained endurance exercise, and might experience 
discomfort if asked to do so in the fasting state. To minimise the impact of this on the blood 
samples post-exercise, the researcher decided to provide a standardised breakfast before 
exercise began. The breakfast consisted of a plain bagel (New York Bakery Company, 
Rotherham, UK) with a sachet of Robertson’s strawberry jam (Premier Foods, St Albans, 
UK) and Lurpak butter (Arla Foods, Viby, Denmark) a 250ml orange juice drink (Tesco PLC, 
Cheshunt, Herts, UK), and water ad libitum, within ten minutes. The total energy content was 
353 kcal, with 66% coming from carbohydrate, 9% from protein, and 25% from fat. The 
standardised breakfast was modelled on previous work into breakfast consumption and 
exercise metabolism (Farah and Gill, 2013).  
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After a further 20 min, ReGro participants either rested for 105 min or completed a 
treadmill run/walk for 45 min at 65% ?̇?𝑂2 𝑚𝑎𝑥 followed by 60 min of rest. Previous work has 
indicated that 120 min of rest after 65 min of cycling exercise corresponding to 
approximately 60% VO2 max was sufficient to retard LNCaP growth (Rundqvist et al., 
2013). However, the lack of control group meant that the effects might have occurred in the 
absence of exercise, and/or were related to the long time-frame after exercise. To ensure that 
that any effects were truly due to the exercise bout it was decided to reduce the time-frame 
post-exercise to 60 min and perform the study in a crossover fashion. Furthermore, his 
timeframe was chosen to coincide with a potential increase in anti-inflammatory mediators 
such as IL-1ra and IL-10 (Fig 5.1). An additional 20 ml of venous blood was then taken. 
Heart rate was monitored (Polar FT1, Polar Electro, Kempele, Finland) during the exercise 
bout to ensure that it corresponded to expected levels as determined by the maximal exercise 
test.  
5.2.7 Cell experiments 
5.2.7.1 Incubation protocol 
 
In order to gain a more comprehensive understanding of how serum factors might affect a 
wide variety of molecular phenotypes of CC, four different cell lines were chosen, namely, 
LoVo, Caco-2, HCT-116 and HT-29 (ATCC, Vanassas, MA, USA). A description of their 
phenotype can be found in Table 1.2. Detailed methods of cell handing and seeding 
procedures can be found in General Methods section 2.9. For the ReGro participants, the 
outer 36 wells of a 96-well cell culture plates (Nunc™; Thermo Fisher Scientific) were filled 
with 100 µl sterile PBS with a multi-channel pipette to limit evaporation. The remaining 60 
wells were divided into four quadrants of 12 wells each, which were seeded with 1 x 104 
cells, except in the case of HCT-116 which was seeded with 5 x 103 cells. Each quadrant 
represented one participant, and three wells were designated for serum obtained from each 
timepoint (i.e. Pre-Exercise, Post-Exercise, Pre-Rest, Post-Rest: Figure 5.1). For PARC 
participants, the remaining 60 wells were instead divided into eight lanes of six wells each. 
Each lane represented one participant at each timepoint (i.e. baseline, 6 months, 12 months). 
Six of the remaining 12 wells were used for the foetal bovine serum (FBS) control, 
and the final six were left empty. One of the empty wells was used as a negative control on 
the day of the assay. The position of the twenty PARC and ReGro participants across the five 
plates was distributed such that there was heterogeneity of CRF on each plate. Serum was 
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prepared on the day of seeding by thawing on ice for ~ 30 min. 200 µl was extracted after 
mixing and added to 1.8 ml of DMEM/F12 free of FBS, but containing PS, in a 2 ml 
Eppendorf. The serum concentration was therefore 10% of the total fluid volume. Tubes were 
labelled and refrigerated at 4 °C. All tubes were incubated at 37 °C for 20 min prior to use. 
After 24 h of seeding, the media containing FBS was removed by multi-channel pipette and 
replaced with media supplemented with participants’ serum or control serum containing FBS, 
and returned to the incubator. The procedure was repeated 48 hours later, except in the case of 
HCT-116 cells which were assayed after 48 hours. For all other cell lines, the assay was 
performed 48 hours after the second media replacement, when cells had reached 60-80% 
confluence.   
5.2.7.2 WST-1 Assay 
 
Culture media was removed from cells and replaced with 100 µl cell proliferation reagent 
WST-1 (Roche Diagnostics Corporation, Indianapolis, IN, USA) and fresh DMEM/F12 in a 
1/10 dilution. An empty well was also filled to serve as a background measurement, whose 
absorbance was subtracted from experimental wells. Plates were then incubated for three 
hours. The colorimetric assay was performed with a microplate reader using a single read 
Endpoint protocol (Bio-Rad Benchmark Plus, Bio-Rad Laboratories, Hercules, CA, USA). 
Dual absorbance was set between 450nm and 690nm as per manufacturers’ instructions, with 
a five second mix time at medium speed prior to plate read. Mean absorbance of six replicate 
wells and the six control wells treated with FBS on the same plate was calculated. The 
absorbance of the negative control was subtracted, and the results expressed as a percentage 
of the FBS control. 
5.2.7.3 Gene expression from cultured cells 
 
Where a significant result was returned from the WST-1 assay, gene expression was 
investigated to determine which pathways might have been responsible. 12 well cell culture 
plates (Nunc™; Thermo Fisher Scientific) were seeded with 3 x 104 cells in 300 µl media. 
Cells were incubated for 24 hours and media replaced with 300 µl 10% serum-supplemented 
media, which was replaced after 48 hours as above. After the 96-hour incubation, cells were 
lysed in situ and RNA extracted using an Isolate II RNA Mini Kit (Bioline) according to 
manufacturers’ instructions. Purified RNA was quantified by Nanodrop Spectrophotometer 
(Thermo Fisher Scientific). 4 µl of eluted RNA was reverse-transcribed using qScript™ 
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cDNA Supermix (Quanta Biosciences, Gaithersburg, MD, USA) as per the recommended 
protocol. 1.5 µl of triplicate samples were RT-PCR amplified in a Viia™ 7 Real-Time PCR 
System (Applied Biosystems) in a 5 µl reaction volume using the methods described 
previously (see 3.9.4 Gene expression from cultured cells) Primer sequences for the selected 
genes can be found in Table 2.4. Three genes (Ki67, c-Myc, MUC2) were selected due to their 
known associations with cell proliferation and oncogenesis (Gerdes et al., 1984; He et al., 
1998; Ho et al., 1993; Leoni et al., 2012), CDH1 (E-Cad) was selected based on its 
association with tumour suppression (Esteller et al., 2001; Visintin et al., 1997), LGR5 to 
assess presence of stem cells (Barker et al., 2007), COX-2 for its involvement in 
inflammation and metastasis (Tsujii et al., 1997) and DNMT3b for de novo methylation 
(Miranda and Jones, 2007) The ribosomal DNA sequence 18S was used as a reference gene 
(Table 2.4). Fold changes in gene expression relative to 18S reference gene in both sample 
and control wells treated with FBS was calculated using the ∆∆CT method described 
previously (Schmittgen and Livak, 2008). 
5.2.8 Statistical analysis 
 
In the ReGro study, a repeated measures analysis of variance (type 1 ANOVA) was conducted 
to determine any differences in cell metabolic activity due to treatment (EX vs. REST) or 
time (Pre vs. Post). Where significant results were returned, Mauchley’s Test of Sphericity 
was conducted to check if sphericity assumptions had been violated. In addition, where any 
differences were returned, post hoc t-tests with the Bonferroni correction were used to locate 
them. For the PARC participants, differences in cell metabolic activity due to group 
allocation (ALP vs UC) after 6 and 12 months was analysed using a type 1 analysis of 
covariance (type 1 ANCOVA) with baseline metabolic activity as a covariate. Any possible 
associations between any of the participants’ characteristics (e.g. age, mass, CRF) and cell 
metabolic activity were explored using Pearson correlations. All tests were performed, and 
figures created, using the Statistical Package for Social Sciences (SPSS) v.20 (IBM, Armonk, 
NY, USA). 
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5.3 Results 
 
5.3.1 Anthropometry, physical activity and cardiorespiratory 
fitness 
 
Baseline characteristics of all participants from ReGro and PARC studies are presented in 
Table 5.1 and 5.2, respectively. According to the Compendium of Physical Activity MET 
Intensities (Ainsworth et al., 2000) ten ReGro participants were taking part in regular (≥ 3 
times per week) vigorous intensity, predominantly aerobic exercise training (e.g. running, 
interval training, lap swimming, circuit training, fast cycling or spinning), and had maintained 
this pattern of activity for ≥ 10 years. Their baseline characteristics can be viewed in Table 
5.3.  The remaining ten were currently not performing any vigorous exercise training (all 
recorded activities being < 6 METS and/or being performed for < 10 min according to PA 
diary and accelerometer readout), and had maintained this pattern for at least 6 years. Their 
characteristics are displayed in Table 5.4. Minutes spent in bouts of MVPA lasting ten 
minutes or more was moderately correlated with CRF (Figure 5.2) and body fat percentage 
was strongly negatively correlated with CRF (Figure 5.3). There was no correlation between 
CRF and age.  
5.3.2 Associations between cell metabolic activity and ReGro 
participants’ baseline characteristics 
 
In ReGro participants, there were no associations between any of the participants’ 
characteristics, including age, body fat, MVPA or CRF on cell metabolic activity in any cell 
lines after being incubated in serum taken in the fasted state. The lack of correlation between 
cell metabolic activity and CRF is displayed in Figure 5.4. After grouping the participants by 
training status, there was a significant reduction (P = 0.046) in cell metabolic activity of 
Caco-2 cells following incubation in serum taken in the fasted state in the ‘Rest’ condition in 
those who did not perform any vigorous exercise training compared with those who did 
(Table 5.6). However, this was not observed in fasted samples taken in the ‘Exercise’ 
condition.    
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Table 5.1 Baseline characteristics of participants in the ReGro study (N = 20). All values 
mean (SD). 
 
Age Mass (kg) BMI Body fat (%) ?̇?𝑶𝟐 𝒎𝒂𝒙 MVPA 
(min/wk) 
MVPA 
pattern (yrs) 
59 (6) 78.6 (14.3) 25.1 (4.6) 21.8 (7) 48 (11) 216 (128) 24 (15) 
 
Table 5.2 Baseline characteristics of participants from PARC study. All values mean (SD) 
where appropriate. 
Group ALP UC 
N 9 11 
Age 71.8 (1.8) 68.2 (2.7) 
Mass (kg) 89.2 (3.8) 90.9 (20.7) 
BMI 28.9 (2.9) 29.8 (5.8) 
Body fat (%) 23.8 (5.5) 25.7 (7.2) 
?̇?𝐎𝟐 𝐦𝐚𝐱 (𝐦𝐥 ∙ 𝐤𝐠 ∙ 𝐦𝐢𝐧
−𝟏
) 25.1 (4.6) 25.8 (5.8) 
Accelerometer-derived MVPA 
(min/wk) 
101 (87) 194 (128) 
Obesity 2 6 
Hypertension 2 3 
Cardiovascular disease 2 2 
Type II diabetes 4  
Pulmonary disease 1 2 
Family history of colon cancer 2 1 
   
 
Table 5.3 Characteristics of the ten males in ReGro study who were undertaking at least three 
sessions of vigorous intensity exercise training per week at time of recruitment. All values 
mean (SD) 
 
Age Mass (kg) BMI Body fat (%) ?̇?𝑶𝟐 𝒎𝒂𝒙 MVPA 
(min/wk) 
MVPA 
pattern (yrs) 
58  (4) 69.6 (11.9) 23.5 (4.0) 19 (8) 57 (7) 278 (112) 26 (12) 
 
 
Table 5.4 Characteristics of the ten males in ReGro study who were not engaged in any 
vigorous intensity exercise training at time of recruitment. All values mean (SD)  
 
Age Height Mass (kg) Body fat (%) ?̇?𝑶𝟐 𝒎𝒂𝒙 MVPA 
(min/wk) 
MVPA 
pattern (yrs) 
61 (7) 1.80 (0.08) 87.5 (10.4) 25 (6) 39 (7) 153 (116) 25 (6) 
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Figure 5.2 No correlation between HCT 116, Caco-2 or HT-29 cell metabolic activity (y axis) 
after incubation in serum from older men free of metabolic and cardiovascular disease in the 
postabsorptive state, and their cardiorespiratory fitness (x-axis). All results expressed as 
percentage foetal bovine serum (FBS) control. Key: Open circles = HCT-116, Crosses = 
Caco-2, Open triangles = HT-29. 
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Table 5.5 Cell metabolic activity after incubation in serum from ReGro participants who 
undertook regular vigorous exercise training versus no vigorous exercise training (% FBS 
control). All values displayed as mean (SD). * Significant difference between conditions (P < 
0.05) 
 
 
Cell line Condition 
Cell metabolic activity (% FBS control) 
Vigorous exercise training No vigorous exercise training 
Caco-2 
Pre-Exercise 90.31 (5.43) 90.58 (5.40) 
Post-Exercise 89.80 (7.34) 88.67 (8.92) 
Pre-Rest 92.62 (4.55)* 86.65 (7.52) 
Post-Rest 90.88 (7.76) 91.24 (7.00) 
HCT-116 
Pre-Exercise 158.00 (10.49) 157.69 (5.28) 
Post-Exercise 161.35 (6.27) 157.95 5.48 
Pre-Rest 160.10 (10.74) 153.37 (7.89) 
Post-Rest 160.47 (5.55) 158.77 (7.58) 
HT-29 
Pre-Exercise 83.44 (5.36) 82.40 (3.69) 
Post-Exercise 85.80 (5.50) 82.01 (3.87) 
Pre-Rest 85.28 (4.69) 81.73 (3.41) 
Post-Rest 85.98 (5.15) 82.16 (4.25) 
 
5.3.3 Cell metabolic activity in response to Exercise or Rest  
 
LoVo cells failed to adhere to the surface of the cell culture wells, and so the results were not 
included. There was no significant effect of treatment (EX vs REST) or time (Pre vs Post) on 
the metabolic activity of HCT-116 cells (Figure 5.5). Incubation in 10% human serum 
stimulated cell metabolic activity to a greater extent (15-55%) than FBS (Figure 5.5). 
Similarly, there was no effect of treatment or time on metabolic activity of HT-29 and Caco-2 
cells (Figure 5.6, Figure 5.7). In contrast, participants’ serum typically stimulated cell 
metabolic activity to a lesser extent than FBS in these cell lines (Figure 5.6, Figure 5.7). 
There was consistent agreement between results within participants irrespective of treatment 
or time of sampling, notably in the HCT-116 cell line (Figure 5.5). There were also no 
significant differences related to whether participants were currently undertaking regular 
vigorous exercise training.    
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Figure 5.3. HCT-116 cell metabolic activity after 48 hours incubation in serum taken when in 
the post-absorptive state (Pre-Exercise and Pre-Rest, solid white and grey bars, respectively), 
one hour after completion of 45 min treadmill exercise at 65% 𝑉𝑂2𝑚𝑎𝑥 in the fed state (Post-
Exercise, white dotted bar) and after 105 min of rest in the fed state (Post-Rest, grey dotted 
bar) from older men free of metabolic and cardiovascular disease. All results expressed as 
percentage foetal bovine serum (FBS) control. No significant differences between treatments. 
Error bars ± 1 SE. 
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Figure 5.4. HT-29 cell metabolic activity after 96 hours incubation in serum taken when in 
the post-absorptive state (Pre-Exercise and Pre-Rest, solid white and grey bars, respectively), 
one hour after completion of 45 min treadmill exercise at 65% 𝑉𝑂2𝑚𝑎𝑥 max in the fed state 
(Post-Exercise, white dotted bar) and after 105 min of rest in the fed state (Post-Rest, grey 
dotted bar) from older men free of metabolic and cardiovascular disease. All results 
expressed as percentage foetal bovine serum (FBS) control. No significant differences 
between treatments. Error bars ± 1 SE. 
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Figure 5.5. Caco-2 cell metabolic activity after 96 hours incubation in serum taken when in 
the post-absorptive state (Pre-Exercise and Pre-Rest, solid white and grey bars, respectively), 
one hour after completion of 45 min treadmill exercise at 65% 𝑉𝑂2𝑚𝑎𝑥 max in the fed state 
(Post-Exercise, white dotted bar) and after 105 min of rest in the fed state (Post-Rest, grey 
dotted bar) from older men free of metabolic and cardiovascular disease. All results 
expressed as percentage foetal bovine serum (FBS) control. No significant differences 
between treatments. Error bars ± 1 SE. 
5.3.4 Associations between cell metabolic activity and PARC 
participants’ baseline characteristics 
 
At all timepoints, serum-stimulated growth was typically greater than FBS control, and was 
most marked in the HCT-116 cell line (Figure 5.7). There were no differences with respect to 
treatment (ALP vs UC) or time (Baseline, 6 months) on serum-stimulated growth of the 
Caco-2 cell line (Figure 5.6). Similarly, there were no differences with respect to treatment 
(ALP vs UC) or time (Baseline, 6 months) on serum-stimulated growth of the HCT-116 cell 
line (Figure 5.7). There was a strong, statistically significant inverse correlation (P < 0.01) 
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between CRF and baseline Caco-2 metabolic activity in the male participants (Figure 5.8). 
There were no associations between serum-stimulated growth and any other variables 
displayed in Table 5.1. The subsequent investigation into the expression of genes in the 
selected panel (DNMT3b, E-Cad, Ki67, LGR-5, C-Myc, COX-2 and MUC2) demonstrated no 
associations with CRF, and indeed there were negligible fold changes compared with 
respective control wells (Table 5.7). Mean (SD) percentage methylation of LINE-1 in sample 
wells was 35.6 (5). There were no associations between LINE-1 methylation and CRF. 
 
Figure 5.6 No significant difference between Usual Care (UC: filled bar) and Active Lifestyle 
Programme (ALP: open bar) in Caco-2 metabolic activity (expressed as % Foetal Bovine 
Serum control) when incubated in serum taken at baseline or after 6 months. Error bars ± 1 
SE. 
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Figure 5.7 No significant difference between Usual Care (UC: filled bar) and Active Lifestyle 
Programme (ALP: open bar) in HCT-116 metabolic activity (expressed as % Foetal Bovine 
Serum control) when incubated in serum taken at baseline or after 6 months. Error bars ± 1 
SE. 
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Figure 5.8 Significant (Pearson’s R = - 0.672, P = 0.002) negative correlation between 
baseline cardiorespiratory fitness (CRF:ml ∙ kg ∙ min−1) and Caco-2 metabolic activity when 
incubated in serum from male polyp patients enrolled in the PARC study (expressed as % of 
Foetal Bovine Serum control).  
 
Table 5.6 Gene expression relative to internal control (18S) in samples after normalising for 
expression in untreated wells (FBS control)  
Gene Mean fold change (SD) Range 
C-Myc 1.31 (1.05) 
2.11 (0.98) 
2.03 (0.76) 
1.81 (0.83) 
2.00 (1.04) 
1.88 (0.75) 
1.68 (1.80) 
3.25 
E-Cad 3.28 
COX-2 2.97 
LGR5 2.72 
Ki67 3.72 
DNMT3b 2.30 
MUC2 7.04 
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5.4 Discussion 
 
5.4.1 Effect of cardiorespiratory fitness and physical activity 
on serum-stimulated growth of colon cancer cells 
 
5.4.1.1 PARC participants 
 
There was a significant correlation between Caco-2 proliferation and baseline CRF in male 
PARC participants. The present result is broadly in agreement with previous studies which 
found that LNCaP prostate cancer cell line growth using an identical incubation protocol was 
increased in serum from obese men compared with lean counterparts (Leung et al., 2004; 
Ngo et al., 2002). This was explained by differences in serum IGF-1, and subsequent work 
demonstrated that an intensive two-week diet and lifestyle intervention that reduced IGF-1 
also reduced LNCaP growth (Ngo et al., 2002); whereas re-introducing IGF-1 to pre-
intervention concentrations restored growth (Ngo et al., 2003).  
The similarity of findings between LNCaP and Caco-2 in the current study, where 
there has been a lack of effect on other cell types, might be due to the sensitivity of both lines 
to IGF-1 (Leung et al., 2004; Ngo et al., 2003; Ngo et al., 2002; Singh et al., 1994). This 
could explain why no effects were observed in the HCT-116 cell line in the current 
investigation, as these are unresponsive to fluctuations in IGF-1 despite expressing its 
receptor (Guo et al., 1992; Lahm et al., 1992; Singh et al., 1994). However, unlike the 
present study, the work of Ngo and colleagues used two well-defined groups i.e. lean vs 
obese (Ngo et al., 2002) and the obese state is known to heighten circulating IGF-1 (Coe et 
al., 2014; Nam et al., 1997). In addition, to the author’s knowledge, no study has found any 
associations between CRF and IGF-1. If anything, aerobic exercise training in the elderly that 
raises CRF induces greater production of IGF-1 in serum (Poehlman et al., 1994). Therefore, 
it is unlikely that IGF-1 was responsible for our results. 
On the contrary, there were no associations with CRF in the HCT-116 cell line. This 
might be because the rapid proliferative capacity of these cells, observed by the researcher 
and other groups (Ahmed et al., 2013) did not allow for a 4-day incubation period before 
confluence. This could be of importance, as work into the LNCaP cell line also found that a 
48 hr treatment was insufficient to induce any changes in cell growth after a high fibre diet 
and aerobic exercise intervention (Soliman et al., 2011). Alternatively, it might be that HCT-
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116 cells are resistant to any variations in serum that are associated with CRF or disease state. 
It is also possible that the findings are peculiar to the Caco-2 cell line. It is wild type for 
several mutations involved in carcinogenesis, including KRAS, PI3KC, BRAF, PTEN, 
TGFBR2 and B-Cat (Ahmed et al., 2013). Obesity and physical inactivity has been linked 
with risk of wild-type B-Cat colorectal tumours, but not when it is mutated (Morikawa et al., 
2013). Although this is highly speculative, these tumour subtype-specific effects might 
extend to the in vitro setting, and potentially explain the lack of consistency in the cell line 
work in the current and previous investigations (Ngo et al., 2002).  
The significant correlation between CRF and Caco-2 proliferation was not related to 
any differences in gene expression of COX-2, DNMT3b, E-Cad, Ki67, LGR-5, C-Myc or 
MUC-2, or global DNA methylation as measured by LINE-1. One possible explanation for a 
lack of findings is that these pathways are unaffected by serum factors associated with poor 
CRF, and the differences in growth patterns might have been related to genes in pathways 
other than those analysed. Additionally, post-translational modifications might have been 
partially responsible for the differences in cell growth. Finally, it might have been that an 
‘edge effect’ in the cell wells confounded the expression of proliferation-associated genes. 
Indeed, there appeared to be pockets within the wells where cells had become confluent, 
which might explain why there were no associations between CRF and the genetic markers of 
cell proliferation, particularly Ki67.  
5.4.1.2 ReGro participants 
 
There were no significant effects of participants’ baseline characteristics, including CRF, on 
any of the cell lines when incubated in serum obtained after an overnight fast (Figure 5.2). 
This is in contrast with the results from the PARC participants that has shown a clear, 
consistent inverse correlation between CRF and growth of the Caco-2 cell line (Figure 5.8). 
One explanation for this difference could be that the mean age of the ReGro participants in 
was ten years younger. In addition, 70% of the participants  had a level of CRF that is 
considered ‘excellent’ or above for their age, with none attaining a score that would be 
considered ‘poor’, based on the age-adjusted criteria defined by the Aerobics Center 
Longitudinal Study group (Sui et al., 2007). Indeed, according to self-report physical activity, 
accelerometry, and recent exercise behaviour recorded in the HAPAQ, most participants were 
also achieving an amount of moderate to vigorous PA (>150 min/wk; Table 5.1) deemed 
sufficient for maintenance of health (O'Donovan et al., 2010). The author postulates that the 
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participants were of sufficient fitness to introduce a ‘ceiling effect’ on the ability of increased 
CRF to inhibit serum-stimulated cell growth. Conversely, the CRF of the male polyp patients 
in the PARC investigation was much lower (25.1 (5.2) vs. 48 (11.7) 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛−1 ). 
Moreover, several of the PARC participants had a presence or history of obesity, and 
metabolic or cardiovascular disease, which might have meant that CRF was associated with 
differential cell growth patterns by happenstance. Certainly, obesity was associated with 
increased serum-induced proliferation of the LNCaP cell line compared with lean men (Ngo 
et al., 2002). This could explain why no such findings were evident in this study, since the 
participants were disease-free in this respect. This raises the possibility that the exclusion 
criteria in this study for ReGro participants i.e. absence of a known metabolic or 
cardiovascular disease, obesity or previous malignancy prevented participants with 
sufficiently poor fitness to demonstrate an effect from taking part. 
Although it might be argued that greater CRF brings with it alterations to hormone 
concentrations, enhanced immunity, reduced inflammation and antioxidative capacity that 
protected against Caco-2 cell proliferation in the present work, it is very likely that the 
correlation with CRF amongst the male polyp patients was confounded by health status, 
which is known to influence serum composition. Cardiovascular and metabolic diseases are 
associated with a host of changes to the serum metabolome (Du et al., 2013). Within the male 
adenoma patients who enrolled in the PARC study were individuals with obesity, morbid 
obesity, diabetes, history of stroke, and cardiovascular disease (Table 5.2) Given the 
heterogeneity of disease states coupled with small sample size, it would be unwise to 
speculate on the potential growth-inhibiting mechanisms afforded by increased CRF, 
especially since it cannot be ruled out that the correlation was merely circumstantial. In 
support of this interpretation, neither increasing CRF in ALP participants, nor CRF in ReGro 
participants, affected Caco-2 cell growth (Figure 5.2, Figure 5.6, Figure 5.7).  
  
5.4.2 Effect of a single bout of exercise on serum-stimulated 
growth of colon cancer cells in ReGro participants 
 
A single bout of exercise did not affect cell proliferation, in contrast with previous work in 
the LNCaP cell line that found that moderate-intensity cycle ergometer exercise reduced 
proliferation by 31%, which was associated with increased serum IGFBP-3 and reduced 
endothelial growth factor (EGF) (Rundqvist et al., 2013). This might be because the work of 
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Rundqvist and colleagues employed young healthy active men, retrieved serum from the 
femoral artery and did so two hours after the exercise bout had finished. It is possible that 
similar results might have been achieved in the present investigation had a serum sample 
been obtained two hours after cessation of the treadmill bout, as opposed to one hour. 
Unfortunately, Rundqvist and colleagues neglected to perform a crossover study as per the 
current study design (Figure 5.1), so it is not known whether the same results would have 
been achieved with an equivalent period of rest. It might reasonably be argued that 3 hours of 
rest in the postabsorptive state (whether or not the participants arrived in this state was not 
specified) might have induced changes to serum which could meaningfully have altered 
serum-stimulated growth of LNCaP cells. In the current study, a crossover design was used to 
negate this, and all participants exercised in the fed state. However, there were no consistent 
differences related to treatment (exercise vs rest) or time (pre vs post) (Figure 5.3, Figure 5.4, 
Figure 5.5). Based on the results of the present work, it might be suggested that the effects of 
moderate-intensity treadmill exercise on serum in the fed state was insufficient to 
significantly alter the growth of colon cancer cell lines in vitro. 
5.4.3 Limitations 
 
A major limitation of the current study was the failure to recruit individuals to the ReGro 
study who were sufficiently physically inactive, despite a prolonged recruitment campaign in 
several media channels, which specifically targeted highly active or inactive men. This could 
imply that the physically inactive, eligible men who viewed the advertisement material either 
felt they did not meet the inclusion criteria, or were disinterested in taking part in a study 
which involved a commitment to exercise. Indeed, it appears that studies into PA behaviour 
tend to attract individuals who are probably already sufficiently active for maintenance of 
health. One notable example was performed by Thompson and colleagues, who recruited 90 
middle-aged men for an analysis of different PA recommendations from health authorities 
versus actual PA via combined accelerometry and heart rate monitoring. Of these men, 98% 
were achieving at least 150 min/week of ‘moderate’ PA (> 3 METS) in bouts of at least ten 
minutes or more, despite level of PA not being part of any inclusion criteria (Thompson et al., 
2009).  
A further limitation is that the CC cell lines used are a limited model to use in studies 
of CC risk, since the cells are already cancerous and display a highly perturbed molecular 
phenotype (Ahmed et al., 2013). Whilst these models are certainly useful, and often match 
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the phenotype of actual cases (Ahmed et al., 2013) they have limited scope in the early stages 
of cancer development, prior to any mutations taking place. Recently, a reliable technique for 
maintaining populations of ‘mini-guts’ derived from biopsies of non-cancerous human colon 
has been developed, which could provide more insight into the origins of carcinogenesis 
(Sato et al., 2011). This could have served as a model of epigenetically ‘vulnerable’ mucosa, 
which might have responded to changes in serum factors that were altered as a result of any 
intervention. This could have included changes to gene expression and DNA methylation 
patterns, and may have been a more informative model than the CC lines used.  
Another potential limitation was that as this investigation was a pilot study, there was 
a possibility that it was underpowered to detect the differences that might have occurred after 
a single bout of exercise. Furthermore, the contents of the serum collected were not analysed, 
largely due to financial constraints and the impending cessation of the period of study. It 
would have been of interest to screen samples for evidence of altered cytokine expression. 
Chronic inflammation is elevated in metabolic and cardiovascular disease states 
(Hotamisligil, 2006), so there might be a case for inflammatory markers being an explanatory 
variable for the differences in Caco-2 cell growth. This is not without precedent, as treatment 
with 50 ng/ml IL-6 has been shown to increase growth of HCT-116 colonies after 72 h of 
incubation (Foran et al., 2010). However, even in heightened inflammatory states such as 
morbid obesity, individual cytokine concentrations of IL-6 and TNFα in serum are three 
orders of magnitude lower (Fontana et al., 2007). The large dose of IL-6 used by Foran and 
colleagues is probably of greater relevance to colitis associated cancer (Terzic et al., 2010). 
This necessitates further investigations using a metabolomics approach to understand the 
components of serum that could promote colon cancer cell growth. 
Indeed, the timeframe for the study days in the ReGro investigation were largely 
based on the assumption that differences in inflammatory cytokines might be responsible for 
exercise-induce effects on cell growth. Another possibility from the realm of epigenetics is 
that miRNA expression might have also changed with exercise. Indeed, high-intensity 
interval training and vigorous continuous exercise in young men has been demonstrated to 
increase the plasma appearance of 12 miRNAs (Cui et al., 2016), which could plausibly have 
interfered with gene expression of CC cells in vitro, perhaps to a greater extent than 
cytokines. For example, miRNA-7 Some of these appear immediately after cessation of 
exercise (Cui et al., 2016) so it is possible that the timing of blood sampling missed the 
critical window where miRNAS could have impacted on cell growth, but this is speculative. 
Another issue was that despite the adenoma patients generally displaying increased growth of 
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cells compared with the ReGro participants, the experiments were conducted on separate 
plates. Therefore, batch effects might have played a role. It would be of interest to repeat such 
an experiment with adenoma patients and matched controls free of adenoma on the same 
plate to determine if this pattern was repeated. Also, a direct comparison between the groups 
is unwise given that it was not confirmed whether the ReGro participants were free of colon 
polyps.  
5.4.4 Conclusion 
 
In conclusion, cardiorespiratory fitness, minutes of MVPA per week, age, and body 
composition did not affect growth of HT-29, Caco-2 or HCT-116 cells when incubated in 
serum from an older non-obese Caucasian male population free of metabolic or 
cardiovascular disease. Furthermore, a single bout of moderate-intensity treadmill exercise in 
the fed state did not affect cell growth compared with an equivalent period of rest. Whilst this 
study suggests that in a disease-free state, CRF, long-term physical activity patterns nor a 
single bout of exercise in the fed state does not instigate any alterations in serum that 
consistently affect the growth of colorectal cancer cells in vitro, its pilot nature means that 
this conclusion cannot be drawn definitively. Equally, whilst CRF was inversely correlated 
with reduced Caco-2 proliferation in male adenoma patients, it is very possible that this 
association was confounded by health status. 
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Chapter 6  
General Discussion 
 
6.1 Summary 
 
Study 1 has demonstrated that changes in self-report physical activity patterns over 
eight years in an aged Caucasian population are associated with changes in DNA 
methylation in peripheral blood, most notably for the genes IL10 and TNF. Gender-
specific associations were also observed for SNCG, SERPINA5 and LINE-1. The 
results might have been confounded by differences in measurement techniques used at 
different study sites, the introduction of folic acid fortification to foods, and that PA 
was self-reported and might not have accurately reflected behaviour.  Study 2 
indicated buccal cell methylation patterns of the CC risk genes investigated in 
adenoma patients are not significantly affected by taking part in a 6 to 12-month 
randomised exercise intervention. However, owing to the paucity of participants it is 
likely that the study was underpowered. It also indicated that the recruitment of colon 
adenoma patients to a long-term randomised exercise intervention study, and that 
reliably obtaining follow-up colon biopsies for such an investigation presents 
numerous challenges. Study 3 inferred that whilst a 6-month exercise intervention in 
male adenoma patients does not affected serum stimulated growth of the HCT-116 
and Caco-2 cell lines, cardiorespiratory fitness in this population was inversely related 
to growth of the Caco-2 cell line in vitro. This relationship was not observed in older 
men free of metabolic or cardiovascular disease, but the reasons for this are not clear. 
Furthermore, in the latter population, a single bout of moderate-intensity treadmill 
exercise in the fed state was not associated with differences in growth of the HT-29, 
HCT-116 or Caco-2 cell line. However, given the pilot nature of the investigation and 
study design it cannot be drawn conclusively that a single bout of exercise has no 
effect on serum factors that could modulate CC cell growth. 
 
6.2 PA and DNA methylation of genes in peripheral 
blood 
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This series of investigations have lent some support to the notion that changes in 
physical activity patterns are associated with changes to DNA methylation patterns in 
the promoter regions in genes associated with risk or presence of chronic disease, 
particularly IL10 and TNF. This was apparent in peripheral blood leukocytes from 
older participants in the Cardiovascular Health Study in samples spaced eight years 
apart. This is broadly in agreement with epidemiological studies that have suggested 
that greater PA in later life is associated with reduced serum markers of inflammation 
(Brinkley et al., 2009; Cesari et al., 2004; Colbert et al., 2004; de Gonzalo-Calvo et 
al., 2012b; Geffken et al., 2001; Jankord and Jemiolo, 2004; King et al., 2003; 
McFarlin et al., 2006; Reuben et al., 2003; Verdaet et al., 2004), and that maintaining 
or increasing PA in later life is associated with improved inflammatory profile in 
peripheral blood (Hamer et al., 2012), improved physical function and disease-free 
survival (Hamer et al., 2014) and reduced cancer mortality (Zhang et al., 2014). 
Beneficial alterations in DNA methylation status might therefore plausibly underpin 
some of the associations between PA and healthy ageing. This is the first study to 
demonstrate that changes in long-term PA patterns are associated with differential age-
related DNA methylation patterns. Given the rapid turnover of peripheral blood 
leukocytes and that the samples were taken eight years apart, we can be confident that 
the changes in the methylation status of TNF and IL10 reflected a genuine long-term 
adaptation. 
Nonetheless, it cannot be ruled out that the apparently beneficial changes 
observed in the present study were linked to folic acid fortification. This has been 
observed in the Womens’ Health Initiative Observational Study, where folic acid 
fortification resulted in increased global DNA methylation in those who were 
deficient; and conversely decreased methylation in those who were sufficient (Bae et 
al., 2014). We observed that LINE-1 methylation decreased, albeit not significantly, 
over the course of eight years in the CHS cohort (Figure 4.2), and we cannot be 
confident that this was related to a change in dietary folic acid intake. In addition, in 
those individuals who maintained or substantially increased PAEE there was a 
reversal of age-related DNA methylation in both TNF and IL10 (Figure 4.3), despite 
both genes following the ‘expected’ association with age observed in previous work 
(Figure 4.2) (Christensen et al., 2009), which is without precedent. Given that this 
occurred in those who did not substantially change their PA behaviour over the course 
of eight years, it seems unlikely that PA was wholly responsible for these changes.  
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What is arguably more of note is that the apparently beneficial changes to TNF and 
IL10 did not occur in those persons who substantially decreased PAEE by >500 
kcal/wk (DEC; Figure 4.3). This might plausibly be associated with age-related 
functional decline, possibly as a result of disease, which has been shown to be linked 
with elevated markers of inflammation such as IL-6 (Reuben et al., 2002). This could 
certainly have confounded the associations observed. However, the reduction in self-
report PA was not associated with any change in self-assessment of health or objective 
measures of functional capacity (see Appendix Aii). On balance, this points to an 
independent role of reducing PA in shifting the methylome towards a more ‘pro-
inflammatory’ state. This tallies with the available evidence from the Whitehall cohort 
linking a reduction in PA in a longitudinal setting being associated with increased 
peripheral markers of inflammation including CRP and IL-6 over ten years of follow-
up (Hamer et al., 2012). It could also play a role in the association between decreased 
fitness and an increase in all-cause, CVD and cancer mortality in the Aerobics Center 
Longitudinal Study cohort (Lee et al., 2011b; Zhang et al., 2014) although this is 
speculative. Based on this evidence, it might be advised that maintenance of habitual 
PA, and interventions to allow older persons to increase or conserve habitual PA, 
should be prioritised. However, it should be made clear that due to the observational 
nature of this investigation, we cannot confirm that the observed associations between 
PA and change in methylation are causally linked.         
   
6.3 PA and DNA methylation of genes in epithelial 
cells  
 
Previous studies have shown that six-month exercise programmes, and even a single 
bout of exercise, affects methylation status of genes involved in metabolic regulation 
in skeletal muscle and adipose tissue (Barres et al., 2012; Nitert et al., 2012; Ronn et 
al., 2013). Nonetheless, it might be argued that the training effects on DNA 
methylation were merely effects of the last bout of exercise, which was performed a 
minimum of 48 hours previously (Nitert et al., 2012; Ronn et al., 2013). This is 
plausible, since the metabolic effects of vigorous exercise persist for several days 
following cessation of a bout (Goodyear and Kahn, 1998) and there could be a role for 
altered DNA methylation in this process. However, unpublished data from a separate 
group demonstrated that gene-specific DNA methylation at multiple loci in skeletal 
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muscle after a three-week exercise programme was unchanged 48 hours after 
cessation of exercise (Barres et al., 2012). This suggests that the changes to the 
methylome observed by Nitert and colleagues was a genuine effect of prolonged 
training (Nitert et al., 2012; Ronn et al., 2013) as opposed to acute exercise, which 
has also been observed (Barres et al., 2012). Therefore, the chronic and acute 
responses of the methylome to exercise training appear to be separate phenomena 
(Barres et al., 2012). 
Despite the apparently beneficial modulations in peripheral blood, adipose 
tissue and muscle tissue as observed by the present work and previous studies, it 
appears to be the case that the response of the methylome to changes in physical 
activity is time-dependent and tissue specific. This is evidenced by the finding that 
buccal cell DNA methylation was unaffected by increasing leisure-time physical 
activity and/or CRF in colon adenoma patients over the course of a single-blind, 
randomised six-month to one year exercise intervention, despite alterations being 
observed over the course of eight years with a change in self-report PA in the 
inflammation-related genes IL10 and TNF. The tissue-specific effects on DNA 
methylation extend to short-term bouts of exercise. For example, overall CpG 
methylation in gene promoters is decreased in vastus lateralis muscle biopsies in the 
hours following isocaloric (400 kcal) moderate (40% ?̇?𝑂2 𝑚𝑎𝑥) or high-intensity (80% 
?̇?𝑂2 𝑚𝑎𝑥) cycling exercise (Barres et al., 2012), but unchanged in peripheral blood 
after 2 hours of treadmill running followed by a 5 km time trial in trained runners 
(Robson-Ansley et al., 2014). Once more, this shows that the response of the 
methylome to exercise is tissue-specific. 
Furthermore, there was no correlation between buccal or sigmoid colon DNA 
methylation at the regions investigated. This introduces the possibility that any 
beneficial epigenetic alterations induced by modestly increasing exercise behaviour 
might not be realised in buccal tissue or colorectal mucosa in the context of a short-
term, well-controlled randomised trial, if at all. Indeed, whilst an apparent reversal of 
age-related methylation of inflammatory genes was observed in peripheral blood in 
older persons with increasing PA (Figure 3.4) it is possible that such findings do not 
extend to buccal or perhaps colon tissue. The paucity of participants in the PARC 
intervention meant that the investigation was likely underpowered, and precludes any 
definite conclusions. 
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In contrast to the findings of the current investigations, the COSTRIDE study 
found that methylation of 45 CpG sites in genes associated with breast cancer risk in 
buccal cells was negatively correlated with increasing time spent in PA after a 12 
month exercise intervention (Bryan et al., 2013). A potential explanation for this was 
that the gene panel from that investigation differed from the present study. Secondly, 
that study was conducted on premenopausal overweight women, and it might be that 
fluctuations in buccal cell DNA methylation are more malleable to changes in 
exercise behaviour in younger persons, although this is not known. Moreover, the 
study did not report whether the participants underwent any weight loss, which has 
previously been demonstrated to be associated with altered DNA methylation patterns 
in peripheral blood and adipose tissue (Milagro et al., 2011), although the effects of 
weight loss on buccal cell methylation has not been investigated. Also, samples 
underwent whole-genome amplification, which is known to affect accurate detection 
of DNA methylation as amplification occurs in a non-linear fashion (Bundo et al., 
2012; Robinson et al., 2010). In addition, the findings of Bryan and colleagues were 
only significant when the entire gene panel was included in their analysis, which they 
incorrectly stated as being representative of ‘global methylation’ (Bryan et al., 2013). 
This introduces the strong possibility of a Type 1 error, and confounds any insight into 
the gene-specific effects (if any) of exercise behaviour on the buccal epigenome.   
The author concedes that the tissue-specific nature of DNA methylation might 
be overcome with the advent of the ‘DNA methylation clock’, which is a ubiquitous 
predictor of tissue age based on robust DNA methylation marks (Horvath, 2013). As 
accelerated age-related DNA methylation is present in diseases that increase CC risk 
(Issa et al., 2001) and in pre-cancerous and cancerous tissue (Ahuja et al., 1998; 
Belshaw et al., 2008; Chan et al., 2002; Horvath, 2013) it would have been of 
particular interest in the present investigation to determine whether ALP affected the 
methylation status of clock genes in the buccal cell epigenome. Unfortunately, the 
less-than-expected yield of DNA from buccal swabs, and the explicit statement in our 
information materials that the research team would not sequence the entire genome of 
the participants, precluded this analysis.   
Future work could be modelled on the BORICC study, an observational 
investigation which found associations between dietary components, age, gender, 
waist circumference, and colon DNA methylation in disease-free participants (Tapp et 
al., 2013). The National Bowel Cancer Screening Programme provides opportunities 
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for research biopsy collection, providing an ideal platform for the analysis of colon 
DNA methylation using epigenome-wide techniques, which are becoming more cost-
effective. This can be combined with increasingly accurate measures of current PA, 
CRF and historical physical activity levels (Besson et al., 2010) from polyp patients 
and individuals free of polyps, and determine whether any of these indices are 
associated with risk of polyps and/or aberrant DNA methylation. As an adjunct 
outcome, such an approach might also be able to inform clinical decisions in patient 
care, since the least fit individuals are at the greatest risk of CC mortality (Peel et al., 
2009).  
 
6.4 Potential role of CRF in mediating serum-
stimulated cancer cell growth 
 
In serum from male adenoma patients, poor CRF was associated with increased 
proliferation of the CC cell line, Caco-2 (Figure 5.8). This might point to a role of 
compromised metabolic and cardiovascular health, indicated by poor CRF, in 
promoting Caco-2 cell proliferation. Compromised metabolic and cardiovascular 
health is possibly a more credible explanation than CRF in explaining variation in 
Caco-2 cell proliferation. This was evidenced by the finding that in men free of 
known metabolic, cardiovascular, malignant or pre-malignant disease, CRF was not 
associated with growth of Caco-2, HT-29 and HCT-116 cells (Figure 5.2). 
Furthermore, improving CRF through taking part in the ALP arm of the PARC 
intervention was not associated with any differences in Caco-2 or HCT-116 
proliferation (Figure 5.6, Figure 5.7).  However, the variation might also be related to 
differing exercise protocols, a lack of statistical power and the timing of blood 
collection, so a direct comparison between the results obtained in these studies should 
be approached with caution. 
   There may be more applicability of the present results for cancer prognosis 
and survival. Indeed, low CRF (Peel et al., 2009) and comorbidities such as diabetes 
have been repeatedly documented to increase risk of CC-specific mortality (Chen et 
al., 2010; Dehal et al., 2012; Huang et al., 2011; Meyerhardt et al., 2003; Mills et al., 
2013; Stein et al., 2010; van de Poll-Franse et al., 2012) as has obesity (Campbell et 
al., 2012; Fedirko et al., 2014; Gibson et al., 2014). Importantly, obesity and PA have 
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been shown to differentially affect prognosis of survivors depending on CC 
phenotype, specifically nuclear beta-catenin and COX-2 status (Morikawa et al., 
2011; Yamauchi et al., 2013). In support of these findings, the Caco-2 cell line is 
COX-2 positive (Tsujii et al., 1997); whereas HCT-116 does not express COX-2 
(Sheng et al., 1998). Though speculative, if those survivors who undertook the 
greatest amount of PA were also most likely to have higher CRF in the study by 
Yamauchi and colleagues (Yamauchi et al., 2013), this might in part explain why a 
strong correlation between proliferation and CRF was found with Caco-2 but not the 
HCT-116 cell line.  
In a disease-free state, it might be argued that increasing fitness has no direct 
effect upon CC risk. Rather, it might be that a low CRF is indicative of associated 
pathology which increases risk of GI cancers. In support of this argument, higher CRF 
was associated with reduced risk of gastrointestinal cancers compared with lower 
CRF in older Finnish males aged 42-60 (Laukkanen et al., 2010). However, the 
minimum cut-off point for the highest tertile of CRF was 33.2 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛−1, a 
score which is considered ‘poor’ in men of this age (Sui et al., 2007). The maximum 
cut-off for the lowest tertile of fitness was 26.9 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛−1, a score which is 
considered ‘very poor’ according to findings from the Aerobics Center Longitudinal 
Study (Sui et al., 2007). Furthermore, men in the lowest tertile of fitness had 
significantly increased BMI, waist-hip ratio, blood glucose, serum insulin, serum fatty 
acids, cigarette smoking in pack years, and alcohol consumption. Many of these are 
independently associated with increased CC risk (Watson and Collins, 2011), but 
puzzlingly none of these factors except CRF was found to be associated with reduced 
risk (Laukkanen et al., 2010). This could suggest that Laukkanen and colleagues did 
not use an appropriate model to determine risk posed by these factors, which in 
isolation might not have a significant association with risk. As CRF was associated 
with all of these risk factors combined, it is perhaps unsurprising that CRF was 
significantly associated with future risk. In this respect, CRF was most likely a proxy 
marker for overall health. 
Interestingly, a gain in age-adjusted fitness in older men is no more protective 
against cancer mortality that maintaining fitness (Zhang et al., 2014), but a loss of 
fitness was associated with markedly increased risk by 26% (Zhang et al., 2014). 
However, it should be noted that in a subgroup analysis, risk was reduced in those 
men who increased fitness sufficiently such that they were no longer in the lowest 
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quintile, compared with those who remained (Hazard Ratio 0.59, CI 0.37–0.94) 
(Zhang et al., 2014). This finding hints at a ‘threshold’ of fitness below which risk of 
cancer mortality (as with digestive cancer mortality and all-cause mortality) is 
increased (Farrell et al., 2007; Peel et al., 2009; Sawada et al., 2014; Sui et al., 2007; 
Zhang et al., 2014). Although this hypothesis requires more investigation, this might 
explain why poor CRF in male polyp patients was negatively associated with serum-
stimulated Caco-2 cell growth (Figure 5.8), but was not associated with further 
increases in CRF in a disease-free population (Figure 5.2). 
The results from the current series of experiments point to a possible role of 
cardiovascular and metabolic health (which could be indicated by low CRF) in 
mediating cancer cell proliferation in vitro. Future in vitro studies could focus upon 
recruiting a larger number of age-matched participants whose health status is clearly 
defined, e.g. obese vs lean, high-fitness vs low fitness and in more colorectal cancer 
cell lines to explore the effects of CRF on different phenotypes. Furthermore, it would 
be of great interest to utilise a metabolomics approach to understand the components 
of serum which might be associated with increased risk of cell proliferation. For 
example, recent metabolomics work in a cohort of 50 men and women aged 56 ± 4 
years and with poor estimated CRF for their age  (?̇?𝑂2 𝑚𝑎𝑥 = 29 ± 3 𝑚𝑙 ∙ 𝑘𝑔 ∙ 𝑚𝑖𝑛
−1) 
demonstrated that higher fitness was associated with greater concentrations of 
phosphatidylcholines in serum, which are anti-inflammatory mediators (Wientzek et 
al., 2014). This could present new avenues of treatment and prevention for CC, in 
particular of COX-2 positive tumours. 
 
6.5 PA as a means to reduce risk of future polyps or 
colon cancer in adenoma patients 
 
Some improvements in subjective colon crypt cell proliferation markers (i.e. Ki67 
positive nuclei) have been observed in male polyp patients (McTiernan et al., 2006), 
as has colon crypt expression of pro and anti-apoptotic proteins (Bax and Bcl-2) in 
both genders (Campbell et al., 2007) after a one year PA intervention. This was 
achieved with a minimum of 250 min/week of MVPA participation, and no data has 
been published on whether this level of activity was maintained post-intervention. The 
same study showed no changes in intestinal PGE2 expression, which is known to be a 
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driver of CC risk and progression, particularly in the transition from adenoma to 
carcinoma (Burn et al., 2011; Pugh and Thomas, 1994). Notably, this was after a well-
controlled 12 month exercise programme where participants in the experimental arm 
engaged in an average of 330 min/week of moderate-vigorous PA (Abrahamson et al., 
2007).  On the other hand aspirin, rapid weight loss in obese women, and dietary 
folate depletion reduces colorectal inflammation within months (Abrahamson et al., 
2007; Krishnan et al., 2001; Pendyala et al., 2011; Protiva et al., 2011), so it is 
unlikely that modestly increasing PA alone in the absence of impacting these factors 
will have any effect on colon inflammation.  
Despite the plentiful epidemiological evidence for an association between CC 
risk and PA, particularly over the life course (Boyle et al., 2011; Wolin et al., 2010; 
Wolin et al., 2009) there is no longitudinal evidence that a change in self-report PA in 
older, sedentary persons affects future adenoma or CC risk. Indeed, the clinical 
outcomes of previous work suggest that a PA-induced reduction in polyp or cancer 
risk does not occur. Follow-up data from the Polyp Prevention Trial demonstrated no 
associations between changes in diet and or recent (i.e. three year) PA levels and risk 
of adenoma recurrence (Colbert et al., 2002; Lanza et al., 2007). Furthermore, based 
on a meta-analysis of studies which investigated associations between leisure-time PA 
and CC risk, those in the 95th percentile had a only a 14% risk reduction compared 
with those in the 20th percentile or below (Harriss et al., 2009a). In light of this, the 
authors concluded that interventions aimed solely at increasing leisure-time PA are 
unlikely to meaningfully affect risk in older sedentary persons (Harriss et al., 2009a). 
The conclusions of Harriss and colleagues (Harriss et al., 2009a) are also supported 
by the available epidemiological evidence from the Cancer Prevention Study II 
cohort, which has suggested that an increase in frequency and intensity of PA over 10-
15 years has no bearing on modifying CC risk, despite consistently higher levels of 
PA (>30 MET hours/week) being associated with reduced risk versus low (< 17.5 
MET hours/week) (Wolin et al., 2010). In agreement with this finding, total or 
moderate self-report PA after the age of 51 in an Australian cohort had no effect on 
future CC risk, but vigorous PA across the adult lifespan substantially reduced risk 
(Boyle et al., 2011). One limitation of these findings is that they are based on self-
report questionnaires, which are notoriously subject to recall bias and might not truly 
reflect PA behaviour, especially when compared with more objectively measured PA 
(Boyle et al., 2015; Helmerhorst et al., 2012). Another possible reason for a lack of 
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association is that older, sedentary persons seldom increase PA, particularly vigorous 
PA, into old age, which means that any associations could be missed without a 
sufficiently large sample size. A further explanation is that the relationships detected 
in these studies are present because an increase in PA in later life has a negligible 
effect on CC risk.  
Whilst an intensive year-long MVPA programme has been successfully 
implemented in adenoma patients, the mean age was ~55 years, and the age range of 
the participants was 35 years (ages 40 to 75) (McTiernan et al., 2006). Plus, those 
with co-morbid conditions (e.g. heart disease, diabetes, COPD, previous cancer) were 
excluded from the intervention (McTiernan et al., 2006). It is highly likely that the 
group studied by McTiernan and colleagues was particularly physically capable 
compared with the typical UK adenoma patient, given that bowel cancer screening in 
the UK is currently offered to persons over 60, including the patients studied in 
Chapter 5 of this thesis (mean age 68.5 yrs). Furthermore, a cross-sectional study of 
health service users in Scotland found that in persons aged over 65, 64.9% were living 
with more than one co-morbidity (Barnett et al., 2012).  It is perhaps unrealistic to 
expect an older sedentary population such as this to embark on a programme of 
vigorous-intensity exercise. Also the available evidence strongly suggests that these 
populations, if anything, prefer ‘moderate’ activities. Certainly, in the ALP arm of the 
PARC intervention study, increases in self-report and accelerometer derived MVPA 
were predominantly achieved through doing ‘moderate’ activities such as brisk 
walking. In addition, the most preferable exercise for CC survivors considering taking 
part in a PA programme was walking or hiking (McGowan et al., 2013), and walking 
was the most popular exercise amongst previously sedentary post-menopausal women 
in the ALPHA trial (Aparicio-Ting et al., 2015).  
Pertinently, the recruitment of patients for the PARC intervention fell short of 
the target number. Also, the low uptake of eligible participants for ‘real world’ 
exercise intervention studies aimed at reducing future disease risk is a frequent 
occurrence. The low (< 10%) recruitment rate of potentially eligible patients 
experienced by the PARC intervention study is reflective of other lifestyle 
interventions for chronic disease risk, including CC and polyp prevention (Jackson et 
al., 2015; McTiernan et al., 2006; Schatzkin et al., 1996). One notable exception was 
the Alberta Physical Activity and Breast Cancer Prevention (ALPHA) trial, which 
recruited 19% of eligible patients contacted into a large (n = 320) RCT (Friedenreich 
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et al., 2010b). Due to the low uptake and long-term compliance experienced by the 
present and previous work (Jackson et al., 2015; Vallance et al., 2008), the usefulness 
of PA interventions alone as a public health strategy, specifically to combat CC risk in 
persons with polyps, is unclear. The outcomes of these studies bring into question the 
worth of continued large-scale studies into time-consuming, intensive exercise-only 
protocols in reducing polyp or CC risk in adenoma patients. Indeed, the available 
evidence strongly suggests that most individuals in this patient group are either unable 
or unwilling to dedicate such a large amount of time to change exercise behaviour in a 
trial setting due to a combination of a lack of knowledge and reluctance to change 
behaviour (Dowswell et al., 2012; Tarr et al., 2014). Therefore, it is highly unlikely 
that such an intensive approach as utilised by the present study will encounter much 
success in a population setting for reduction of CC or polyp risk at the present time.   
Further evidence for this conclusion can be found in recent findings from the 
‘MOVE!’ lifestyle intervention study to prevent diabetes in U.S. veterans, where from 
an eligible pool of 1.8 million just 1% adequately completed the programme (Jackson 
et al., 2015). In addition, it is questionable that activity levels would be adequately 
maintained. This is supported by the results of the PARC intervention study where 
fitness gains and increased leisure-time PA after 6 months were not maintained after 
12 months in ALP (see 5.5 Tables and figures: Figure 5.7, Figure 5.8, Figure 5.9, 
Figure 5.10). A previous larger RCT (n = 377) in breast cancer survivors demonstrated 
that higher levels of PA were also not maintained six months after a PA intervention 
(Vallance et al., 2008), so there is also the possibility that fitness or PA increases 
might not be sustained after cessation of a trial. On the other hand, recent results from 
the ALPHA trial have shown that 62% of women who completed a one-year exercise 
intervention maintained an adequate (>150 min MVPA per week) level of activity 12 
months later (Aparicio-Ting et al., 2015). It should be noted that in that study 58% of 
the control group also achieved this target, the activity measurement was in the form 
of a self-report questionnaire (Friedenreich et al., 2006) which was poorly correlated 
with accelerometer-derived PA (Friedenreich et al., 2006; Helmerhorst et al., 2012), 
and > 20% of the participants did not complete the questionnaire. More objective 
follow-up PA data is lacking from the extant literature.   
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6.6 From epidemiology to physiology: the future 
role of exercise science research in CC prevention 
 
This series of investigations has focused principally on the role of PA in regulating the 
methylome and its relevance to colon cancer risk. However, this could ultimately be a 
moot point, since there is little likelihood that a sedentary older adenoma patient at 
risk of CC will increase PA sufficiently to induce a meaningful, clinically important 
change to future risk (Dowswell et al., 2012; Tarr et al., 2014). In the author’s view, it 
is therefore of interest to pursue alternative avenues for reduction of CC-specific risk 
in high-risk populations. Examples include prescription of anti-inflammatory 
medications and Vitamin D and calcium supplements, where recruitment rates are 
high (> 30% eligible participants contacted) as is long-term compliance with 
medication (> 85% for > 2 years). Plus, the clinical trial data for effective reduction of 
future advanced adenoma or cancer risk is convincing (Baron et al., 2003; Burn et al., 
2011; Flossmann et al., 2007; Grau et al., 2003; Sandler et al., 2003). This is not to 
diminish the role of modestly increasing PA, for example walking behaviour, in 
improving other outcomes in chronic age-related disease and all-cause mortality 
(Blair et al., 1996; Stofan et al., 1998; Sui et al., 2007; Swift et al., 2013). It is also 
evident that rapid weight loss might induce similar benefits in obese persons 
(Pendyala et al., 2011), although more clinical trial evidence is necessary to determine 
if this is the case. This is currently being pursued in the BeWEL study (Anderson et 
al., 2014), and it is to be verified whether the modest weight loss (3.5 kg, or 3.9% of 
body weight) achieved in that study affects future polyp risk.  
There is a need for a more mechanistic, targeted approach toward CC 
prevention via known biomarkers of risk, particularly with respect to exercise. To 
date, the PARC intervention included (Chapter 4), exercise prescription has been 
based on epidemiological associations over the life course (McTiernan et al., 2006). 
This approach is not suitable for tackling CC risk in older, previously sedentary 
persons, for two reasons. First, there is likely to be considerable resistance to 
behaviour change (Dowswell et al., 2012; Tarr et al., 2014). Second, the effects of 
such prescriptions on risk biomarkers purportedly linked with PA are highly 
inconsistent, including CRF (Bouchard et al., 2011; McTiernan et al., 2006), insulin 
sensitivity (Boule et al., 2005) chronic inflammation (Woods et al., 2012) and 
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oxidative stress (Campbell et al., 2010b), and might render untailored interventions 
ineffective. Future intervention studies should be based on the work of Pendyala and 
colleagues, who showed that a standardised weight loss protocol resulted in reduced 
colorectal inflammation, one of the most important risk markers for CC (Pendyala et 
al., 2011). This was based on the evidence that obesity induces chronic inflammation 
(Fontana et al., 2007), ergo weight (fat) loss combats gut inflammation, which was 
confirmed after the participants underwent rapid fat loss (Pendyala et al., 2011).  
Perhaps the most plausible risk biomarker that is linked with risk of CC and a 
lack of PA is hyperinsulinaemia (Giovannucci, 2007). There are convincing and 
consistent associations between metabolic syndrome and CC and adenoma risk, 
notably in relation to hyperinsulinaemia and particularly in men (Campbell et al., 
2010a; Chen et al., 2013; Comstock et al., 2014b; Giovannucci, 2007; Jenab et al., 
2007; Ollberding et al., 2012; Ortiz et al., 2012; Vidal et al., 2012). There is strong 
clinical trial evidence that this is amenable to exercise training (Knowler et al., 2002) 
and accumulating evidence that low-volume, high-intensity interval training (HIIT) 
can improve insulin sensitivity in a matter of weeks, in both non-clinical and clinical 
populations with metabolic disease (Babraj et al., 2009; Gibala and McGee, 2008; 
Gillen et al., 2014; Little et al., 2011; Trapp et al., 2008). The author tentatively 
suggests that some of the findings observed by McTiernan and colleagues with respect 
to crypt proliferation (Campbell et al., 2007; McTiernan et al., 2006), whilst they did 
not measure metabolic parameters such as fasting blood glucose and serum insulin, 
could have plausibly occurred due to improved insulin sensitivity that can accompany 
exercise training in previously sedentary individuals (Goodyear and Kahn, 1998). 
This could have impacted upon crypt cell growth patterns, and indeed insulin 
administration has been consistently demonstrated to invoke proliferation and 
tumorigenesis in human cell lines and rodent models (Corpet et al., 1997; Hvid et al., 
2013; Sun and Jin, 2008; Tran et al., 2006).  
The author suggests that future investigations into PA and adenoma or CC risk 
using exercise as an intervention could utilise a HIIT approach in younger individuals 
with metabolic syndrome, given that this method appears to show the greatest effect 
in improving metabolic health, which is strongly linked with CC risk (Chen et al., 
2013; Giovannucci, 2007) and mortality (Wolpin et al., 2009) and presents far fewer 
time constraints for study participants, and, indeed, the general population. A prior 
investigation in men with metabolic syndrome demonstrated beneficially altered DNA 
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methylation in muscle and adipose tissue after high-intensity exercise training (Nitert 
et al., 2012; Ronn et al., 2013). Colon biopsies could be obtained before and after a 
similar intervention and markers of risk, including crypt proliferation and CGI 
methylation, can then be analysed. Given the increase in incidence of metabolic 
syndrome in the UK, this could prove a fruitful direction of investigation. 
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Supplementary material: Analysis of variance in change in methylation with change 
in physical activity, ΔPAEE 
 
1. Summary of ANOVA models: 390 white participants 
Study group of 390 white participants comprising 253 women and 137 men with the following mean (SD) 
characteristics at baseline: women were aged 70.7(4.0) years, with waist circumference 91.2 (13.2) cm 
and leisure time PAEE 1313 (1335) kcal/wk; men were aged 71.4 (4.3) years with waist circumference 
97.0 (10.0) cm and PAEE 2226 (2209) kcal/wk. 
 
1.1 TNF 
No power transformation 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.244 10 0.0244 1.97 0.0352 
Sex 0.009 1 0.0091 0.74 0.3913 
ΔPAEE 0.184 2 0.0922 7.45 0.0007 
Age 0.050 1 0.0498 4.02 0.0456 
ΔWaist 0.000 1 0.0003 0.02 0.8846 
Sex*ΔWaist 0.058 1 0.0581 4.69 0.0310 
Error 4.620 373 0.0124   
Total 5.220 389    
ANOVA table 
 
1.2 IL10 
No power transformation 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.480 10 0.0480 3.57 0.0002 
ΔPAEE 0.083 2 0.0413 3.08 0.0471 
Error 5.061 377 0.0134   
Total 5.644 389    
ANOVA table 
 
1.3 SERPINA5 
No power transformation 
Study group of 352 individuals (230 women and 122 men) 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.089 10 0.0089 1.66 0.0887 
Sex 0.003 1 0.0031 0.59 0.4447 
ΔPAEE 0.046 2 0.0228 4.27 0.0148 
Sex*ΔPAEE 0.050 2 0.0248 4.63 0.0104 
Error 1.798 336 0.0054   
Total 1.971 351    
ANOVA table 
  
Appendix Aii
Study group of 390 Caucasian participants comprising 253 women and 137 men with the following mean 
(SD) characteristics at baseline: women were aged 70.7 (4.0) years, with waist circumference 91.2 (13.2) 
and leisure time PAEE 1313 (1355) kcal/wk; men were aged 71.4 (4.3) years with waist circumference 
97.0 (10.0) cm and PAEE 2226 (2209) kcal/wk
Text
r  of ANOVA models: 390 Caucasian participants 
1.4 SNCG 
Transformation: (y + 0.65)1.4 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.537 10 0.0537 2.17 0.0190 
Sex 0.011 1 0.0112 0.45 0.5012 
ΔPAEE 0.001 2 0.0004 0.01 0.9853 
Sex*ΔPAEE 0.206 2 0.1031 4.16 0.0163 
Error 9.258 374 0.0248   
Total 9.946 389    
ANOVA table 
 
 
1.5 LINE1 
Transformation: (y+0.25)1.5 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.008 10 0.00082 1.64 0.0941 
Sex 0.000 1 0.00038 0.75 0.3862 
ΔPAEE 0.001 2 0.00069 1.38 0.2520 
Sex* ΔPAEE 0.004 2 0.00176 3.53 0.0302 
Error 0.187 374 0.00050   
Total 0.201 389    
ANOVA table 
 
 
2. Summary of ANOVA models: 390 white and 31 non-white participants 
Study group of 31 non-white participants comprising 19 women and 11 men with the following mean 
(SD) characteristics at baseline: women were aged 70.3(4.1) years, with waist circumference 93.0 (12.5) 
cm and leisure time PAEE 1118 (1391) kcal/wk; men were aged 70.8 (4.7) years with waist circumference 
99.2 (8.9) cm and PAEE 1277 (1290) kcal/wk. The 31 individuals belonged to the following racial groups: 
9 White Hispanics, 26 Black Americans; 1 Native American / Alaskan Native, 1 Asian / Pacific Islander, 
2 Other, and 1 Hispanic Other. The ANOVA tables correspond to model terms derived from the sub-
group of 390 whites and applied to the combined white and non-white participants.  
 
 
2.1 TNF 
No power transformation 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.253 11 0.0230 1.77 0.0570 
Sex 0.012 1 0.0116 0.89 0.3451 
ΔPAEE 0.152 2 0.0758 5.85 0.0031 
Age 0.028 1 0.0282 2.17 0.1411 
ΔWaist 0.000 1 0.0000 0.00 0.9641 
Sex*ΔWaist 0.062 1 0.0616 4.75 0.0299 
Error 5.225 403 0.0130   
Total 5.770 420    
ANOVA table 
 
  
2.2 IL10 
No power transformation 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.484 11 0.0440 3.22 0.0003 
ΔPAEE 0.081 2 0.0404 2.96 0.0532 
Error 5.566 407 0.0137   
Total 6.149 420    
ANOVA table 
 
2.3 SERPINA5 
No power transformation 
Study group of 382 individuals (249 women and 133 men) 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.091 11 0.0082 1.47 0.1413 
Sex 0.004 1 0.0042 0.75 0.3884 
ΔPAEE 0.054 2 0.0271 4.83 0.0085 
Sex*ΔPAEE 0.050 2 0.0248 4.42 0.0127 
Error 2.049 365 0.0056   
Total 2.241 381    
ANOVA table 
 
2.4 SNCG 
Transformation: (y + 0.65)1.4 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.644 11 0.0585 2.22 0.0128 
Sex 0.032 1 0.0319 1.21 0.2715 
ΔPAEE 0.006 2 0.0028 0.11 0.8995 
Sex*ΔPAEE 0.146 2 0.0728 2.76 0.0643 
Error 10.643 404 0.0263   
Total 11.420 420    
ANOVA table 
 
 
2.5 LINE1 
Transformation: (y+0.25)1.5 
 
Source Sum Sq. d.f. Mean Sq. F Prob>F 
Plate 0.009 11 0.00080 1.54 0.1156 
Sex 0.001 1 0.00070 1.34 0.2481 
ΔPAEE 0.001 2 0.00053 1.01 0.3634 
Sex* ΔPAEE 0.003 2 0.00132 2.53 0.0809 
Error 0.210 404 0.00052   
Total 0.224 420    
ANOVA table
3. Contingency Tables for change in DNA methylation (%
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Miss Kelly Semper:  
To be determined 
k.semper@uea.ac.uk 
 
 
    
 
 
 
 
Our       
Research 
Is aimed at finding ways to 
reduce your risk... 
 
If you are taking part in the NHS National Bowel Cancer 
Screening Programme then you may be eligible for our 
study. If you are interested, then please contact a member of 
the research team, or ask the screening nurse at NNUH about 
the ‘Active Lifestyle Programme’.  
Thank you. 
 
 
Bowel        
Cancer 
By taking part in a free 1-year 
physical activity programme 
with lifestyle workshops and 
free fitness tests...  
 
Miss Liane Thomas  
To be determined 
liane.thomas@uea.ac.uk 
Mr Barnabas Shaw:  
To be determined 
b.shaw@uea.ac.uk  
The Active  
Lifestyle Programme 
 
Is the second most 
common cancer 
diagnosed in the UK… 
 
Alternatively, please call the  
University of East Anglia Research Office: 01603 593098 
Version 2 13/04/2012012 
Appendix Bi
 Version 1 07/01/2013 
 
 
 
 
 
 
 
 The Effects of a 12 month Active Lifestyle Programme on patients diagnosed as 
being at increased risk of developing further polyps as determined by colonoscopy. 
 
 
Dear  
 
Re: Invitation to participate in an Active Lifestyle Study: What effect does physical activity 
have on exercise participation and bowel health?  
 
I am delighted to let you know about a new research study for people who are undergoing a 
colonoscopy. Consultants from the Gastroenterology Unit and health researchers from the 
University of East Anglia are working together to investigate how a structured exercise and 
educational programme affects exercise participation and bowel health.  
 
This study will be asking some eligible participants to undertake a programme of exercise and 
attend exercise-related educational workshops. We hope to gain a better understanding of how 
active lifestyle programmes like this impact upon physiological markers of bowel health and health 
behaviours. 
 
Please find enclosed a patient information sheet, which describes the study in more detail and 
answers the most frequently asked questions.  
 
If you are interested in the study please bring the tear off slip in the bottom of this letter with you to 
your appointment. A member of the study team (Mr Barnabas Shaw, Miss Kelly Semper or Mrs 
Liane Lewis) will be present at the NNUH on the day of  your colonoscopy to talk to you about the 
study should you be interested. This is entirely voluntarily and your treatment will not be effected 
should you decide not to meet one of the researchers.  
  
Yours sincerely, 
 
 
Mr. James Hernon 
Consultant Surgeon, Norfolk and Norwich University Hospital. 
…………………………………………………………………………………………. 
 
The Effects of a 12 month Active Lifestyle Programme on patients diagnosed as being at 
increased risk for developing further polyps as determined by colonoscopy. 
 
Yes. I am interested in the above named study. 
  
 
No, I am not interested in taking part in the study  
 
 
Name:   ___________________________ 
Telephone Number: ___________________________ 
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Consent Form – Initial Biopsies 
The Effects of a 12 month Active Lifestyle Programme on patients diagnosed 
as being at increased risk of developing further polyps as determined by 
colonoscopy. 
Thank you for your initial interest to take part in our study. You will soon be undergoing your 
colonoscopy at the Norwich and Norfolk University Hospital. 
Depending on the outcome of your colonoscopy, you may be eligible to take part in this 
research study. With your consent the surgeon will take five further small biopsy samples 
from your colon for research purposes. These samples will be anonymised and transferred to 
the Institute of Food Research by the research team.  
With your consent, we might store any leftover samples at a NHS approved tissue bank for 
future studies of bowel health after the study has finished for a period of 5 years. You can 
still take part in this study even if you do not consent to this tissue being stored, in which case 
the tissue will be destroyed after the study.    
As the additional research biopsies to be taken are small in size (2-3mm across), there is only 
a small risk that you will experience any adverse health effects from this procedure. Simple 
biopsies such as this carry a very small risk of perforation (tearing) of the bowel, and this 
occurs in less than 1 in 1000 cases.  
 Please initial box 
I confirm that I have read and understood the above information 
I consent for further tissue samples to be extracted during my colonoscopy for analysis 
purposes.  
I consent for these samples to be transferred to the Institute of Food Research by the research 
team. 
I consent for any leftover tissue extracted to be anonymously stored at a NHS approved tissue 
bank for future studies of bowel health after the study has finished for a period of five (5) 
years.  
 Name of Participant  Date  Signature 
Name of person taking  Date  Signature 
 informed consent 
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Consent Form – Initial Biopsies 
The Effects of a 12 month Active Lifestyle Programme on patients diagnosed 
as being at increased risk of developing further polyps as determined by 
colonoscopy. 
You will soon be undergoing your follow-up colonoscopy at the Norwich and Norfolk 
University Hospital. 
 
With your consent the surgeon will take five further small biopsy samples from your colon 
for research purposes. These samples will be anonymised and transferred to the Institute of 
Food Research by the research team.  
 
With your consent, we might store any leftover samples at a NHS approved tissue bank for 
future studies of bowel health after the study has finished for a period of 5 years. You can 
still take part in this study even if you do not consent to this tissue being stored, in which case 
the tissue will be destroyed after the study.    
 
As the additional research biopsies to be taken are small in size (2-3mm across), there is only 
a small risk that you will experience any adverse health effects from this procedure. Simple 
biopsies such as this carry a very small risk of perforation (tearing) of the bowel, and this 
occurs in less than 1 in 1000 cases.  
 
           Please initial box 
 
I confirm that I have read and understood the above information 
 
I consent for further tissue samples to be extracted during my colonoscopy for analysis 
purposes.  
 
I consent for these samples to be transferred to the Institute of Food Research by the research 
team. 
 
I consent for any leftover tissue extracted to be anonymously stored at a NHS approved tissue 
bank for future studies of bowel health after the study has finished for a period of five (5) 
years.  
 
 
 
   Name of Participant                           Date                                               Signature 
 
 
Name of person taking                         Date                                               Signature 
   informed consent 
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Dear  
 
Re: Invitation to participate in an Active Lifestyle Study: What effect does physical activity 
have on exercise participation and bowel health?  
 
I am delighted to let you know about a new research study for people who have undergone a 
screening colonoscopy. Consultants from the Gastroenterology Unit and health researchers from the 
University of East Anglia are working together to investigate how a structured exercise and 
educational programme affects exercise participation and bowel health.  
 
This study will be asking some eligible participants to undertake a programme of exercise and 
attend exercise-related educational workshops. We hope to gain a better understanding of how 
active lifestyle programmes like this impact upon physiological markers of bowel health and health 
behaviours. 
 
Please find enclosed a patient information sheet, which describes the study in more detail and 
answers the most frequently asked questions.  
 
If you are interested in participating in this study, please contact a member of the research team, and 
we can arrange a formal consultation at the University of East Anglia:  
 
Mr Barnabas Shaw BSc. MSc.  
Email: B.Shaw@uea.ac.uk 
Tel: 07933090196 
 
Mrs Liane Lewis BSc.  
Email: Liane.Thomas@uea.ac.uk 
Tel: 07933090197 
 
Miss Kelly Semper BSc. 
Email: K.Semper@uea.ac.uk 
 
Yours sincerely, 
 
 
 
 
 
 
 
 
Mr. James Hernon 
 
 
Consultant Surgeon, Norfolk and Norwich University Hospital. 
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                                          PATIENT CONSENT FORM 
                                                            The University of East Anglia 
 
 
The Effects of a 12 month Active Lifestyle Programme on patients diagnosed as being at 
increased risk of developing further polyps as determined by colonoscopy. 
 
Patient Identification Number for this study: 
Investigators: Consultant, Professor John Saxton, Students 
Name of patient:                                                                                                                           
1. I confirm that I have read and understood the Patient Information Sheet Version ____ 
dated ____/____/____ for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
2. I understand that my participation is voluntary and that I am free to withdraw at any time, without 
giving any reason, without my medical care or legal rights being affected.  
 
3. I understand that relevant sections of any of my medical notes and data collected during the study 
may be looked at by responsible individuals of the research team, where it is relevant to 
my taking part in this research. I give permission for these individuals to have access to 
my records. 
4. I consent for tissue collected during the study (i.e. venous blood, cheek swab and colon 
tissue) to be transferred to the Institute of Food Research for analysis purposes  
5. I agree to my G.P. being informed of my participation in the study. 
 
6. I agree to take part in the above study. 
 
7. I am aware that I may be contacted to be interviewed at 1 and 12 months. 
 
 
 
 
 
 
 
 
Name of Participant 
 
 
Date Signature 
Name of individual taking consent (if not researcher) 
 
 
Date Signature 
Researcher Date Signature 
 
Please initial 
box 
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Dear Dr Cooper 
 
Re: patient name (xx/xx/19xx) 
 
I am writing to inform you that xxxxx has consented to be contacted regarding  his involvement in an 
exercise intervention based at the University of East Anglia, supported by the Norfolk and Norwich 
University Hospital.  
The new project is aiming to identify the biological and psychological effects of a 12 month Active 
Lifestyle Programme on patients diagnosed as being at increased risk for developing further colon 
polyps at their screening colonoscopy. Alongside the 12 month exercise intervention, questionnaires 
to assess behavioural changes with regards to lifestyle factors will also be administered to each 
participant. As well as these procedures some participants may be asked to participate in interviews 
at the start and end of the intervention, and focus groups after trial completion to gain a more 
detailed account of personal experiences with both physical activity and the trial itself.  
 
If you have any concerns or questions regarding your patient participating in this study please do not 
hesitate to contact a member of the study team on 01603 593098. 
 
Yours Sincerely, 
 
Professor John Saxton 
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Patient Information Sheet 
 
The Effects of a 12 month Active Lifestyle Programme on patients diagnosed as being at 
increased risk for developing further polyps by their screening colonoscopy. 
 
 
We are inviting you to take part in our research study. Before you decide whether or not to take part we want you to 
understand why we are doing this research and what it will involve for you. This information sheet provides an 
overview of the study, and it should take about fifteen minutes to read. Please feel free to discuss the study with 
family and friends. If there is anything you are not clear about, the contact details of the researchers are provided at 
the end. We will happily go through the information sheet with you and answer any questions you have.  
 
We have compiled a list of Frequently Asked Questions (FAQs) which cover the main aspects of the research: 
 
What is the purpose of the study?  
 
Recently, some evidence has accumulated which suggests that people who have exercised regularly throughout 
their life might be at reduced risk of developing certain types of cancer, in particular colon (bowel) cancer. 
However, at the present time, we do not know whether a physically active lifestyle can have a positive effect on 
biological markers associated with colon cancer risk.  Also, we do not know how taking part in a programme like 
this affects exercise behaviour and attitudes towards exercising after colonoscopy screening.    
 
Therefore, we are aiming to find out whether an active lifestyle programme, incorporating supervised exercise 
sessions and healthy living workshops over a 12-month period has a positive impact on bowel health and exercise 
behaviour in people diagnosed with benign polyps or adenomas as a result of their screening colonoscopy. We also 
want to investigate if changes in exercise habits can affect physical function and feelings of well-being. 
 
Why have I been invited?  
 
You have been selected as being a potentially suitable participant as you have presented to the Norfolk and 
Norwich University Hospital on the National Bowel Cancer Screening Programme. We are looking to recruit 
participants from this population subject to the outcome of your test.   
 
Do I have to take part?  
 
Your participation is entirely voluntary. If you decide not to take part, this will not affect the standard of care you 
receive from the hospital or any other health professional. You are also free to withdraw from the study at any time 
without giving reason.  
 
 
What will happen to me if I take part/what do I have to do? 
 
If you decide to take part and you meet our inclusion criteria (i.e. the surgeon identifies you as being as either 
‘low’, ‘intermediate’ or ‘high’ risk for developing further polyps during the routine colonoscopy) you will have five 
small pinch biopsies taken from your colon, as well as any abnormal tissue that would be routinely removed. Once 
you have the results of your colonoscopy we will contact you to arrange a formal meeting with the research team at 
the University of East Anglia. If after the meeting you are still happy to take part, we will invite you to complete 
baseline tests. Afterwards, you will be randomly assigned to one of two groups; namely the Active Lifestyle 
Programme (ALP) or Usual Care (UC). You have an equal chance of being in either group. This is known as a 
randomised controlled trial, and we are running the study this way because we do not know which treatment is best. 
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You will be involved in the study for 12 months, and the total length of the research will be 2 years. The figure 
below outlines all of the procedures involved: 
 
 
Colonoscopy  
Excluded 
  Not meeting inclusion 
criteria  
   Declined to participate  
   Other reasons 
Randomization 
Included 
Meeting inclusion criteria 
(low, intermediate or high 
risk) 
 
 
 
Baseline tests 
Fitness test, Questionnaires, Blood 
samples 
 
Week 12-24  
One supervised exercise session per week 
Home-based exercise 4 times per week  
Lifestyle workshops every fortnight 
Week 0-12 
Two supervised exercise sessions per week 
Home-based exercise 3 times per week 
Lifestyle workshops every fortnight 
Active Lifestyle Programme (ALP) 
Encouragement to continue with their usual 
lifestyle habits in regards to physical activity.  
Usual care group 
Week 24 Repeated testing 
Lifestyle, physical activity,  
Body composition, Fitness test, 
Blood samples 
Supervised 
exercise 
Warm up 
Aerobic exercise 
Upper body 
strength 
Cool down 
 
Week 24-48  
Home-based exercise 5 times per week 
Monthly phone calls 
 
 
Week 12 Repeated testing 
Lifestyle and physical activity 
questionnaires 
Body composition 
Week 36 Repeated testing 
Lifestyle and physical activity 
questionnaires 
Body composition 
Week 48 Repeated testing 
Lifestyle, physical activity,  
Body composition, Fitness test, 
Blood samples 
Colonoscopy (high risk only) 
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The second colonoscopy at the end of the study only applies to those individuals diagnosed as ‘high’ risk at the first 
colonoscopy, which is routine. As before, the surgeon will take five further pinch biopsies as well as any abnormal 
tissue. We will monitor your physical activity levels, body composition, and diet, and ask both groups to complete 
questionnaires every 3 months. We will take venous blood samples from you and ask you to complete a fitness test 
every 6 months. The principal difference will be that the ALP group will aim to achieve 300 min per week of 
moderate to vigorous physical activity for the duration of the study; whereas UC will maintain their normal 
lifestyle habits. To help achieve this goal, ALP will receive 36 personal training sessions at the University of East 
Anglia over 6 months. This will be complemented by 12 lifestyle workshops at the University. You may also be 
asked to participate in a face to face interview at the start and end of the study, or a focus group after 12 months, 
subject to your consent. 
 
Can I expect any payment/reimbursement of costs? 
 
Unfortunately, we cannot offer any financial reward or cover any personal expenses. However, ALP will receive 
free personal training and lifestyle workshops, and we will make data pertaining to health such as body 
composition, cardiorespiratory fitness and diet analysis available to both groups at the end of the study.      
 
What are the treatment alternatives? 
 
Currently, there are no treatment guidelines for individuals diagnosed as being intermediate or high risk for 
developing further polyps, other than further screening colonoscopies.   
 
What are the possible disadvantages/risks of taking part? 
 
The potential for risks to occur will be minimised. We will make sure that you can safely complete the exercise 
sessions before you take part, so that the likelihood of anything untoward happening during the exercise will be 
minimal. Exercise protocols will be tailored to your needs and your heart rate will be monitored during the 
exercise. In the event that something does go wrong and you are harmed during the research study, there are no 
special compensation arrangements. If you are harmed and this is due to someone’s negligence then you might 
have grounds for legal action for compensation, but you could have to pay your legal costs. 
 
Are there any side-effects of taking part? 
 
If you haven't exercised for a while, and are part of the ALP group, physical activity might initially make you feel 
tired, and you could feel slightly breathless, but as you do it more regularly you will feel increasingly better.  
 
What are the possible benefits of taking part in this study? 
We cannot guarantee that you will benefit personally, but you will receive free fitness tests. The information which 
we will obtain might help improve medical care for patients at elevated risk like yourself.   
 
What happens when the research study stops? 
 
When the study finishes, we plan to publish the findings in a peer-reviewed scientific journal. We will not monitor 
you after your involvement in the study has finished. We will make data pertaining to health such as body 
composition, cardiorespiratory fitness and diet analysis available to both groups at the end of the study. If you are 
randomised to UC, you will be given the materials provided to ALP should you request them.    
 
What if there is a problem?  
 
In the event that something does go wrong and you are harmed during the research study, there are no special 
compensation arrangements. If you are harmed and this is due to someone’s negligence then you might have 
grounds for legal action for compensation, but you could have to pay your legal costs. 
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Will my taking part in the study be kept confidential?  
 
The confidentiality of our patients and the data which this study will generate is of utmost importance. All data 
from this study will be anonymised with a unique code during the study so the researcher analysing your data will 
be blinded as to your identity, which group you are in and to information collected during the study. This is one of 
the clauses, which you will sign in agreement on the official consent form. Our procedures for handling, processing 
and storage of and destruction of data are compliant with the Data Protection Act 1998.    
 
What if relevant new information becomes available?  
 
We will inform you if relevant new information becomes available which might affect the way we treat you. We 
will also discuss whether we need to make any amendments with the trial steering committee, which is responsible 
for the conduct of the research. 
 
What will happen if I do not want to carry on with the study?  
 
You are free to withdraw from the study at any time without giving reason, and this will not affect the standard of 
care you receive from the hospital or any other health professional. Should you wish, we can also destroy any 
identifiable data/tissue samples that we have collected from you.  
 
What if there is a problem?  
If you have any cause to complain about any aspect of the way in which you have been approached or treated 
during the course of this study, the Patient Advice and Liaison Service is available to you. In order to use this 
service you can choose one of the following options: 
  
Phone: 01603 289036  
Email: PALS@nnuh.nhs.uk 
Website: http://www.pals.nhs.uk/ 
 
Will my GP be notified?  
 
With your consent, we will write and inform your family doctor that you are taking part in this study. 
 
What will happen to any samples I give?  
 
Any tissue samples that you provide will be transferred to the Institute of Food Research, where we will analyse 
them for indicators of bowel health. They will be stored there for the duration of the study. Responses to 
questionnaires, physical activity, diet and fitness data will be stored and analysed at the University of East Anglia 
for the duration of the study.  
 
Will any genetic tests be done? 
 
There are several genes which are known to be involved with the development of bowel cancer. These genes can be 
affected by ageing, which may in turn affect the risk of developing the disease. We want to understand whether 
exercise can reverse the gene ageing process, and we will look for signs of this in the colon biopsies we obtain. We 
also would like to see whether any changes are reflected in other areas of the body, which is why we would like to 
analyse these genes in your blood and cheek cells. We will only analyse genes that are known to be implicated in 
bowel cancer, and we will not sequence your entire genome.          
 
What will happen to the results of the research study? 
 
We plan to publish the results of this study in a peer-reviewed scientific journal. However, you will not be 
personally identifiable from these results. In addition, the results from initial fitness testing and overall conclusions 
of the study will be available to you. Any further information will be available upon request. With your consent, we 
will anonymously store any leftover blood and tissue samples we collected from you at a NHS approved tissue 
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bank for a period of 5 years. These samples might be used for future research into bowel health. You can still take 
part in the study even if you do not wish to have any leftover tissue stored in this way, in which case they shall be 
destroyed once the study has finished. All of these procedures will be compliant with the Human Tissue Act 2004.   
 
Who is organising and funding the research? 
 
The research forms part of a PhD programme funded by the University of East Anglia. The research is being 
conducted in collaboration with the Norfolk and Norwich University Hospital and the Institute of Food Research.  
 
Who has reviewed the study? 
 
All research in the NHS is looked at by independent group of people, called a Research Ethics Committee, to 
protect your interests. This study has been reviewed and given favourable opinion by Norfolk Research Ethics 
Committee.  
 
Further information and contact details  
If you have any specific questions about the study, we will be more than happy to answer them for you.  
 
In the event of further questions please contact: 
 
Mr Barnabas Shaw BSc. MSc.  
Email: B.Shaw@uea.ac.uk 
07933090196 
 
Miss Liane Lewis BSc.  
Email: Liane.Thomas@uea.ac.uk 
07933090197 
 
Miss Kelly Semper BSc. 
 Email: K.Semper@uea.ac.uk 
 
 
Thank you for taking the time to consider participating in this study 
 
Prof John Saxton (Project co-ordinator), Tel: 01603 593098, Email: john.saxton@uea.ac.uk 
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Health Questionnaire 
Preventative Action against risk of Colon Cancer (PARC) 
 
Title:     
Name: 
 
 
Gender  M  F  
 
 
DOB (dd/mm/yyyy) : 
 
__ __/__ __/ __ __ __ __ 
 
Medical information 
1. Please tick if you suffer from, or have suffered from, any of the following:  
 
 Heart disease (e.g. angina, palpitations)   High blood pressure  Vascular disease (e.g. 
peripheral arterial disease, hypercholesterolaemia)  Stroke  Type 2 Diabetes  
 Pulmonary disease (e.g. asthma, COPD)   Inflammatory bowel disease (e.g. Crohn’s 
disease, ulcerative colitis)  Familial adenomatous polyposis (FAP)   Cancer  Seizures 
 Joint problems (e.g. arthritis)  Back pain   Other 
 
If you have ticked any of the above, please give details, including any treatments: 
 
 
 
 
 
 
 
2. Is there a history of colon cancer in your family  Yes  No 
 
If yes, please give details: 
 
 
 
 
 
 
Address: 
 
 
 
Postcode: 
Telephone number: 
 
Mobile number: 
 
Email: 
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3. Has your doctor advised you against taking regular exercise?  Yes  No 
 
If yes, please give any reasons why: 
 
 
 
 
 
 
 
 
4. Do you take any laxatives (e.g. bulking agents, stool softeners, irritants)? 
 Yes  No 
 
If yes, please give details as to the type of medication, the amount, and how often it is taken: 
 
Medication                                                Amount                                    Frequency (per week) 
 
 
 
 
 
 
 
 
 
 
 
 
5. Do you take any non-steroidal anti-inflammatory drugs (NSAIDS) (e.g. aspirin, 
ibuprofen)?  Yes  No 
 
If yes, please give details as to the type of medication, the amount, and how often it is taken: 
 
 
Medication                                                Amount                                    Frequency (per week) 
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6. Do you regularly take any other prescribed or over the counter medication?   
 Yes  No 
 
If yes, please give details: 
 
Medication                                                Amount                                    Frequency (per week) 
 
 
 
 
 
 
 
 
 
 
 
7. Do you smoke cigarettes?  Yes  No 
 
If yes, how many per day?: _____  
 
 
  
8. Do you drink alcoholic beverages?  Yes  No 
 
If yes, how often per week? 
  Less than once  Once  Twice  Three to six times  Daily 
Approximately how many units of alcohol do you drink per week (for reference, 1 pint of 
standard beer, lager or cider  =  ~ 3 units; a standard 175 ml glass of wine = ~ 2 units; and 
a single measure of a spirit = ~ 1 unit)?: _____   
 
9. What is your marital status? 
 
 Single  Partnered      
 Married  Separated      
 Divorced  Widowed 
 
10.   How many visits have you made to your GP in the past 12 months? 
Please state: ____ 
Thank you.  
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Health Questionnaire PARC- Physical Activity and Risk of Colon Cancer 
Participant ID: ____________________________   Date: ________________ Time point:      ____________________________ 
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Your Health and Well-Being 
 
 
The following survey asks questions about your general health, lifestyle behaviour in 
regards to exercise and diet and assesses your weekly physical activity habits. It is 
important that you answer EACH question of the following survey.  
 
1. In general, would you say your health is: 
Excellent Very good Good Fair Poor     
   1    2    3    4    5 
 
 
 
2. Compared to one week ago, how would you rate your health in general now? 
Much better 
now than 
one 
week ago 
Somewhat 
better 
now than 
one 
week ago 
About the 
same as 
one week ago 
Somewhat 
worse 
now than 
one 
week ago 
Much worse 
now than 
one 
week ago 
    
   1    2    3    4    5 
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3. The following questions are about activities you might do during a typical day.  
Does your health now limit you in these activities?  If so, how much?  
 
 
 Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
    
 a Vigorous activities, such as running, lifting  
heavy objects, participating in strenuous sports ......................  1 .............  2 .............  3 
 b Moderate activities, such as moving a table, pushing  
a vacuum cleaner, bowling, or playing golf.............................  1 .............  2 .............  3 
 c Lifting or carrying groceries ....................................................  1 .............  2 .............  3 
 d Climbing several flights of stairs .............................................  1 .............  2 .............  3 
 e Climbing one flight of stairs ....................................................  1 .............  2 .............  3 
 f Bending, kneeling, or stooping ................................................  1 .............  2 .............  3 
 g Walking more than a mile ........................................................  1 .............  2 .............  3 
 h Walking several hundred yards ...............................................  1 .............  2 .............  3 
 i Walking one hundred yards .....................................................  1 .............  2 .............  3 
 j Bathing or dressing yourself ....................................................  1 .............  2 .............  3 
 5 | P a g e  
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4. During the past week, how much of the time have you had any of the 
following problems with your work or other regular daily activities as a result of 
your physical health? 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
     
 a Cut down on the amount of  
  time you spent on work or  
  other activities ..................................  1 .............  2 ..............  3 ..............  4 .............  5 
 b Accomplished less than you  
  would like ........................................  1 .............  2 ..............  3 ..............  4 .............  5 
 c Were limited in the kind of  
  work or other activities ....................  1 .............  2 ..............  3 ..............  4 .............  5 
 d Had difficulty performing the 
  work or other activities (for  
  example, it took extra effort) ...........  1 .............  2 ..............  3 ..............  4 .............  5 
 
5. During the past week, how much of the time have you had any of the following 
problems with your work or other regular daily activities as a result of any 
emotional problems (such as feeling depressed or a nxious)? 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
     
 a Cut down on the amount of  
  time you spent on work or  
  other activities ..................................  1 .............  2 ..............  3 ..............  4 .............  5 
 b Accomplished less than you  
  would like ........................................  1 .............  2 ..............  3 ..............  4 .............  5 
 c Did work or other activities 
  less carefully than usual ...................  1 .............  2 ..............  3 ..............  4 .............  5 
 
6.   During the past week, to what extent has your physical health or emotional 
problems interfered with your normal social activities with family, friends, 
neighbours, or groups? 
Not at all Slightly Moderately Quite a bit Extremely     
   1    2    3    4    5 
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7. How much bodily pain have you had during the past week? 
None Very mild Mild Moderate Severe Very severe      
   1    2    3    4    5    6 
 
 
8. During the past week, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
Not at all A little bit Moderately Quite a bit Extremely     
   1    2    3    4    5 
 
 
9. These questions are about how you feel and how things have been with you 
during the past week.  For each question, please give the one answer that comes 
closest to the way you have been feeling.  How much of the time during the past 
week… 
 All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
     
 a Did you feel full of life? ..................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 b Have you been very nervous? ..........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 c Have you felt so down in the  
dumps that nothing could  
cheer you up? ...................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 d Have you felt calm and   
peaceful? ..........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 e Did you have a lot of energy? ..........  1 ..............  2 ..............  3 ..............  4 ..............  5 
 f Have you felt downhearted   
and low? ...........................................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 g Did you feel worn out? ....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 h Have you been happy? .....................  1 ..............  2 ..............  3 ..............  4 ..............  5 
 i Did you feel tired? ...........................  1 ..............  2 ..............  3 ..............  4 ..............  5 
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10. During the past week, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting with 
friends, relatives, etc.)? 
 
All of 
the time 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time     
   1    2    3    4    5 
 
 
11. How TRUE or FALSE is each of the following statements for you? 
 
 Definitely 
true 
Mostly 
true 
Don’t 
know 
Mostly 
false 
Definitel
y 
false 
     
 a I seem to get ill more 
easily than other people ..................  1 .............  2 .............  3 ...............  4 ..............  5 
 b I am as healthy as  
anybody I know ..............................  1 .............  2 .............  3 ...............  4 ..............  5 
 c I expect my health to  
get worse .........................................  1 .............  2 .............  3 ...............  4 ..............  5 
 d My health is excellent .....................  1 .............  2 .............  3 ...............  4 ..............  5 
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2. EXERCISE BEHAVIOUR 
 
WHY DO YOU ENGAGE IN EXERCISE? 
 
We are interested in the reasons underlying peoples’ decisions to engage, or not engage in 
physical exercise. Using the scale below, please indicate to what extent each of the following 
items is true for you. Please note that there are no right or wrong answers and no trick 
questions. We simply want to know how you personally feel about exercise.  
 
(1-19) Please circle one number on each line indicating how true each statement is for you.  
 
 
 
 
 
 
   
 
 
 
  Not 
true 
  for me 
Sometimes 
true for me 
Very true   
   for me 
1 I exercise because other people say I should 0 1 2 3 4 
2 I feel guilty when I don’t exercise 0 1 2 3 4 
3 I value the benefits of exercise 0 1 2 3 4 
4 I exercise because it’s fun 0 1 2 3 4 
5 I don’t see why I should have to exercise 0 1 2 3 4 
6 I take part in exercise because my 
friends/family/partner say I should 
0 1 2 3 4 
7 I feel ashamed when I miss an exercise sessions 0 1 2 3 4 
8 It’s important to me to exercise regularly 0 1 2 3 4 
9 I can’t see why I should bother exercising 0 1 2 3 4 
10 I enjoy my exercise sessions 0 1 2 3 4 
11 I exercise because others will not be pleased with me if 
I don’t 
0 1 2 3 4 
12 I don’t see the point in exercising 0 1 2 3 4 
13 I feel like a failure when I haven’t exercise in a while 0 1 2 3 4 
14 I think it is important to make the effort to  
exercise regularly 
0 1 2 3 4 
15 I find exercise a pleasurable activity 0 1 2 3 4 
16 I feel under pressure from my friends/family 
to exercise 
0 1 2 3 4 
17 I get restless if I don’t exercise regularly 0 1 2 3 4 
18 I get pleasure and satisfaction from  
participating in exercise 
0 1 2 3 4 
19 I think exercising is a waste of time 0 1 2 3 4 
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(20-29) With the next questions we want to know how confident you are right now that 
you could exercise 30min on most days of the week? 
 
  
    Not very  
  confident 
    Very  
  confident 
20 The weather was bothering you 0 1 2 3 4 5 6 7 8 9 10 
21 You were bored by the programme or activity 0 1 2 3 4 5 6 7 8 9 10 
22 You were not exactly sure what exercise to do 0 1 2 3 4 5 6 7 8 9 10 
23 You felt pain when exercising 0 1 2 3 4 5 6 7 8 9 10 
24 You had to exercise alone  0 1 2 3 4 5 6 7 8 9 10 
25 You did not enjoy it  0 1 2 3 4 5 6 7 8 9 10 
26 You were too busy with other activities 0 1 2 3 4 5 6 7 8 9 10 
27 You felt tired  0 1 2 3 4 5 6 7 8 9 10 
28 You felt stressed 0 1 2 3 4 5 6 7 8 9 10 
29 You felt depressed 0 1 2 3 4 5 6 7 8 9 10 
 
 
 
            
 
 
 
3. How much PHYSICAL ACTIVITY do you do? 
 
We are interested in finding out about the kinds of physical activities that people do as part of  
their everyday lives. The questions will ask you about the time you spent being physically 
active in the last 7 days. Please answer each question even if you do not consider yourself to 
be an active person. Please think about the activities you do at work, as part of your house 
and yard work, to get from place to place, and in your spare time for recreation, exercise or 
sport. Think about all the vigorous and moderate activities that you did in the last 7 days. 
Vigorous physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal. Moderate activities refer to activities that take moderate 
physical effort and make you breathe somewhat harder than normal.  
 
 
 
 Do not agree 
at all 
Completely 
agree 
33 I intend to exercise regularly over the next month   1 2 3 4 5 6 7 
34 I intend to exercise regularly over the next 6 months         
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PART 1: JOB-RELATED PHYSICAL ACTIVITY  
The first section is about your work. This includes paid jobs, farming, volunteer work,  
and any other unpaid work that you did outside your home. Do not include unpaid work you 
might do around your home, like housework, yard work, general maintenance, and caring for 
your family. These are asked in Part 3.  
 
1. Do you currently have a job or do any unpaid work outside your home?  
       Yes  
 
      No      Skip to PART 2: TRANSPORTATION 
 
The next questions are about all the physical activity you did in the last 7 days as part of 
your paid or unpaid work. This does not include traveling to and from work.  
 
2.  During the last 7 days, on how many days did you do vigorous physical activities 
like heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?  
Think about only those physical activities that you did for at least 10 minutes at a time.  
 
_____  days per week 
No vigorous job-related physical activity     Skip to question 4 
 
 
3. How much time did you usually spend on one of those days doing vigorous physical 
activities as part of your work?  
 
_____  hours per day 
_____  minutes per day 
 
4. Again, think about only those physical activities that you did for at least 10 minutes at 
a time. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads as part of your work? Please do not include 
walking.  
 
_____  days per week 
 
 No moderate job-related physical activity     Skip to question 6  
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5. How much time did you usually spend on one of those days doing moderate physical  
activities as part of your work?  
 
_____  hours per day 
_____  minutes per day 
 
6. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time as part of your work? Please do not count any walking you did to travel to or 
from work.  
 
_____  days per week 
 
 No job-related walking    Skip to PART 2: TRANSPORTATION 
 
7. How much time did you usually spend on one of those days walking as part of your  
work?  
 
_____  hours per day 
_____  minutes per day  
 
PART 2: TRANSPORTATION PHYSICAL ACTIVITY  
 
These questions are about how you traveled from place to place, including to places like 
work, stores, movies, and so on.  
 
8. During the last 7 days, on how many days did you travel in a motor vehicle like a 
train, bus, car, or tram?   
 
_____  days per week             
No traveling in a motor vehicle     Skip to question 10  
 
9. How much time did you usually spend on one of those days traveling in a train, bus,  
car, tram, or other kind of motor vehicle?  
 
_____  hours per day 
_____  minutes per day 
Now think only about the bicycling and walking you might have done to travel to and 
from work, to do errands, or to go from place to place.  
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10.  During the last 7 days, on how many days did you bicycle for at least 10 minutes at a  
time to go from place to place?   
 
_____  days per week  
 No bicycling from place to place      Skip to question 12  
 
11.  How much time did you usually spend on one of those days to bicycle from place to  
place?  
 
_____  hours per day 
_____  minutes per day 
 
12.  During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time to go from place to place?  
 
_____  days per week  
No walking from place to place    Skip to PART 3: HOUSEWORK,  
HOUSE MAINTENANCE, AND  
CARING FOR FAMILY  
13. How much time did you usually spend on one of those days walking from place to  
place?  
 
_____  hours per day 
_____  minutes per day 
 
PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY  
This section is about some of the physical activities you might have done in the last 7 days in  
and around your home, like housework, gardening, yard work, general maintenance work, 
and caring for your family.  
 
14. Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, chopping wood, shoveling snow, or digging in the garden 
or yard?  
 
_____  days per week  
 No vigorous activity in garden or yard    Skip to question 16  
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15.  How much time did you usually spend on one of those days doing vigorous physical  
activities in the garden or yard?  
 
_____  hours per day 
_____  minutes per day 
 
16.  Again, think about only those physical activities that you did for at least 10 minutes 
at a time. During the last 7 days, on how many days did you do moderate activities 
like carrying light loads, sweeping, washing windows, and raking in the garden or 
yard?  
 
_____  days per week  
  
No moderate activity in garden or yard     Skip to question 18  
 
17.  How much time did you usually spend on one of those days doing moderate physical  
activities in the garden or yard?  
 
_____  hours per day 
_____  minutes per day  
 
18.  Once again, think about only those physical activities that you did for at least 10 
minutes at a time. During the last 7 days, on how many days did you do moderate 
activities like carrying light loads, washing windows, scrubbing floors and sweeping 
inside your home?  
 
_____  days per week   
 
 No moderate activity inside home    Skip to PART 4: RECREATION,  
SPORT AND LEISURE-TIME  
PHYSICAL ACTIVITY  
19.  How much time did you usually spend on one of those days doing moderate physical  
activities inside your home?  
 
_____  hours per day 
_____  minutes per day  
 
PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY  
This section is about all the physical activities that you did in the last 7 days solely for  
recreation, sport, exercise or leisure. Please do not include any activities you have already  
mentioned.  
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20. Not counting any walking you have already mentioned, during the last 7 days, on how 
many days did you walk for at least 10 minutes at a time in your leisure time?  
 
_____  days per week  
 
 No walking in leisure time       Skip to question 22  
 
 
21.  How much time did you usually spend on one of those days walking in your leisure  
time?  
 
_____  hours per day 
_____  minutes per day  
 
22. Think about only those physical activities that you did for at least 10 minutes at a 
time. During the last 7 days, on how many days did you do vigorous physical 
activities like aerobics, running, fast bicycling, or fast swimming in your leisure time?  
 
_____  days per week  
 
     No vigorous activity in leisure time     Skip to question 24  
 
23. How much time did you usually spend on one of those days doing vigorous physical 
activities in your leisure time?  
 
_____  hours per day 
_____  minutes per day  
 
24.  Again, think about only those physical activities that you did for at least 10 minutes 
at a time. During the last 7 days, on how many days did you do moderate physical 
activities like bicycling at a regular pace, swimming at a regular pace, and doubles 
tennis in your leisure time?  
 
_____  days per week  
   
 No moderate activity in leisure time    Skip to PART 5: TIME SPENT  
SITTING  
25.  How much time did you usually spend on one of those days doing moderate physical 
activities in your leisure time? 
  
_____  hours per day 
_____  minutes per day  
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PART 5: TIME SPENT SITTING  
The last questions are about the time you spend sitting while at work, at home, while doing  
course work and during leisure time. This may include time spent sitting at a desk, visiting  
friends, reading or sitting or lying down to watch television. Do not include any time spent 
sitting in a motor vehicle that you have already told me about.  
 
26. During the last 7 days, how much time did you usually spend sitting on a weekday?  
 
_____  hours per day 
_____  minutes per day  
 
27.  During the last 7 days, how much time did you usually spend sitting on a weekend 
day?  
 
_____  hours per day 
_____  minutes per day  
 
28. During a typical 7-Day period (a week), how many times on the average do 
you do the following kinds of exercise for more than 15 minutes during your 
free time (write on each line the appropriate number). 
 
Times Per 
Week 
a) STRENUOUS EXERCISE 
(HEART BEATS RAPIDLY)                   __________ 
(e.g., running, jogging, hockey, football, soccer, 
squash, basketball, cross country skiing, judo, 
roller skating, vigorous swimming, 
vigorous long distance bicycling) 
 
 
b) MODERATE EXERCISE 
(NOT EXHAUSTING)                     __________ 
(e.g., fast walking, baseball, tennis, easy bicycling, 
volleyball, badminton, easy swimming, alpine skiing, 
popular and folk dancing) 
 
 
c) MILD EXERCISE 
(MINIMAL EFFORT)                    __________ 
(e.g., yoga, archery, fishing from river bank, bowling, 
horseshoes, golf, snow-mobiling, easy walking) 
 
2. During a typical 7-Day period (a week), in your leisure time, how often do you engage in any 
regular activity long enough to work up a sweat (heart beats rapidly)? 
 
OFTEN   SOMETIMES   NEVER/RARELY 
    1.       2.      3.   
 
Food diary 
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Record all foods and portion sizes you eat on four days of the week in the table below. The 
record should include at least one day of the weekend and three week days. Try to give as 
much detail as possible.  
 
Week day Type of food eaten Time eaten Portion size (in 
grams, cups, 
table spoons) 
e.g. Monday Semi-skimmed Milk 8:53am 250ml glass 
 Toast- white bread 8:55am 3 slices 
 Butter  8:55am 1 tsp 
 Cheddar cheese 8:55 30g 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 
Week day 
 
Type of food eaten 
 
Time eaten 
 
Portion size (in 
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grams, cups, 
table spoons) 
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
    
 18 | P a g e  
 Version 1 25/01/2012 
 
Week day Type of food eaten Time eaten Portion size (in 
grams, cups, 
table spoons) 
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What you should 
know... 
 
Colorectal cancer is the 
second most common 
cancer in the UK, but is 
also the most 
preventable. 
 
As with all cancers, the 
risk of developing colon 
cancer depends on a 
number of factors and 
varies from person to 
person.  
Many of the factors that 
increase our chances of 
developing the disease 
are linked to our way of 
life. 
This means that there are 
changes we can make to 
reduce our risk: 
- Healthy/fibre rich diet 
- Physical Activity 
- Maintain Healthy   
Weight 
- Limit Alcohol Intake 
and Cigarette Smoking.  
 
 
Some important 
Facts... 
 
x regular physical can 
reduce colon cancer 
risk by 24% 
 
x being overweight or 
carrying extra weight 
around your waist 
increases the risk of 
developing colon 
cancer 
 
x physical activity can 
help you to maintain 
a healthy body weight  
and therefore 
decrease your  risk of 
developing colon 
cancer 
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Understanding the science behind the 
benefits of exercise.... 
 
 
 
 
Elevated  levels of 
insulin are thought to be 
related to colon cancer 
risk. Physical activity 
has been shown to lower 
insulin levels and could 
therefore protect against 
colon cancer. 
 
Physical activity can help 
to  move food through the 
digestive system more 
efficiently. This can reduce 
exposure of the colon to 
potentially cancerous 
substances. 
The immune system also 
benefits from exercise. 
Regular physical activity 
can boost immune 
function to help  fight off 
disease. 
 
Did you know..? 
 
Being physically active 
for at least 30 minutes a 
day helps you feel and 
look better. It can even 
improve your mood and 
decrease stress levels. 
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Getting started... 
 
x Wear comfortable clothing 
x Bring suitable shoes (trainers) 
x Don’t exercise on an empty stomach but also leave 
time after a large meal (at least 2 hours) 
x Make sure you have plenty of fluids with you  
x Always handy to carry a small  snack in case it is 
needed 
Don’t worry if... 
 
x You have not exercised in the past- we are here to help 
you to settle in and familiarise you with the exercise 
equipment. As well as this we will tailor the exercise 
programme to your individual capabilities.  
x You feel breathless- this is normal, especially if you 
are not used to exercising. During the supervised 
exercise, a qualified exercise instructor will be present 
to monitor your condition. 
x Your muscles hurt after the exercise- this is also quite 
normal, frequent exercise will make your muscles 
adapt, which will result in increased in strength. 
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How much is enough? 
 
x Research shows that risk of colon cancer 
decreases with increasing amounts of 
physical activity 
 
x The minimum amount for health benefits is 
30 minutes of moderate to vigorous activity 
per day on most days of the week.  
 
x However, to maximise the health benefits of 
exercise, an attainable target of 300 minutes of 
moderate to vigorous physical activity per 
week is recommended. 
 
x Examples of moderate and vigorous physical 
activities are shown in the table below. 
 
x Physical activity does not have to happen in a 
gym. There are many alternative ways to be 
physically active.  
 
 
Moderate Intensity  Vigorous Intensity 
Cycling = Sweeping  Aerobics = Mow Lawn 
Swimming = Hoovering  Tennis = Climb Stairs 
Brisk Walk = Gardening  Jogging = Heavy Lifting 
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Raises 
Heart Rate 
Raises Body 
Temperature 
 
Increased 
Muscle 
Oxygen and 
Nutrient 
Supply 
PREVENTS: 
 
INJURY 
MUSCLE CRAMPS 
6 8- 9 10- 11 12 - 13 14- 15 16- 18 20 
Rest Very 
Light 
Light Moderate Hard Very  
Hard 
Extremely 
Hard 
 
Rate of Perceived Exertion (RPE) Scale  
WARMING 
UP 
Increases 
blood flow 
to muscle 
Structure of an Exercise Session 
Use the RPE Scale below to monitor how hard you exercise. 
Rate your exercise intensity on a scale of 6 (at rest) to 20 
(extremely hard). 
Try to aim for moderate to hard intensity throughout exercise. 
Use this scale to record your level of activity later on in the 
booklet. 
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H
E
A
D
 
 
T
O
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O
 
S
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G
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Warm Up  
5 – 10 minutes to gradually elevate heart rate. 
Mobilise your joints (see exercises below)  
Version 1 10/02/2012 
 
Main exercises 
Start your exercise at a low intensity (RPE 9-
10) and slowly build up over a period of 
10minutes until you reach RPE 13-15 
x Brisk walking 
x Slow cycling 
x Light jogging 
 
Keep a moderate to hard intensity for a 
minimum of 20-30 minutes, depending on 
how comfortable you feel. 
 
 
 
Cool down 
Stretch your muscles to avoid stiffness. 
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Strategies for 
success... 
 
x Try to build as much 
activity into your daily 
routine as possible. 
x Plan a minimum of 30-
minutes per day where 
you can be active...and 
stick to it, e.g. a brisk 
walk 
x Get friends and family 
involved in your daily 
activities. 
x Make sure you 
incorporate a variety of 
activities to avoid 
boredom. 
 
 
  
 
How to include exercise 
into my daily routine... 
 
E Try to take the stairs 
instead of the lift 
E Walk to the corner 
shop instead of 
driving. 
E Take the dog for 
long walks in the 
park. 
E Get off the bus one 
stop earlier. 
E Don’t use the remote 
control- get up and 
change the channel.  
How will I incorporate exercise into MY daily 
routine...?  
 
 
 
 
 
 
 
Is there anyone I could exercise with on a regular 
basis? 
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. 
My Goals 
Goal setting should be S.M.A.R.T. 
D Specific 
D Measurable  
D Attainable 
D Realistic 
D Timely 
 
I aim to increase my step count by 3000 
steps each day for the next month. 
My goals for the future 
Short term goals (by the end of the month) 
 
 
 
 
 
 
 
 
Long term (by the end of the intervention), i.e. how 
am I going to make sure that I remain physically 
active? 
“Failing to prepare, is preparing to fail” – John Wooden. 
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Overcoming Barriers... 
Support from 
Family and 
Friends 
- A bicycle ride with 
your family 
- Play with your grand 
children 
- Sunday afternoon 
walks 
 
Planning 
for success 
- Make specific activity 
diaries for each week 
- Adjust for unexpected 
circumstances 
- Check timetable of 
activities in your area 
and plan around these 
 Make 
housework 
fun 
- Do your housework to 
music you like 
- Gardening can be as 
strenuous as cycling 
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Ideas to get you started at home... 
 
GP Referral Scheme 
Ask your GP for details. 
The scheme offers a variety of activities in several centres in 
and around Norwich. You can choose from circuit training 
and aqua classes. 
Cost: £2.50 per class 
http://www.exercise-referral.co.uk/ 
 
Active Norfolk 
FREE lead group walks 
Exercise classes for over 50s 
Where: several locations around Norfolk 
http://www.activenorfolk.org/ 
Tel: 01603- 732 333 
 
Fitness in later life (FILL) 
Badminton 
Aerobic classes 
Walking, stretching and strengthening 
Where: Sportspark at University of East Anglia 
Costs:  £3.20 per class 
http://sportspark.co.uk/ 
Tel: 01603- 592 398 
 
Go4less 
This is a FREE discount card by Norwich City Council  
Up to 50% discount 
Can be used at a variety of fitness centres. 
- Riverside Leisure Centre 
- Norman Centre 
Available at Tourist Information in the Forum 
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Guided walks around Mousehold Heath 
Organised by Norwich City Council 
 
ATP Health and Fitness 
A mixture of exercise classes, from tailored 
programmes to structured sessions.  
Where: locations throughout Norwich 
Costs: £5 per class- special offers are available 
 
Eaton Community Centre 
Circuit Classes, Line Dancing 
Cost: £5 
Where: Eaton Park Community Centre 
www.friendsofeatonpark.co.uk/community.html 
Tel: 01603- 504 420 
 
Ask one of the instructors if you want any further 
details. 
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Week 1              Date Commencing……………. 
Day Activity, Duration (minutes) and RPE Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 2             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Physical Activity Diary     My Start Date...................... 
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Week 3             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 4             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 5             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 6             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 7            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 8             Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 9            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 10            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 11            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
 
Week 12            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 13            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
 
Week 14            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 15            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
 
Week 16            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 17            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 18            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 19            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 20            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 21            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 22            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 23            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 24            Date Commencing……………. 
Day Activity, Duration (minutes) 
and RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 25            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
 
Week 26            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 27            Date Commencing……………. 
Day Activity, Duration (minutes) 
and RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 28            Date Commencing……………. 
Day Activity, Duration (minutes) 
and RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 29            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 30            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 31            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 32            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 33            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 34            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 35            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
 
Week 36            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 37            Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 38           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 39           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 40           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 41           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 42           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 43           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 44           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 45           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Week 46           Date Commencing……………. 
Day Activity, Duration (minutes) and 
RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
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Week 47           Date Commencing……………. 
Day Activity, Duration (minutes) 
and RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday  
 Week 48           Date Commencing……………. 
Day Activity, Duration (minutes) 
and RPE 
Step 
count 
Monday   
Tuesday   
Wednesday   
Thursday   
Friday   
Saturday   
Sunday   
 
Version 1 10/02/2012 
 
 
Plot all your physical activities her ...
Version 1 10/02/2012 
 
 
Tell us what you think about the programme: 
 
What did you like? 
 
 
 
 
 
 
 
 
 
What would change? 
 
 
 
 
 
 
 
 
 
 
Any other comments? 
 
 
 
 
 
 
 
 
Version 1 10/02/2012 
Thank you for taking part in our study… 
If you have any queries, comments or suggestion 
please contact: 
Barnabas Shaw: B.Shaw@uea.ac.uk, 
   Tel: 07794474533 
Liane Thomas:   Liane.Thomas@uea.ac.uk 
   Tel: 07846986239 
Kelly Semper:    K.Semper@uea.ac.uk 
   Tel: 07557796917 
Project Supervisor: Prof John Saxton 
John.Saxton@uea.ac.uk 
   Tel: 01603-593098 
  
  
 
 
If you are:  
x male 
x aged 50-75 
x non-smoking 
x free of any current or previous bowel conditions (e.g. bowel cancer, polyps 
or  inflammatory bowel disease) 
x able to attend two morning, and two afternoon or evening visits (can be 
weekend days) at the University of East Anglia 
x prepared to do one fitness test and one exercise session 
x prepared to have 4 blood samples taken (4 teaspoons worth per occasion, 
on the morning visits) 
then you might be eligible. Please contact Mr Barney Shaw if you are interested, 
and we can post/email an invitation letter and a Participant Information Sheet. 
 
 
 
Barney Shaw: 
07933090196 
b.shaw@uea.ac.uk 
 
Thank you 
You can help 
 
Version 3 26/04/2013 
Our       
Research 
Is aimed at understanding how 
physical activity reduces the risk of 
the disease 
Bowel        
Cancer 
Volunteers needed! 
Is the third most common cancer 
diagnosed in the UK… 
By taking part in the ReGro (Regular 
exercise and colon cell Growth) 
study. Your involvement will be less 
than three weeks in total 
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RE: Does Regular and acute exercise affect Growth of colon cells (ReGro)? 
 
Thank you for your interest in the above study. Our research is investigating the links between 
exercise and bowel cancer risk.   
 
Please find enclosed a Patient Information Sheet, which explains the study in more detail and 
answers some of the most frequently asked questions. 
 
Please feel free to discuss this information with family and friends before making any decisions, 
however if you still have any further questions, please feel free to contact me on the addresses/ 
telephone numbers provided below. 
 
Yours sincerely, 
 
 
 
 
 
 
 
 
 
 
Barnabas Shaw 
 
 
 
 
 
 
Mr Barnabas Shaw, BSc., MSc. 
ENV 0.58 
School of Allied Health Professions 
Faculty of Medicine & Health Sciences 
University of East Anglia 
Norwich Research Park 
Norwich 
Norfolk 
NR4 7TJ 
Email: B.Shaw@uea.ac.uk 
Research telephone: 07933090196 
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Participant Information Sheet 
 
Does Regular and acute exercise affect Growth of colon cells (ReGro)? 
 
We are inviting you to take part in our research study (the ReGro study). Before you decide whether or not to take 
part we want you to understand why we are doing this research and what it will involve for you. This information 
sheet provides an overview of the study, and it should take about fifteen minutes to read. Please feel free to discuss 
this document with family and friends. If there is anything you are not clear about, the contact details of the 
researchers are provided at the end. We will happily go through the information sheet with you and answer any 
questions you have.  
 
We have compiled a list of Frequently Asked Questions (FAQs) which cover the main aspects of the research: 
 
What is the purpose of the study?  
 
Evidence suggests that people who have exercised regularly throughout their life might be at reduced risk of 
developing certain types of cancer, in particular colon (bowel) cancer. Secondly, bowel cancer survivors who 
exercise regularly are less likely to contract it again, and more likely to live longer. This might be related to 
changes seen in blood with physical exercise.  
 
We think that these changes make colon cancer less likely to develop and spread. We want to test this by treating 
colon cells with serum from blood obtained from people who exercise regularly and people who do not exercise 
regularly.   
 
Why have I been invited?  
 
You have been selected as being a potentially suitable participant as you have responded to an advertisement for 
the study and you fit the study inclusion criteria.   
 
Do I have to take part?  
 
Your participation is entirely voluntary. You are also free to withdraw from the study at any time without giving 
reason.  
 
What will happen to me if I take part/what do I have to do? 
 
If you decide to take part and you meet our inclusion criteria we will invite you for a meeting at the Exercise 
Science Laboratory at the University of East Anglia, answer any questions you might have, and take written 
informed consent (see below for a flowchart showing what will happen if you take part).  
After we take your consent we will ask you to complete two questionnaires: one about your general health which 
will take about 10 minutes to complete, and another about the amount of physical activity you have done 
throughout your life, which will take about one hour. Both will be completed at your informed consent meeting. 
 
 
 
 
Meeting at 
UEA 
Baseline 
measures 
Group 
allocation 
Group 1 Exercise 4 day rest Rest 
Group 2 Rest 4 day rest Exercise  
Fitness test, diet record, 
physical activity record 
Standardi
-sed 
breakfast 
Blood 
sample 
Blood 
sample 
Standardi
-sed 
breakfast 
Blood 
sample 
Blood 
sample 
Appendix Ciii
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At the end of your informed consent meeting, you will be given a 4 day food record (to record your normal diet, 
including alcohol and other liquids) and a physical activity record to complete, and a small device, called an 
accelerometer, to wear on your hip for one week. This is the size of a small matchbox, about the same weight, and 
records any movements you do. When you return (at least one week later later) we will take your  
x height 
x weight 
x blood pressure 
x body fat percentage  
x and perform an exercise stress test, which involves walking/running on a treadmill until you reach your 
exercise limit.  
 
This will be conducted in the presence of a medical professional who will ensure that it is safe for you to complete 
the test. These will be your ‘baseline measures’. You will also sign another consent form countersigned by the 
medical professional, which will permit us to take your blood during the study. We will make sure all of this can be 
completed at a time that suits you.   
 
After the tests, you will be randomly allocated into either Group 1 or Group 2 (as shown in the flowchart) 
 
At least 4 days later, you will arrive in the morning at the laboratory having not eaten for at least 10 hours. After 
you are rested and feel comfortable, the researcher (Mr Barnabas Shaw) will take a 16 ml (4 x 4 ml tubes) blood 
sample from your right or left arm (just above the crease of the elbow).  
 
Afterwards, you will consume a standardised breakfast consisting of a plain bagel, a sachet of butter and 
strawberry jam, an orange juice drink, and as much water as you like. You will then complete either an 
‘Exercise’ session on the treadmill, which will last for 45 min at continuous speed, or a ‘Rest’ session which will 
last for the same length of time depending on whether you are in Group 1 or 2.   
 
After the session has finished, you will be given the opportunity to shower and change. Exactly 1 hour after 
finishing the session, the researcher will take another 16 ml blood sample from the other arm.  
 
This process will be repeated at least 4 days later, with the only difference being that you will complete the session 
that you did not undergo first time round.  
 
Between the sessions, you will be asked not to do any other exercise for 4 days prior to the second session (other 
than that you would normally do with work). We will also ask you to consume the same foods you have already 
recorded on your 4 day record.   
 
Each time blood is taken, the yellow fluid in the blood (the ‘serum’) will be extracted, frozen and later used for 
treating the colon cells. We are planning to add the serum we collected from you to human colon cells (some of 
which are cancerous, others which are healthy). We will measure the growth of the cells and some of the factors 
produced by the cells which are associated with cancer risk and development after we add the serum. We think that 
changes in the serum caused by physical exercise (over a long period of training or after just one session) might 
affect growth and some of these factors.  
 
 
Can I expect any payment/reimbursement of costs? 
 
We will cover the cost of the standardised breakfast, travel costs and any parking charges you might incur.  
 
 
What are the treatment alternatives? 
 
We are not testing the effectiveness of exercise as a treatment for any disease in this study. This is an investigative 
study of the biological links between exercise and bowel cancer risk. 
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What are the possible disadvantages/risks of taking part? 
 
The potential for risks to occur will be minimised. We will make sure that you can safely complete the exercise 
sessions before you take part, so that the likelihood of anything untoward happening during the exercise will be 
minimal. The medical professional will not be present for the exercise session, but the intensity of the session is 
less than that of the exercise stress test, which is designed to find out whether you can safely complete the exercise 
session There will be at least two individuals who are immediate life support trained in the vicinity of the 
laboratory whilst you do the exercise session. This session is tailored based on your capability and your heart rate 
will be monitored during the exercise.  
 
In the event that something does go wrong and you are harmed during the research study, there are no special 
compensation arrangements. If you are harmed and this is due to someone’s negligence then you might have 
grounds for legal action for compensation, but you could have to pay your legal costs.  
 
Are there any side-effects of taking part? 
 
If you haven't exercised for a while, you might find the fitness test and exercise sessions demanding. However, we 
will ensure that you are physically capable of doing the exercise before taking part.  
 
What are the possible benefits of taking part in this study? 
We cannot guarantee that you will benefit personally, but the information which we will obtain might help improve 
our understanding of the link between exercise and bowel cancer.   
 
What happens when the research study stops? 
 
We will not monitor you after your involvement in the study has finished. We will make data pertaining to health 
such as body composition, cardiorespiratory fitness and diet analysis available at the end of the study.  
 
Will my taking part in the study be kept confidential?  
 
The confidentiality of our patients and the data which this study will generate is of utmost importance. All data 
from this study will be anonymised with a unique code during the study so the researcher analysing your data will 
be unaware of your identity, which group you are in and to information collected during the study. This is one of 
the clauses, which you will sign in agreement on the official consent form. As soon as your involvement in the 
study has finished (i.e. after your final laboratory visit) any personally identifiable information such as your name, 
address and telephone number will be destroyed. We plan to store non-identifiable data such as height, weight and 
fitness level, together with any serum samples at the Institute of Food Research, until the project has been 
completed, after which these will be destroyed. Our procedures for handling, processing and storage of and 
destruction of data are compliant with the Data Protection Act 1998.     
 
 
What if relevant new information becomes available?  
 
We will inform you if relevant new information becomes available which might affect how the study is run. We 
will also discuss whether we need to make any amendments with the trial steering committee, which is responsible 
for the conduct of the research. 
 
What will happen if I do not want to carry on with the study?  
 
You are free to withdraw from the study at any time without giving reason. Should you wish, we can also destroy 
any identifiable samples that we have collected from you.  
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What if there is a problem?  
If you have any cause to complain about any aspect of the way in which you have been approached or treated 
during the course of this study, then please contact the researcher (Mr Barnabas Shaw) in the first instance. 
Alternatively you can contact project co-ordinator (Professor John Saxton), or the Associate Dean for Postgraduate 
Research (Dr Christina Jerosch-Herold). All contact details are presented at the end of this document. 
  
Will my GP be notified?  
 
We will write and inform your family doctor that you are taking part in this study should you so wish, but if you are 
in otherwise good health this will not be necessary. However, if as a result of the exercise stress test an abnormality 
in your heart function is detected, we will inform your GP and recommend you visit them at the earliest possible 
opportunity. 
 
What will happen to any samples I give?  
 
The blood samples that you provide will be processed at the University of East Anglia Exercise Science 
Laboratory, and serum from this blood transferred to the Institute of Food Research, where we will use it for cell 
experiments and analyse it for indicators of bowel health. They will be stored there for the duration of the study. 
Responses to questionnaires, physical activity, diet and fitness data will be securely stored and analysed at the 
University of East Anglia for the duration of the study. Any leftover samples will be disposed of in accordance with 
the codes of practice at the University of East Anglia and Institute of Food Research. 
 
Will any genetic tests be done? 
 
No genetic data will be collected from you.  
 
What will happen to the results of the research study? 
 
We plan to publish the results of this study in a peer-reviewed scientific journal. However, you will not be 
personally identifiable from these results. In addition, the results from initial fitness testing and overall conclusions 
of the study will be available to you. Any further information will be available upon request.  
 
Who is organising and funding the research? 
 
The research forms part of a PhD programme funded by the University of East Anglia. The research is being 
conducted in collaboration with the Institute of Food Research.  
 
Who has reviewed the study? 
 
This study has been reviewed and given favourable opinion by University of East Anglia Faculty of Medicine and 
Health Sciences Ethics Committee.  
 
Further information and contact details  
If you have any specific questions about the study, we will be more than happy to answer them for you.  
 
In the event of further questions please contact: 
 
Mr Barnabas Shaw BSc. MSc. Email: B.Shaw@uea.ac.uk 
Research Tel: 07933090196 
 
Thank you for taking the time to consider participating in this study 
 
Prof John Saxton (Project co-ordinator), Tel: 01603 593098, Email: john.saxton@uea.ac.uk 
Dr Christina Jerosch-Herold (Associate Dean for Postgraduate Research), Tel: 01603 593316, Email: 
C.Jerosch-herold@uea.ac.uk  
 Version 2 13/02/2013 
 
  
PARTICIPANT CONSENT FORM 
The University of East Anglia 
 
 
Does Regular and acute exercise affect Growth of colon cells (ReGro)? 
Participant Identification Number for this study: 
Investigators: Mr Barnabas Shaw, Professor John Saxton, Dr Nigel Belshaw 
Name of participant:                                                                                                                           
1. I confirm that I have read and understood the Participant Information Sheet Version ____ 
dated ____/____/____ for the above study. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time, without giving any reason, without my medical care or legal rights being affected.  
 
3. I consent for samples collected during the study (i.e. serum from venous blood) to be 
transferred to the Institute of Food Research for analysis purposes  
 
 
4. I agree to take part in the above study. 
 
 
 
 
 
 
 
 
 
 
2 copies to be kept; 1 for site file, 1 for participant. 
 
Name of Participant 
 
 
Date Signature 
Name of individual taking consent (if not researcher) 
 
 
Date Signature 
Researcher Date Signature 
 
Please initial 
box 
Appendix Civ
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Time in 
minutes 
Activity 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Day: 
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Life Calendar 
 
 
Similar to timelines, life calendars are used to document events in your life as they 
occurred in time.  Research has shown that when questions are asked about events 
and activities from the past, life calendars can be very useful in helping you to 
remember these events more accurately.  
 
Our questionnaire will ask you about physical activity performed from the age of 21 
years onwards.  Therefore, to help you recall events, we will construct your own life 
calendar.  To do this we would like you to try and remember the year of certain 
important life events, both happy and sad.  We will ask you a set of questions to guide 
you, but you do not have to answer them if you feel uncomfortable. 
 
We will then use the calendar to refer back to whilst filling in the questionnaire.  
However, the details you give here will not be used as part of the research project and 
at the end of the interview the calendar will be yours to keep. 
 
All information you provide will be treated as confidential information.  
 
 
To know when to start your life calendar, we need to know:- 
 
1. What is your date of birth?.................................................................... 
 
2. What was the year was when you were 21 years old?................................ 
 
 
Life Calendar questions 
 
Housing 
1. What year did you buy your first house? 
2. Do you remember any other house moves or changes in location as 
particularly memorable? 
Education and Work 
3. Have you been a student at any time from the age of 21 years old? 
4. Do you have any memorable job or career changes from the age of 21 years 
old? 
Life Events 
5. If you are married, what year did you get married? 
6. If you have children, what year were they born? 
7. If you have grandchildren, what year were they born? 
8. Do you remember any significant deaths in your family or close friends? 
9. Have you ever been divorced? 
Health 
10. Do you remember any particular time when you were admitted to hospital 
or had a long period of time off work due to illness? 
11. Have you had any significant accidents or injuries that you remember? 
Holidays and Travel  
12. Are there any holidays you consider particularly memorable? 
13. Have you ever spent a longer period of time travelling abroad or around the 
country? 
Others  
14. Can you recall any other memorable events in your life, such as passing a 
test/exam or winning the lottery? 
Appendix Cvi
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Life calendar: Years 1959 – 2013 
Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1959 
 
 
 
 
 
 
 
 
1960 
 
 
Fidel Castro 
becomes Cuban 
Premier 
First sections 
of M1 
motorway 
opened 
 
Ben Hur wins 
Oscar for Best 
Picture 
Nigeria gains 
independence 
from UK 
Farthing 
removed from 
UK currency 
      
 
1961 
 
 
 
John F. 
Kennedy 
becomes 
President, 
Spurs do 
League and Cup 
double 
      
 
1962 
 
 
 
Telstar 
launched 
Marilyn Monroe 
found dead 
Pete Best 
replaced by 
Ringo Starr 
Cuban Missile 
crisis 
The ‘Big 
Freeze’ in the 
UK, 1962-63 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1963 
 
 
Beeching 
report 
published 
First Bond film 
(Dr No) 
released 
Martin Luther 
King ‘I have a 
dream’ speech 
JFK 
assassinated 
      
 
1964 
 
 
 
BBC2 starts 
broadcasting 
Daily Herald 
replaced by 
The Sun 
Harold Wilson 
becomes Prime 
Minister  
      
 
1965 
 
 
 
Winston 
Churchill dies 
      
1966 
 
 
Hosts England 
win football 
World Cup 
 
 
      
1967 
 
 
Beatles release 
Sgt Pepper’s 
Lonely Hearts 
Club Band 
(Summer of 
Love)  
Che Guevara 
captured in 
Bolivia 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1968 
 
 
Enoch Powell 
delivers ‘Rivers 
of Blood’ 
speech 
Robert F. 
Kennedy 
assassinated 
Black Power 
Salute from 
John Carlos 
and Tommie 
Smith at 
Mexico 
Olympics 
 
 
      
1969 
 
 
 
 
 
 
 
Apollo 11 Moon 
landing 
 
 
      
1970 
 
 
Apollo 13 
mission 
Beatles disband 
Brazil ’70 
World Cup 
 
      
1971 
 
 
Miners’ strike 
The Godfather 
released in 
cinemas 
UK currency 
goes decimal 
      
 
1972 
 
 
 
Bobby Fischer 
becomes world 
chess champion 
Munich Olympic 
massacre  
 
 
      
1973 
 
 
UK enters EEC 
Watergate 
scandal 
emerges 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1974 
 
 
Muhammad Ali 
defeats George 
Foreman in the 
‘Rumble in the 
Jungle’ 
      
 
1975 
 
 
 
Birmingham Six 
arrested 
Fall of Saigon 
signifies end of 
Vietnam War 
 
      
1976 
 
 
 
 
Raid on 
Entebbe, 
Agatha Christie 
dies, UK 
summer 
heatwave 
 
 
      
1977 
 
 
Red Rum wins 
3rd Grand 
National 
Elvis Presley 
dies 
 
      
1978 
 
 
John Paul II 
becomes Pope 
Hosts 
Argentina win 
World Cup  
 
 
      
1979 
 
 
Margaret 
Thatcher 
becomes Prime 
Minister 
Lord 
Mountbatten 
assassinated 
 
 
      
1980 
 
 
John Lennon 
shot 
Ronald Reagan 
becomes 
president 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1981 
 
 
Diana and 
Charles 
wedding, Anwar 
Sadat 
assassinated 
 
 
      
1982 
 
 
Falklands War 
 
 
      
1983 
 
 
USA invades 
Grenada 
 
      
1984 
 
 
World Aid 
following 
drought in 
Ethiopia 
 
      
 
 
1985 
 
 
 
 
Live Aid 
Concert at 
Wembley 
 
 
      
1986 
 
 
Space Shuttle 
‘Challenger’ 
disaster 
Maradona 
‘Hand of God’ 
 
      
1987 
 
Great storm of 
1987 
Black Monday 
 
      
1988 
 
 
Lockerbie 
Airline bomb  
 
 
      
1989 
 
 
Berlin wall 
destroyed 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1990 
 
 
Nelson Mandela 
released 
Margaret 
Thatcher 
resigns 
Gazza’s tears 
at Italia ‘90 
 
      
1991 
 
 
Gulf War       
 
1992 
 
 
 
European Union 
formed. 
Summer 
Olympics in 
Barcelona 
      
 
1993 
 
Waco massacre 
      
 
1994 
 
 
 
 
 
 
Nelson Mandela 
elected 
President of 
South Africa 
Channel Tunnel 
opens 
 
      
1995 
 
 
Kobe 
earthquake 
South Africa 
win Rugby 
World Cup 
 
      
1996 
 
 
Euro ’96 in UK, 
Summer 
Olympics in 
Atlanta 
 
      
1997 
 
 
Tony Blair 
elected Prime 
Minister, 
Princess Diana 
dies 
 
      
1998 
 
 
France win 
football World 
Cup 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
1999 
 
 
Euro currency 
established 
War in Kosovo 
Manchester 
United win 
Treble 
Millennium 
celebrations 
      
 
2000 
 
 
 
Concorde crash 
in Paris 
George Bush 
elected 
President 
 
      
 
2001 
 
 
 
September 11th 
attacks 
Foot and Mouth 
outbreak 
 
      
2002 
 
 
Queen 
Elizabeth II 
Golden Jubilee 
War in 
Afghanistan 
begins 
 
      
2003 
 
 
Iraq War 
begins 
 
 
      
2004 
 
 
Indian Ocean 
tsunami 
 
      
2005 
 
 
Pope John Paul 
II dies 
Labour wins 
third 
successive 
General 
Election 
 
 
      
2006 
 
Italy win World 
Cup in Germany 
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Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
 
2007 
 
 
 
iPhone released 
Benazir Bhutto 
assassinated 
      
 
2008 
 
 
 
Beijing  
Olympics 
Global Financial 
Crisis begins 
Barack Obama 
elected 
President 
 
 
      
 
2009 
 
 
 
Swine flu 
pandemic 
Michael 
Jackson dies 
 
 
      
2010 
 
 
Iceland volcano 
ash cloud 
Aung San Suu 
Kyi released 
Tory/Lib Dem 
coalition 
government 
formed 
      
        
 
2011 
 
 
 
Hosni Mubarak 
resigns, Colonel 
Gaddafi, Osama 
bin Laden killed 
Prince William 
and Kate 
Middleton 
married 
      
2012 
 
 
London 
Olympics 
Manchester 
City win 
football 
Premiership 
      
 
 
10 | P a g e  
Version 1 26/04/13 
Yr World Events Housing Education/Work Life 
Events 
Health Travel Others 
 
2013 
 
 
 
Pope Benedict 
XVI resigns 
Hugo Chavez 
dies 
Sir Alex 
Ferguson 
retires 
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Historical Adulthood Physical Activity 
Questionnaire (HAPAQ) 
 
Period between 21 and 29 years old 
  
Activity in and around the house  
 
Between the ages of 21 and 29 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
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Activity at work  
 
Between the ages of 21 and 29 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 21 and 29 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 21 to 29 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 60 and 69 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 60 to 69 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 60 and 69 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
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Period between 30 and 39 years old 
  
Activity in and around the house  
 
Between the ages of 30 and 39 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
    
 
  
 
 
 
16 | P a g e  
Version 1 26/04/13 
Activity at work  
 
Between the ages of 30 and 39 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 30 and 39 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 30 to 39 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 30 and 39 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 30 to 39 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 30 and 39 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
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Period between 40 and 49 years old 
  
Activity in and around the house  
 
Between the ages of 40 and 49 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
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Activity at work  
 
Between the ages of 40 and 49 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 40 and 49 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 40 to 49 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 40 and 49 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 40 to 49 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 40 and 49 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
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Period between 50 and 59 years old 
  
Activity in and around the house  
 
Between the ages of 50 and 59 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
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Activity at work  
 
Between the ages of 50 and 59 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 50 and 59 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 50 to 59 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 50 and 59 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 50 to 59 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 50 and 59 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
   
 
 
 
27 | P a g e  
Version 1 26/04/13 
 
 
Period between 60 and 69 years old 
  
Activity in and around the house  
 
Between the ages of 60 and 69 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
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Activity at work  
 
Between the ages of 60 and 69 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 60 and 69 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 60 to 69 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 60 and 69 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 60 to 69 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 60 and 69 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
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Period between 70 and 75 years old 
  
Activity in and around the house  
 
Between the ages of 70 and 75 years old, how many hours on average per day did you 
spend sitting at home? This includes activities such as eating, drinking, reading, 
doing needlework, listening to radio, watching TV. You should give a separate answer 
for working and non-working days. 
Hours per working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Hours per non-working day 
Up to 1 Up to 2 Up to 3 Up to 4 Up to 6 Over 6 
      
 
Did you do any regular housework? This includes preparing food, cooking, washing 
up, cleaning the house, doing the laundry and ironing. This should be on average at 
least one hour per day for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular DIY or house and car maintenance (excluding gardening)? 
This should be on average at least one hour per week for at least one year. 
Yes 
 
 No 
 
For how many years?       
Years  
 
Did you do any regular gardening? This includes mowing, watering, weeding, 
pruning, digging, chopping wood. This should be on average at least one hour per 
week for at least one growing season. 
Yes 
 
 No 
 
For how many growing seasons?       
Years  
 
Excluding travel to and from work, what form of transportation did you use most 
often to get about?  You can give more than one form of transport if you think you 
used them equally as much. 
Usual mode of travel 
Car / motor 
vehicle 
Walk Public transport Cycle 
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Activity at work  
 
Between the ages of 70 and 75 years old, how many years were you in each of the 
following occupations? 
 Years 
Student  
Employed (Paid and unpaid: voluntary work)  
Housewife/husband  
Retired  
Professional sport person  
Guide: The sum of years should not be over 10, unless the participant has been 
carrying 2 occupations the same time. 
 
I am now going to show you some pictures which demonstrate four different types of 
work classified depending on the intensity of physical activity involved.  
 
During this decade try to remember the type of activity your work involved, excluding 
housework.  Try to classify each job into one of these four categories, which ever is 
most representative of what you did.   
 
For each category, how many years of the decade did you hold such a job and how 
many hours per week on average did you work? 
 Years Months Hours per week 
Sedentary occupation    
Standing occupation    
Manual work    
Heavy manual work    
Guide: The sum of years should not be over the number of years previously indicated 
unless some works have been held concomitantly. 
 
For how many years did you work as a professional sports person? On average how 
many hours per week did you do this job? What sport was it?  
 Years Months Hours per week 
Sport:    
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Commuting to work  
 
Between the ages of 70 and 75 years old, regarding travel to and from your place of 
work or study, did you ever regularly travel by bike, at least once a week for at least 
one year? 
Yes 
 
 No 
 
For how many years did you do this?       
Years  
On average, how many journeys per week did you cycle, counting return journeys 
only?       
Number of journeys  
On average, how many miles was that return journey? 
Mileage  
 
Did you ever regularly travel to your place of work or study by foot, at least once a 
week for at least one year? 
Yes 
 
 No 
 
For how many years did you do this? 
Number of journeys  
On average, how many journeys per week did you walk, counting return journeys 
only? On average, how many miles was that return journey?   
Mileage  
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Sporting and Recreational Activity  
 
From the ages of 70 to 75 years old, did you do any regular sports in a competitive 
or strenuous nature? By this we mean it made you out of breath and/or sweat a lot. 
It must have been undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 70 and 75 years old? 
For how many years did you do this sport and on average how many hours per week? 
 Years Hours per 
week 
Minutes per 
week 
Swimming    
Cycling     
Running    
Football, rugby or hockey     
Cricket     
Volleyball, basketball or 
netball  
   
Racket sports     
Aerobics     
Fighting sports    
Other sport:    
Other sport:    
 
From the ages of 60 to 69 years old, did you undertake any regular sport 
or recreational exercise on a casual basis? This means it was not competitive 
and didn't make you out of breath and/or sweat a lot. It must have been 
undertaken for at least one hour per week for at least one year. 
Yes 
 
 No 
 
 
I am now going to show you some illustrations of different sports which may be 
undertaken on a competitive level.  
 
Can you identify your sport amongst these? If not what other sports did you do 
between the ages of 70 and 75 years old? 
For how many years did you do this sport and on average how many hours per week? 
 
 Years Hours per 
week 
Minutes per 
week 
Walking for pleasure    
Swimming for pleasure    
Jogging    
Conditioning exercises (Yoga, 
weights…) 
   
Golf    
Bowling    
Fishing or hunting    
Other exercise undertaken on a 
casual basis: 
   
Other exercise undertaken on a 
casual basis: 
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1. 
Sedentary occupation 
 You spent m
ost of your tim
e sitting (such as in an  
 office). 
 
  
2. 
Standing occupation 
You spent m
ost of your tim
e standing or w
alking. 
H
ow
ever, your w
ork does not require intense physical 
effort (e.g. shop assistant, hairdresser, guard). 
 
 
3. 
M
anual w
ork 
       This involved som
e physical effort including handling of 
       heavy objects and use of tools (e.g. plum
ber,  
       electrician, carpenter). 
 
 
4. 
H
eavy m
anual w
ork 
This im
plied very vigorous physical activity including  
handling of very heavy objects (e.g. dock w
orker, m
iner,  
bricklayer, construction w
orker). 
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SPORTS 
 
1. Swimming 
 
 
2. Cycling 
 
3. Running 
 
4.Football, rugby or 
hockey 
 
 
 
5. Cricket 
 
 
  
6. Volleyball, basketball 
      or netball 
 
 
 
7. Racket sports 
 
 
  
8. Aerobics 
 
9. Fighting sports 
 
10. Other sports  
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EXERCISES 
 
 
1. Walking for pleasure 
 
 
 
 
2. Swimming for Pleasure 
 
 
3. Jogging 
 
4. Conditioning exercises 
(e.g. yoga, weights etc) 
 
 
 
  
5. Golf 
 
 
  
6. Bowling 
 
 
 
  
7. Fishing or Hunting 
 
8. Other exercises 
 
 
 
 
